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ABSTRACT 
 
Development and Characterization of Silk based Bio-polymeric Porous 
Matrices for Tissue Engineering Applications 
 
Tissue engineering has emerged as a promising approach for the development of artificial body 
organs, repair, recover or improve tissue structures and functionality. 3D porous scaffolds 
possessing biomimicking properties are needed to support the neogenesis of tissues and mass 
transport of cells, nutrients and metabolic waste. Keeping this in view, the present dissertation 
work was undertaken for the development of SF based scaffolds with improved surface, 
mechanical and biological properties that can be used as artificial extracellular matrices for tissue 
regeneration. The silk fibroin was extracted from B. mori silk cocoon and the process was 
optimized by Response surface methodology using Box-Behnken Design. Porous SF and 
SF/PVA) blend scaffolds were prepared by salt leaching process and characterized for 
morphological (SEM), structural (XRD and FTIR), thermal (DSC and TGA) and mechanical 
(compressive strength) behaviour. The SF scaffolds were further modified with soluble eggshell 
membrane protein (SEP) with the aim of improving cell affinity for tissue regeneration. The pore 
size of the prepared SEP-SF and SEP-(SF/PVA) scaffold were in the range of 250-350µm and 
porosity of 90-93%. The measured compressive strength of SF and SF/PVA (50:50) scaffold 
were 279.8 ± 36.2 KPa and 235 ± 67.1 KPa respectively. The existence of soluble eggshell 
membrane protein on the scaffold surface, structural and thermal stability was confirmed by 
EDX, XRD, FTIR, DSC and TGA analysis. An increase in compressive strength of the prepared 
SF scaffolds was achieved by modification with SEP (321.5 ± 42.2 KPa for SEP-SF 
and247.5± 23.7 KPa for SEP-(SF/PVA) scaffolds). The cell culture study has indicated the 
significant improvement in cell adhesion and proliferation observed with hMSCs cultured on SF 
and SF/PVA scaffolds modified with SEP. The cyto-compatibility of the SEP conjugated SF 
scaffolds was confirmed by in-vivo animal model testing. This study has demonstrated that the 
biomimic property of SF scaffold can be enhanced by surface modification with SEP. Finally, it 
is concluded that the SEP conjugated SF/PVA (50:50) has the potential for use as artificial extra 
cellular matrix particularly for soft and other non-load bearing tissue engineering applications. 
 
Key Words: Biopolymer, Silk Fibroin, Tissue Engineering, Eggshell Membrane Protein, Surface 
Modification, PVA, Biocompatibility 
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GENERAL INTRODUCTION 
 
1.1. Background 
Millions of patients worldwide suffer from tissue or organ failures because of the consequencse 
of trauma, injury, systemic disorders, infection or other conditions that include transplantation, 
surgical repair and chemotherapy in few cases [Langer and Vacanti, 1993; Vacanti, 2006]. 
Tissue and organ failure accounts for approximately fifty percentage of total annual expenditure 
in health care in US [Lanza et al., 1993] and much lesser in India despite of the great need of 
expenditure that ultimately results in more number of patients death [Deolalikar et al., 2008]. 
Moreover, the current clinical treatment methods such as autologous or allogenic grafting suffer 
from several drawbacks including immune-rejection, disease transmission and lack of sufficient 
donor organs [Fuchs et al., 2001; Lanza et al., 2000; Saltzman et al., 2004]. As a result, none of 
these techniques can fully recover the structure and function of damaged and/or diseased tissue 
[Asnaghi et al., 2009]. In recent years, tissue engineering is considered as most promising 
approach to overcome these limitations through the development of an artificial functional tissue 
construct.   It has been reported that tissue engineering transplant having autologous cells can 
effectively surmount the limitations of direct transplantation including the graft rejection and 
disease transmission. Most importantly such approach reduces the requirement of donors [Minas 
et al., 1999; Dorfman et al., 1998]. However, the main challeneges lie in engineering a suitable 
polymeric matrix, cell with their regenerative potential and delivery of signalling molecules. In 
this context, the design and fabrication of three dimensional scaffolds from biocompatible and 
biodegradable materials with tailor properties is an essential component to regulate vital cellular 
function such as morphogensis, differntiation, proliferation, adhesion and migration. The 
material properties of the scaffods and its structural charatcteristics are time factors that can 
affect cellular behaviour and ultimately determine the performance of a tissue engineered 
construct [Sundelacruz et al., 2009]. It is further evident that a single biomaterial may not 
possess all the desired properties and hence the development of a suitable polymer blend or 
composite material with appropriate composition [Cai et al., 2002] is prime requirement.  
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1.2. General strategies for tissue regeneration 
 
Tissue engineering (TE) applies the principles and methods of interdisciplinary engineering and 
life sciences to fundamentally understand the tissue structure/function and their replacement. 
This medical approach offers remedy to existing problems through delivery of stem cells and 
bioactive molecules onto three dimensional (3D) artificial extracellular matrix [Langer and 
Vacanti, 1993]. During past two decades, most of the development in guided TE techniques has 
been based on either cells or matrices only. However, present trend in TE deals with a combination 
of both in addition to active macromolecules to achieve the target tissue. Thus, TE approaches can 
be classified on the basis of these three phenomena, either studied individually or in combination 
[Langer and Vacanti, 1993; Fuchs et al., 2001]: 
 
1.2.1. Cell and cell based therapies: Isolated cells are directly injected intravenous or into specific 
host organ in cell based TE approach. Injected cells in such approach utilize blood stream as source 
of nutrients and bioactive molecules while the host tissue matrix as cell support system for 
adherence, recognition and proliferation [Matas et al., 1976]. Pros of injection approach includes the 
cell specificity that is needed to be supplied, and avoids any kind of surgery complications. This 
approach has find application in restoring lost organ metabolic function. However, the application in 
replacement of organ structure/function is limited. The cell based in vivo repair can be enhanced by 
in vitro production of specific tissues. 
 
1.2.2. Inducing tissue regeneration by soluble bioactive factors: Bioactive signaling molecules 
such as low-molecular-weight (LMW) drugs, oligonucleotides and proteins (cytokines, 
chemokines, hormones, growth factors) that are capable of regulating specific cellular 
metabolism inside host. Such specific cellular response includes cell survival, growth, migration 
and differentiation of a specific subset of cells by triggering specific activation reaction in 
metabolic pathway [Chen et al., 2009]. Based on their cellular response, these signaling 
molecules can find place in overlapping classes of mitogens (stimulating cell division), growth 
factors (proliferation-inducing) and morphogens (controlling cell differentiation). Precise 
regulation of bioactivity of such signaling molecules at the damaged site may effectively control 
regeneration process. ECM (natural/synthetic) contains a wide range of adhesive molecules on 
interfacial surface to bind and modulate the bioactivity of signaling molecules [Discher et al., 
2005; Ramirez et al., 2003]. 
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1.2.3. Employing artificial support system (scaffold): In this approach, cellular or acellular scaffold 
system consisting of natural or synthetic biomaterial is implanted into the host. In cell culture study it 
has been found that detached adult cells tend to reform their original structures in different set of 
micro-environmental conditions [Folkman et al., 1980]. Isolated donor cells also have the potential for 
morphogenesis but limited when injected as a suspension into the host. This is primarily due to of 
absence of 3D support system immerged in a pool of bioactive molecules that provide in vivo 
microenvironment. In addition, implantation of larger tissue volume faces limited interaction with 
host environment for nutrients uptake, gas exchange and waste elimination. Such findings have lead 
to developing artificial tissue construct by attaching cells on scaffold templates.  
 
1.3. Overview of potential Tissue Engineering applications 
Tissue engineering aims at regenerating the diseased tissues (and organs as a future perspective) 
in vitro or through a combination of in vitro and in vivo processes and implanting the product at 
the diseased site to achieve full functionality. Improved healing processes and a higher quality of 
life are expected results, probably leading to lower costs of treatment in the long term. It offers 
the potential of a paradigm shift in medicine: new forms of therapy can be envisioned which 
allow the repair or regeneration of cells, tissues and organs which have lost their function due to 
disease, injury or congenital defects. Potential applications of tissue engineering are envisioned 
in the following fields: 
 
i. Skin, 
ii. Cartilage, 
iii. Bone, 
iv. Cardiovascular diseases, 
v. Organs, 
vi. Central nervous system, 
vii. Miscellaneous e.g. ligaments, tendon, skeletal muscle etc. 
 
Although tissue engineering research is being carried out in all these fields, only a very few 
products have already entered the market, and the present state of the art in science and 
technology does not allow a precise assessment which of these developments will finally yield 
new therapeutic options and commercially viable products. Therefore, a broad variety of 
information sources and methods has to be used for potential tissue engineering. 
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1.4. Tissue Engineering challenges and future prospects 
 
1.4.1. TE Research & Development 
The field challenge concerns acquiring a fundamental understanding of tissue differentiation 
mechanisms that might be harnessed for the development of tissue-engineered products. One 
product that the tissue engineering industry is pursuing is ―bone-on-demand,‖ to be used in cases 
where new bone formation is needed. One component is the availability of biomaterials that act 
as scaffolds for tissue repair and reconstruction, or for the deposition of engineered tissues and 
cells preceding implantation. Recent research is directed towards addressing these scaffolds with 
the goal of creating materials that have the desired functional properties for tissue engineering 
applications. For example, so-called blended-polymer scaffolds have an extended lifetime in the 
body that is more suitable for orthopedic applications than non-blended scaffolds [Spain et al., 
1998]. Development of new materials of this type that enable different applications of tissue 
engineering is likely to be the focus of considerable future research. For the biological 
component of tissue engineering, rapid advances are being made in identifying new cell types 
for use in tissue regeneration. For example, undifferentiated stem cells are attracting intense 
interest because of their capacity to be transformed into almost any cell type that may be needed. 
 
1.4.2. TE Clinical Barriers 
The ultimate goal of tissue engineering is to produce tissues that will function successfully for 
the lifetime of the recipient. According to Griffith and Naughton [Griffith et al., 2003] specific 
methods are needed to assess quantitatively the long-term outcome of engineered connective 
tissues, such as cartilage, tendon and blood vessels. Failure of these engineered tissues may be 
fetal. To date, tissue engineering has been successful in producing simple vascular tissues, such 
as skin and cartilage which are sufficiently thin to receive oxygen and other nutrients by passive 
diffusion [Malda et al., 2003]. Molecular diffusion is only relevant at very small length-scales, 
and thus found inadequate to support mass transfer in a thick tissues. A major obstacle in tissue 
engineering is the inability to maintain large masses of living cells upon transfer from the in vitro 
culture conditions into the host in vivo [Mooney et al., 1999]. In order to achieve complex-
engineered tissues and organs, vascularization of the regenerating tissue is essential. Vasculature 
and in particular capillaries, are required to supply essential nutrients to the cells, supplying 
oxygen, removing waste and providing a biochemical communication ―highway‖ [Koet al., 
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2007; Cassell et al., 2002; Eiselt et al., 1998; Nerem et al., 1998; Nguyen et al., 2001a; Nguyen 
et al., 2001b]. All tissues and organs (with the exception of a minority of tissues such as 
cartilage) need to be vascularized to be able to survive. 
  
1.4.3. Industrial Challenges 
Quality control of the materials used in various surgical applications is a key challenge for the 
tissue engineering industry. For example, living human cells are being used in scaffolds to repair 
structural tissue damage. These materials need to be produced and cultured under good 
manufacturing practice (GMP) conditions to meet FDA standards especially the cells that are 
grown ex vivo. As a result, the tissue engineering industry is striving to create appropriate quality 
control standards and evaluate them. 
 
1.4.4. Future Prospective of Tissue Engineering 
With the advancement of the concept of ―regenerative medicine‖ and in particular the field of 
tissue engineering a completely new form of medical treatment can be envisaged with the 
potential to change medical practice profoundly. Tissue engineering is emerging as a vibrant 
industry with a huge potential market. The biomaterials, scaffolds, artificial organs, and 
differentiating cells that are combined to create a tissue engineering product address significant 
medical needs, such as major tissue and organ damage or failure. The industry still faces 
numerous technical challenges including the establishment of a consensus quality control 
program that ensure the functionality and safety of tissue engineering products. Efforts to address 
these issues are underway, and if past success is any indication, this technology is certainly one 
that will have major impact in future health care practice. 
 
Tissue engineering has significant market potential and financial investment continues apace.  
The positive results regarding specific products and processes in clinical settings will support the 
R&D scenario of field. Technical advances in the various components of the industry will 
contribute to market growth. In future, efforts will likely increasingly focus on the development 
of tissue-engineered products under consensus safety and efficacy standards, including potential 
source of cells and tissues, characterization and testing of materials, quality assurance and 
control, preclinical and clinical evaluation [Omstead et al., 1998]. The FDA has already provided 
some regulatory guidance concerning specific materials, such as certain marketed artificial skin 
products; in the next few years, these guidelines will likely be increasingly formalized and 
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structured, ensuring that tissue engineering products not only work but are also safe. Significant 
future developments will include the continued development of artificial organs that use cells 
embedded into appropriate support structures.  The range of human tissue that can be engineered 
will also increase dramatically in the future, so in addition to the traditional targets, such as skin 
and liver, other tissues and organs will see their day. A great deal of excitement in clinical circles 
is that of developing artificial human thyroid tissues which are capable of producing T cells, and 
this will be a major area for continued R&D [Martin et al.,2000]. Finally, stem cells and their 
manipulation for therapeutic purposes will continue to be a major area of development, because 
of the pluripotency of these cells.  
 
1.5.  Silk as Ideal Biopolymer for Tissue Engineering 
In general, silks are defined as protein polymers that are produced by Lepidoptera larvae 
undergoing complete metamorphosis or adult forms eg. silkworms, spiders, scorpions, mites and 
flies [Altman et al., 2003] which differ at the molecular level. Silk has been of interest since its 
discovery in china in around 5000 years back and is being manufactured through sericulture 
across Asia and Europe. India is the second largest producer and largest consumer in the world 
[Giridhar et al., 2010]. The commercial interest of silk is not only for its textile properties such as 
texture, tenacity and dyeing butalso for its application in cosmetic products andpharmaceuticals 
[Brooks et al., 1989]. The wide application of silk as biomedical sutures over decades have 
shown path to their utilization as bio-polymeric scaffolds in tissue engineering. Besides the 
biocompatibility with host tissue, the mechanical strength of a biomaterial plays important role in 
scaffold designing [Li et al., 2002; Ko et al., 1998; Ko et al., 1999]. The viscoelastic nature of 
biological tissues confines the application of synthetic polymers since it has been observed that 
increase in strength compromises with toughness of synthetic polymers. Silk finds the ideal 
candidature for biomedical applications because of combined strength and toughness, primarily 
due to its antiparallel β pleated molecular structure. Among varieties of silk sources, those from 
silkworm silk (Bombyx mori) and spider silk (Nephila clavipes) are most extensively used for 
various applications. While the availability of Bombyx mori silk is abundant due to farming, the 
practice is almost impossible with Nephila clavipes because of their predatory nature. The 
progress in biotechnology have made possible to produce recombinant type spidroinin a variety 
of host organisms.This chapter deals with the silk protein from most common silkworm species, 
Bombyx mori and its application in bio-scaffold development for tissue regeneration. 
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1.5.1. Structure and composition 
 
Silkworm silk is commonly produced from the cocoons of domestic moths, Bombyx mori. Silk 
fibers are 10-25 μm in diameter. Each fiber consists of core protein covered by a coating of 
hydrophilic proteins called sericins (20–310 kDa) that glues core fibers together [Sinohara et al., 
1979; Kaplan et al., 1998; Zhou et al., 2000; Inoue et al., 2000]. The fibers are not circular in 
cross section but appear triangular as shown in Figure 1.1. Twenty-five to thirty percent of the 
silk cocoon mass is sericin, which is removed during the de-gumming process. The core protein 
consists of three chains: heavy chain (~390 kDa), light chain (~26 kDa) and a glycoprotein, P25 
(25 kDa) [Inoue et al., 2000].  The disulfide linkage between the Cys-c20 (twentieth residue from 
the carboxyl terminus) of the heavy chain and Cys-172 of the light chain holds the fibroin 
together and a 25 kDa glycoprotein, named P25, is non-covalently linked to these proteins 
[Tanaka et al.,1999]. Light chain is necessary for the secretion of protein from the silk glands. 
P25 is connected to both heavy and light chains by noncovalent interactions. P25 is necessary for 
the assembly of heavy and light chains [Inoue et al., 2000]. Heavy chain is fiber forming protein 
and its structure determines properties of silk fiber. Heavy chain is commonly referred as fibroin 
protein. Electrophoretic analyses of silk cocoons have revealed the presence of several minor 
proteins of unknown function. These low molecular weight proteins are classified as non-
structural silk proteins [Kodrik et al., 1992]. 
 
 The gene for the fibroin protein (H-fib gene) is located on 25th chromosome of Bombyx mori 
silkworm and consists of two exons and one intron [Zhou et al., 2000, Zhou et al., 2001]. A 
number of silk polymorphs have been reported, including the glandular state prior to 
crystallization (silk I), the spun silk state which consists of the β-sheet secondary structure 
(silk II), and an air/water assembled interfacial silk (silk III, with a helical structure) [Kaplan 
et al., 1998; Jin et al., 2003; Motta et al., 2002]. The silk I structure is the water-soluble state 
and upon exposure to heat or physical spinning easily converts to a silk II structure. The silk 
fibroin obtained from silkworm cocoon exists in silk II structure consisting of 5263 residues 
with molecular weight of 39.1kDa. The primary structure of heavy chain consists of 12 
repetitive regionscalled crystalline regions and 11 non-repetitive interspaced regions called 
amorphous regions [Zhou et al., 2001].  
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 The crystalline regions make up 94% of the sequence and each repetitive region in an average 
413 residues in length and consist of Gly-X repeats (X=Ala/ Ser/Thr/Val) [Zhou et al., 2001] 
forming hexapeptides sub-domain including: GAGAGS, GAGAGY, GAGAGA and 
GAGYGA as shown in table 1.1. These sub domains end with tetrapeptides such as GAAS or 
GAGS [Zhou et al., 2000; Zhou et al., 2001; Gage et al., 1980]. The repeat GAGAGS is the 
most frequently (70%) occurring hexapeptide repeat sequence. The crystalline repetitive 
region is responsible for the secondary structure (antiparallel β-pleated sheets) of the protein. 
Each crystal is on an average made up of 4 individual β strands each 11 amino acids long. The 
β strands are connected to one another by β turn made up of GAAS amino acids. The full 
form of abbreviations used for amino acids is given in appendix A. 
 
 The β-sheet structures are asymmetrical with one side occupied with hydrogen side chains 
from glycine and the other occupied with the methyl side chains from the alanines that 
populate the hydrophobic domains. The β-sheets are arranged in such a way that the methyl 
groups and hydrogen groups of opposing sheets interact to form the inter-sheet stacking in the 
crystals. Strong hydrogen bonds and van der Waals forces generate a structure that is 
thermodynamically stable [Kaplan et al., 1998]. The inter and intra-chain hydrogen bonds 
form between amino acids perpendicular to the axis of the chains and the fiber [Kaplan et al., 
1998].  
 
Table 1.1: Amino acid content of B. mori silk fibroin [Kaplan et al., 1998; Gandhi M.R., 2007] 
 
AAs content  Hexapeptide repeats content 
Gly 45.9% GAGAGS 70% 
Ala 30.3% GAGAGY 20% 
Ser 12.1% GAGYGA 6% 
Tyr 5.3% GAGAGA 4% 
Val 1.8%  
Other AAs 4.7% 
 
 The amorphous regions consist of 42-43 residues and are linkers between repetitive domains 
[Zhou et al., 2001]. The less crystalline forming regions of the fibroin heavy chain, also 
known as linkers, are between 42–44 amino acid residues in length. All the linkers have an 
Chapter 1: General Introduction 
 
10 
 
identical 25 amino acid residue (non-repetitive sequence) which is composed of charged 
amino acids not found in the crystalline regions [Zhou et al., 2001]. The primary sequence 
results in a hydrophobic protein with a natural co-block polymer design.  
 
1.5.2. Bio-relevant Properties 
1.5.2.1.  Physical properties 
 Silk fibres from the Bombyx mori silkworm have a triangular cross section with rounded 
corners, 5-10 μm wide. The fibroin-heavy chain is composed mostly of beta-sheets, due to a 
59 aminoacid repeat sequence with some variations [Lewin et al., 2006]. The flat surfaces of 
the fibrils reflect light at many angles, giving silk a natural shine. Silkworm fibres are 
naturally extruded from two silkworm glands as a pair of primary filaments (brin), which are 
stuck together, with sericin proteins that act like glue, to form a bave (Fig 1.1A. SEM 
photographs).  
 Silk has a smooth, soft texture that is not slippery, unlike many synthetic fibers. 
 Silk is one of the strongest natural fibres but loses up to 20% of its strength when wet. It has 
a good moisture regain of 11%. Its elasticity is moderate to poor if elongated even a small 
amount, it remains stretched.  
 Silk is a poor conductor of electricity and thus susceptible to static cling. 
 Natural and synthetic silk is known to manifest piezoelectric properties in proteins, probably 
due to its molecular structure [Fukada et al., 1983]. 
 An important feature of silk as a biomaterial, compared with other fibrous proteins such as 
collagen, is the versatility of options for sterilization [Sugihara et al., 2000]. Sterilization of 
silk fibroin scaffolds by autoclaving does not change morphology [Meinel et al., 2004a] or β-
sheet structure when heated to 120°C [Furuzono et al., 2004]. Comparatively, collagen 
denatures at these temperatures [McClain et al., 1972]. Silk fibroin scaffolds can also be 
sterilized using ethylene oxide [Altman et al., 2003], γ-radiation, or 70% ethanol 
[Karageorgiou et al., 2004; Li et al., 2006]. 
 
1.5.2.2. Chemical properties 
 The high proportion (50%) of glycine, which is a small amino acid, allows tight packing and 
the fibers are strong and resistant to breaking. The tensile strength is due to the existence of 
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many inter seeded hydrogen bonds that works when fibres are stretched, resisting breakage 
due to the applied force. 
 Silk is resistant to most mineral acids, except sulfuric acid. Silk becomes yellow in colour by 
perspiration. 
 The silk I structure is observed in vitro in aqueous conditions and converts to a β-sheet 
structure when exposed to methanol or potassium chloride [Huemmerich et al., 2006].  
 The silk II structure excludes water and is insoluble in several solvents including mild acid 
and alkaline conditions, and several chaotropes. Silk is insoluble in most solvents, including 
water, dilute acid or dilute alkaline solutions. 
 
1.5.2.3. Mechanical Properties 
The properties of silk are due to the extensive hydrogen bonding, hydrophobic nature of protein, 
and significant crystallinity. The elastic modulus of Bombyx mori silk is 15-17 GPa and has a 
tensile strength of 610-690 MPa [Altman et al., 2003]. While spider silk has strength as high as 
1.75 GPa with a breaking elongation of over 26%. The geometry and mechanical properties are 
important design criteria for Tissue engineering scaffolds. The study conducted by Altman G.H. 
et al [Altman et al., 2003] is summarized in table 1.2. It indicates that the tensile strength of silk 
is much higher than polylactic acid (PLA) which is most commonly used biomaterial. PLA has 
the tensile strength of 28-50 MPa. In tissue engineering, scaffolds provide initial framework for 
the cells to grow and attach. The strength should be high enough to withstand initial loading 
conditions. Tendon and bone has the tensile strength of 150 and 160 MPa respectively. PLA with 
the low tensile strength is not able to provide strong support for the tendon or bone cells to 
proliferate. Cross linked collagen with the tensile strength of 47-72 MPa is also not strong 
enough. Silk which is much stronger than PLA and cross linked collagen, will provide enough 
support. 
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Figure 1.1: (A) SEM image showing cross section of Bombyx mori silk fiber (B) structure of silk 
fibre and (C, D)  the schematic of structure of Bombyx mori silk fibroin protein. The primary 
structure consists of 12 repetitive regions interspaced by 11 non-repetitive regions. The 
repetitive region is responsible for the formation of β-sheets crystals while the non-repetitive 
region forms the amorphous part of the protein. 
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Table 1.2: Comparison of mechanical property of B. mori silk fiber with other biomaterial fibers 
and tissues [Gosline et al., 1999; Cunniff et al., 1994]  
 
Fibre UTS (MPa) Elastic 
Modulus(GPa) 
% Strain at 
break 
B. mori silk 740 10 20 
Spider silk 875-972 11-13 17-18 
Tendon 
(comprised of 
mainly collagen) 
150 1.5 12 
Bone 160 20 3 
Kevlar 49 fiber 3600 130 2.7 
Synthetic Rubber 50 0.001 850 
 
 
1.5.2.4.  Biological Properties  
Apart from the geometry and mechanical properties; biocompatibility and biodegradation are 
important considerations for the fabrication of scaffolds. Silk materials are of considerable 
interest due to their structural properties and superior biocompatibility. 
 
1.5.2.4.1. Biocompatibility 
There were several concerns regarding the biocompatibility of silk from Bombyx mori. Sutures 
made from virgin silk compared with sutures from de-gummed silk showed differences in 
hypersensitivity [Altman et al., 2003]. The inflammatory response of de-gummed silk fibroin in 
vitro compared with polystyrene and poly(2-hydroxyethyl methacrylate) showed less adhesion of 
immuno-competent cells [Santin et al., 1999]. Virgin silk (fibroin containing sericin gum) is 
potential allergen but degummed silk in which sericin is removed is biocompatible. Sericin, a 
glue-like protein that holds the fibroin fibres together, has been identified as the source of 
immunogenic reactions [Soong et al., 1984, Panilaitis et al., 2003]. Numerous in vitro studies 
have demonstrated that once sericin is extracted, fibroin supports cell attachment and 
proliferation for a variety of cell types [Gupta et al., 2007; Roh et al., 2006; Servoli et al., 2005; 
Minoura et al., 1995; Jin et al., 2004; Inouye et al., 1998].  In vitro evaluation of degummed 
fibroin demonstrates that the interactions of fibroin with the humoral components of the 
inflammatory system are comparable with those of polystyrene and poly (2-hydroxyethyl 
methacrylate), the two materials used extensively for biomedical applications [Santin et al., 
1999]. Silk films implanted in vivo induced a lower inflammatory response than collagen films 
and PLA films [Meinel et al., 2005]. Silk fibroin non-woven mats implanted subcutaneously in 
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rats induced a weak foreign body response and no occurrence of fibrosis. There was little 
upregulation of inflammatory pathways at the implantation site and no invasion by lymphocytes 
after six months in vivo [Dal et al., 2005].  
 
1.5.2.4.2. Biodegradation 
      The degradation of biomaterials is important in terms of restoring whole tissue structure and 
function in vivo. Control over the rate of degradation is an important feature of functional tissue 
design, such that the rate of scaffold degradation matches the rate of tissue growth [Lanza et al., 
2000]. Silk fibroin fibers retain more than 50% of their mechanical properties after two months 
of implantation in vivo; thus, they are defined as a non-degradable biomaterial by the United 
States Pharmacopeia [Horan et al., 2005]. Natural polymers like collagen and silks degrade via 
the action of proteases. The rate of silk fibroin degradation depends upon the structure, 
morphology, mechanical and biological conditions at the location of implantation. Degradation 
studies involving the systematic exposure of silkworm silk to enzymes have found that silk will 
degrade as a result of proteolysis [Taddei et al., 2006], with protease being reported to have the 
greatest effect [Arai et al., 2004; Horan et al.,2005; Li et al., 2003]. A correlation between in 
vitro and in vivo rates of degradation of silk fibroin fibers has also been established [Horan et al., 
unpublished]. Arai et al. [Arai et al., 2004] compared degradation of silk fibers with silk films 
when exposed to different amounts and types of enzymes. Silk fibroin porous sponges from 
regenerated B. mori fibers degraded differently with different processing conditions [Kim et al., 
2005c]. Silk fibroin degradation could be regulated by changing crystallinity [Minoura et al., 
1990a], pore size, porosity, and molecular weight distribution (MWD) of the silk fibroin. A 
change in MWD can be achieved by treating silk fibroin under alkaline conditions and heat. A 
decrease in MWD may disrupt ordered structures and reduce cross-links, potentially resulting in 
faster degradation. It will be useful to understand the mechanism and correlation of silk fibroin 
degradation with mechanical properties. The degradation of silk fibroin material also depends on 
the processing method for biomaterial development. The degumming process may cause 
unwanted degradation of fibroin [Jiang et al., 2006] while methanol treatment may significantly 
reduce the rate of degradation [Minoura et al., 1990b; Uebersax et al., 2006]. Fibroin films are 
reported to experience more significant degradation than fibres [Arai et al., 2004] and aqueous-
derived silk fibroin  scaffolds degrade more rapidly than hexa-fluoro  isopropanol (HFIP) 
derived scaffolds [Kim et al., 2005c], possibly due to increased surface area. The potential to 
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manipulate the rate of degradation is important for tissue engineering applications, and control 
over the physical form and post-treatment of a silk biomaterial may allow tailoring of the 
degradation. In the case of bone, for example, the ability of a scaffold to maintain structural 
integrity over an extended period of time is crucial as it allows mass transport of nutrients and 
waste products while bone ingrowth, matrix deposition and remodelling occurs and a vascular 
network is formed. In other situations, such as wound healing, more rapid degradation may be 
desirable. Silkworm silks have similar structural characteristics to amyloid [Li et al., 2001] and 
dissolved fibroin has been reported to accelerate amyloid accumulation in mice [Lundmark et al., 
2005]. The presence of amyloids in the body has been linked with neuro-degenerative diseases 
including Alzheimer‘s and Parkinson‘s.  
 
1.5.3. Control of morphology of silk biomaterials 
Several different material morphologies can be formed from aqueous or solvent formulations of 
the natural fiber form of silk for utilization as biomaterials in biomedical applications. The fibers 
must first be dissolved in aqueous systems, followed by reprocessing into desired material 
formats. The processibility of silk into a number of forms provides flexibility in their application 
for different kinds of tissue engineering. The commonly applied forms of native silk may be 
classified as below:   
 
1.5.3.1. Silk fibers—Silk fibers can be obtained by reeling from silkworm cocoons [Kaplan et 
al., 1998]. Sutures braided from silk fibers have been used for centuries in gummed (virgin) and 
de-gummed (black braided silk) forms as sutures for surgical options [Altmanet al., 2003]. A 
thorough review of the utilization of virgin and black braided silk (coated with silicone or wax to 
prevent fraying) and associated immune responses has been previously described [Altman et al., 
2003]. Silk sutures have been used for tendon tissue engineering [Kardestuncer et al., 2006]. 
Sutures modified with immobilized Arg-Gly-Asp (RGD) peptide to increase cell attachment, 
were cultured with human tenocytes and supported increased adhesion after 3 days when 
compared with unmodified silk fiber and tissue cultured plastic [Kardestuncer et al., 2006]. An 
increase in collagen type I and decorin transcript levels was observed on the RGD-modified 
sutures compared with unmodified silk and tissue culture plastic at six weeks [Kardestuncer et 
al., 2006].  
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1.5.3.2. Non-woven silk fibroin mats—Non-woven mats are of interest due to the increased 
surface area and rougher topography for cell attachment. Silk fibroin has been used to generate 
non-woven silk mats from reprocessed native silk fibers or by electrospinning. Electrospun fibers 
can be produced in a wide range of diameters, ranging from a few nanometers to a few microns 
depending on the mode of processing [Reneker et al., 1996]. Electrospinning of aqueous silk 
fibroin solution mixed with poly(ethylene oxide) (PEO) was established and fiber morphology 
based on scanning electron microscopy (SEM) analysis showed uniform fibers less than 0.8 μm 
in diameter [Jin et al., 2002]. hMSCs cultured on these mats showed attachment and spreading 
[Jin et al., 2004]. Silk fibroin mats prepared from formic acid with fiber diameters averaging 100 
nm showed a Young‘s modulus of 515 MPa, ultimate tensile strength (UTS) of 7.25 MPa and 
strain of 3% [Ayutsede et al., 2005]. Electrospun non-woven meshes can be prepared as 
predominately random coil structure from which β-sheet structures can be formed via methanol 
treatment [Min et al., 2004]. 
 
1.5.3.3. Silk fibroin films—Silk fibroin films have been cast from aqueous or organic solvent 
systems, as well as after blending with other polymers. Silk films prepared from aqueous silk 
fibroin solution had oxygen and water vapor permeability dependent on the content of silk I and 
silk II structures [Minoura et al., 1990a, 1990b]. Alteration of silk structure was induced by 
treatment with 50% methanol for varying times. Changes in silk structure resulted in differing 
mechanical and degradability properties of the films [Minoura et al., 1990b]. Nanoscale silk 
fibroin films can also be formed from aqueous solution using a layer-by-layer technique [Wang 
et al., 2005]. These ultrathin films were stable due to hydrophobic interactions and predictable 
film thickness could be obtained based on control of solution conditions.  
 
1.5.3.4. Silk fibroin hydrogels—Hydrogels are three-dimensional polymer networks which are 
physically durable to swelling in aqueous solutions but do not dissolve in these solutions. 
Hydrogel biomaterials provide important options for the delivery of cells and cytokines. Silk 
fibroin hydrogels have been prepared from aqueous silk fibroin solution and are formed from β-
sheet structures [Kim et al., 2004; Ayub et al., 1993]. An increase in silk fibroin concentration, 
increase in temperature, decrease in pH, and an increase in Ca
++
 concentration decreased the time 
of silk fibroin gelation. Hydrogel pore size was controllable based on silk fibroin concentration 
and temperature [Kim et al., 2004].  
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1.5.3.5. Silk fibroin porous sponges—Porous sponge scaffolds are important for tissue 
engineering applications for cell attachment, proliferation, and migration, as well as for nutrient 
and waste transport. Regenerated silk fibroin solutions, both aqueous and solvent, have been 
utilized in the preparation of porous sponges. Sponges have been formed using porogens, gas 
foaming, and lyophilization [Nazarov et al., 2004]. Solvent-based sponges were prepared using 
salt or sugar as porogen. Solvents like 1,1,1,3,3,3-hexafluroisopropanol (HFIP) do not solubilize 
salt or sugar; so pores sizes in the sponges reflect the size of the porogen used in the process 
[Nazarov et al., 2004].  
 
 
1.6. Scope and Objective 
It is fact that there is urgent need of alternative treatment for tissue diseases, tissue injuries and 
organ failure because of having several limitations associated with the current clinical methods 
including insufficient tissue regeneration because of poor cell retention and survival, immuno-
rejection, significant donor site morbidity leading to loss of functional tissue. In this situation, 
recently, tissue engineering has been emerged as an attractive alternative technique for the 
clinical treatment of damaged and/or diseased tissue through the generation of functional tissue. 
In this context, the design and fabrication of a suitable three dimensional (3D) artificial extra 
cellular matrix from biocompatible and biodegradable materials with tailor properties is the main 
challenge. Among the various polymeric biomaterials, silk fibroin obtained from silk cocoon has 
been reported to be a potential candidate for the tissue engineering application. It is ultimately 
demonstrated that a combination of different polymers and/or their composites with other 
bioactive substances are essential to meet the desired properties of the scaffold for clinical tissue 
engineering application. In this strategy, in the present work 3-D matrices with desired surface, 
structural and biological properties will be fabricated from silk fibroin protein and PVA 
polymers by applying salt leaching method.  
 
The objectives of the thesis work are: 
 
i. Optimization of process conditions for extraction of silk fibroin from B. mori silk cocoon 
ii. To prepare silk fibroin based porous scaffold by salt leaching method  
iii. To modify the surface properties of scaffold for enhanced cell adhesion and proliferation 
iv. To characterize the prepared scaffolds 
v. To study the biocompatibility of scaffolds by in vitro cell culture and in vivo animal 
model 
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1.7. Thesis Outline 
The whole thesis work has been organized in 5 chapters as follows: Chapter 1- includes the 
introduction and significance of the research work, Chapter 2- presents the literature review 
including concepts and fundamental understanding of recent advancement in silk based tissue 
engineering and possible improvement in potency of current implantable silk fibroin 
biopolymers in tissue repair. It has also been discussed, the need and possible ways to improve 
their bio-relevant properties of SF scaffold to make it  more effective to be used as tissue 
engineering scaffold materials, Chapter 3-presents the materials and methods employed for the 
preparation of silk fibroin matrices and heir physical, chemical and biological characterisation, 
Chapter 4- deals with the results and discussion of experimental work which is  subdivided into 
the following parts: Part I reports the optimization of process conditions to rgenerate native silk 
into silk fibroin solution and its characterization. The objective of Part II is to examine the 
processability of concentrated aqueous silk fibroin solutions into highly porous gel spongesand 
study of their various properties for possible tissue engineering applications. Part III deals with 
the development and characterization of salt leached silk fibroin scaffolds and their comparative 
study after cross-linking with eggshell membrane (ESM) protein. Part IV demonstrates the green 
process for the fabrication of SF/PVA scaffolds of various pore sizes and their modification with 
SEP with an aim to study their bio-relevant properties, Chapter 5- includes a brief summary and 
conclusion of the thesis work along with suggested future study. 
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LITERATURE REVIEW 
 
2.1. Biomaterials for scaffold development 
 
According to the European Society for Biomaterials (ESB), the definition of ‗Biomaterial‘ is 
material intended to interface with biological systems to evaluate, treat, augment or replace any 
tissue, organ or function of the body [Williams et al., 1999]. In general, a biomaterial is a non-
living substance used as a medical device that is designed to regulate the cellular behavior in 
biological microenvironment [Davis et al., 2005]. Biomaterial-based 3D porous systems present 
an ideal substrate for cell–cell and cell–material communications both in culture and inside the 
body, and their properties can be modified to induce differentiation of cells into specific lineages 
[Sundelacruz et al., 2009]. In recent years, wide range of natural and synthetic biomaterials have 
been developed and designed for this purpose. Typically, three main classes of biomaterials, such 
as ceramics, synthetic polymers and natural polymers, are used for scaffolds fabrication in tissue 
engineering. 
 
2.1.1. Natural polymers 
The use of natural polymers as scaffold materials is most promising for tissue engineering and 
other biomedical applications because of their excellent biocompatibility and biodegradability. In 
the last decade natural materials, such as collagen, silk fibroin, various proteoglycans, alginate 
based substrates and chitosan, have drawn much attention in the field of tissue engineering [Pati 
et al., 2013; Bhat et.al. 2013; Liu et al., 2010; Gomathi et al., 2003]. The scaffolds made up of 
natural polymers are biologically active and promote cell proliferation and adhesion. In addition, 
they are biodegradable and replaced by biological ECM over time. However, such scaffolds face 
challenges being homogenous, reproducibility of structure and load bearing strength for 
orthopedic applications.Therefore, it is reported that these polymers must be further modified 
with improved form [Das et al., 2012] and property that is desirable for tissue engineering 
applications [Jayasinghe et al., 2010]. Polymers from natural sources such as proteins, 
polysaccharides and polyesters are considered to be potential candidates for scaffold preparation. 
 
2.1.1.1. Protein-derived polymers 
The most important protein derived polymers used for scaffold preparation are collagen and silk 
fibroin proteins. Type I Collagen is the most abundant and widely investigated for tissue 
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engineering applications [Hayashi, 1994]. Heat treatments and/or chemical glycation procedures 
are used to fabricate matrices with adequate mechanical properties. Collagen microsponges into 
synthetic polymeric scaffolds increase their mechanical performance [Chen et al., 2004]. 
Collagen-based scaffolds, combined with active agents like growth factors have more therapeutic 
influence on tissue engineering approaches [Wallace and Rosenblatt, 2003]. Another important 
polymer is silk protein that has robust mechanical properties due to presence of highly repetitive 
primary sequence of simple amino acids leading to formation of β-sheets.  Research have shown 
the utilisation of silk fibroin in tissue engineering applications, particularly where high 
mechanical strength and slow biodegradation is required [Altman et al., 2003]. Experimental 
studies of MSCs seeded highly porous silk scaffolds for in vitro cartilage [Wang et al., 2005] and 
bone [Kim et al., 2005] regeneration have shown promising results. 
 
2.1.1.2. Polysaccharides 
Polysaccharides have wide applications in tissue engineering particularly for the enhancement of 
desired mechanical properties. These biopolymers can broadly be divided into four major groups 
according to the sources from which these are obtained. The polysaccharides are subdivided, 
based on their chemical structure. Starch and cellulose are the most important plant saccharides 
having tissue engineering application particularly for bone regeneration [Wan et al., 2006; 
Salgado et al., 2002]. The cohesive and hydrogen-bonded structure of cellulose fibres makes it 
exceptionally water insoluble with great strength exhibiting poor degradation in vivo. Alginate, 
an algal polysaccharide has potential to combine with calcium [Percival and McDowell, 1990] 
and this property is reported to have mineralisation effect in orthopaedic tissue engineering. 
Chitin and its derivative chitosan obtained from animal exoskeleton have been studied for bone 
regeneration and have been found with excellent biodegradability and cell-adhesive property 
[Venkatesan and Kim, 2010]. Hyaluronic acid, an important GAG component has been used for 
finishing the scaffold surface for improving its biocompatibility [Mao et al., 2003]. Non-toxicity 
of Pullulan and unique rheological properties of xantan gum from microbial culture also finds 
application in vivo. Bacterial cellulose (BC) has high water- holding capacity, crystallinity, 
biocompatibility and shows high tensile strength in wet state [Mano et al., 2007]. 
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2.1.1.3. Naturally derived polyesters 
Polyhydroxyalkanoates (PHAs) obtained from micro-organisms are thermoplastic polyesters 
with good biodegradability and biocompatibility. Among various PHAs, PH (Butyrate) and PH 
(Butyrate- co-Valerate) are commonly used for tissue engineering applications. More flexible, 
less crystalline and easy to process scaffold materials can be produced by copolymerization of 
pure PHB. These materials can be used as support material for tissue engineering application 
[Masaeli et al., 2013]. 
 
2.1.2. Synthetic Polymers 
Various synthetic polymers have been employed for scaffolds development including poly-l-
lactic acid (PLLA), polyglycolic acid (PGA) and their copolymer poly-dl-lactic-co-glycolic acid 
(PLGA). These materials have been much successful towards cartilage, bone, skin, bladder, and 
liver TE since their architecture and degradation can be well controlled by varying individual 
polymer composition [Lu et al., 2000; Oh et al., 2003; Rowlands et al., 2007]. However, 
limitations of these polymers include the risk of implant rejection due to less bioactivity and the 
degradation byproduct (CO2 gas) that lowers the local pH finally responsible for cell and tissue 
necrosis [Liu et al., 2006]. 
 
2.1.3. Ceramics 
Ceramic scaffolds, such as hydroxyapatite (HA) and tri-calcium phosphate (TCP) can be used for 
bone regeneration and generally not used for soft tissue regeneration. Such scaffolds are 
characterized by high mechanical strength, low elasticity, and a hard brittle surface. In bone 
tissue engineering, they exhibit chemical and structural similarity to the mineral phase of native 
bone and enhance osteoblast differentiation and proliferation [Hench et al., 1998; Ambrosio et 
al., 2001]. The application of ceramics is common in dental and orthopedic surgery for filling 
and coating implant surface of host bone. However, due to their brittleness and difficulty in 
remodeling check their clinical application of scaffold based bone regeneration [Wang et al., 
2003]. In addition, with ceramic scaffolds, difficulty has been reported to control their 
biodegradation rate [Tancred et al., 1998]. 
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2.1.4. Polymer/Polymer blend and Polymer/Ceramic Composite 
Each of the individual biomaterial groups mentioned above has some pros and cons, so the 
development of composite scaffolds comprising a number of phases is becoming increasingly 
important. For example, different research groups have attempted to integrate ceramics into 
polymeric scaffolds [Kim et al., 2006; Huang et al., 2008] while many others have combined 
natural polymers with other natural [Cai et al., 2002] or synthetic polymers [Wu et al., 2007] in 
order to improve their biological activity. Composite or blend materials, combining natural and 
synthetic polymers, have been developed to combine the desired characteristics of both polymer 
to overcome the drawbacks of organic material classes. Such scaffolds show some promise 
towards successful implantation, at least one phase cause problem associated with 
biocompatibility, biodegradability or both. Most of the biomaterials in scaffolds can be improved 
by modifying their surfaces chemically or physically, and a variety of such surface modified 
scaffolds have been used for investigating cells behaviour [Mano et al., 2007]. Modification of 
biomaterials and understanding of cell behavior have made it clinically possible to replace or 
reconstruct damaged host cells and tissues [Beckstead et al., 2006]. Development of cell-material 
microarrays has allowed rapid testing of biomaterial interactions with cells [Peters et al., 2009]. 
Considerable research work has been done to develop, design and demonstrate the increasing 
advantages of polymer based cell system in tissue regeneration [Chen et al., 2004; Chen et al. 2002]. As 
far as there is advancement in biomaterial research, new biomaterials and novelty in their usage 
will continue to emerge. 
 
2.2. Scaffold Fabrication Methods 
A variety of well‐known fabrication techniques are used in scaffold design for TE applications. 
A well-designed three-dimensional scaffold is one of the fundamental requirements that guide 
tissue formation in vitro and in vivo. Frontiers areas in medicine is changing rapidly from 
utilizing synthetic implants and tissue grafts to a tissue engineering approach that uses 
degradable porous scaffolds integrated with biological cells or molecules to regenerate tissues 
[Hollister et al.,  2005]. Therefore, the selection of scaffold is important to enable the cells to 
behave in the desired manner to generate tissues and organs of the desired shape and size. In the 
body, cells and tissue are organized into three-dimensional architecture. To engineer these 
functional tissue and organs, scaffolds have to be fabricated by different methodology to 
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facilitate the cell distribution and guide their growth into three-dimensional space. The main 
techniques for scaffolds fabrication are summarized below: 
 
2.2.1. Solvent casting 
Solvent casting is a very simple, easy and inexpensive method for scaffold fabrication. It does 
not require any large equipment; it is totally based upon the evaporation of some solvent in order 
to form scaffolds by one of the two routes. One method is to dip the mold into polymeric 
solution and allow sufficient time to draw off the solution; as a result a layer of polymeric 
membrane is created. Other method is to add the polymeric solution into a mold and provide the 
sufficient time to evaporate the solvent that create a layer of polymeric membrane, which adhere 
to the mold [Mikos et al., 2004]. One of the main drawbacks of this technique is the use of toxic 
solvent that denatures the protein and may affect other solvents. There is a possibility that the 
scaffolds designed by these techniques may also retain some of the toxicity. To overcome these 
problems scaffolds are fully dried by vacuum process to remove toxic solvent. However, this is 
very time consuming technique and to overcome these problems some researchers have 
combined it with particulate leaching techniques [Mikos et al., 1993a; 1993b; 1996] for the 
fabrication of scaffolds. 
 
2.2.2. Particulate-leaching techniques  
Particulate leaching is one of the most common methods that are widely used for preparation of 
scaffolds with controlled porosity [Ma & Langer, 1999; Lu et al, 2000]. Salt, wax or sugars as 
porogens are used to create the pores or channels. In this method, salt is grounded into small 
particles and those particles that have desired size are poured into a mold and filled with the 
porogen. A polymer solution is then cast into the salt-filled mold. After the evaporation of the 
solvent, the salt crystals are leached away using water to form the pores of the scaffold. The 
process is easy to carry out. The pore size can be controlled by controlling the amount, size and 
shape of the porogen [Plikk et al., 2009]. The particulate leached scaffold with porosity up to 93 
% and pore diameter up to 500 micrometers can be prepared [Mikos et al., 1993a; 1993b]. Main 
advantage of this technique is its simplicity, versatility and easy to control the pore size and 
geometry. Pore geometry is controlled by the selection of the shape for specific porogen agent, 
where as pore size is controlled by sieving the porogen particle to the specific dimensional range 
[Mano et al., 2007]. However, certain critical variables such as pore shape and inter-pore 
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openings are not controlled [Moore et al., 2004]. To overcome these drawbacks advanced 
fabrication technologieshave been developed as described below. 
 
2.2.3. Gas foaming 
Many of the fabrication techniques require use of organic solvents and high temperature. The 
residues that remains after completion of process can damage cells and nearby tissues. This may 
also denature the biologically active molecules incorporated within the scaffolds. The gas 
foaming technique does not require the use of organic solvents and high temperature. This 
technique uses high pressure soluble inert gas, e.g. CO2 or N2, in the supercritical region as 
blowing agent for the fabrication of highly porous scaffolds [Harris et al., 1998; Singh et al., 
2004; Wang et al., 2006]. The porosity and porous structure of the scaffolds depend upon the 
amount of gas dissolved in the polymer. Instead of using a single polymer, this method is also 
applicable for composites of polymer and (bio) ceramic to employ in hard TE constructs [Kim et 
al., 2006]. The advantage is the elimination of solvent, thus avoid the risk of remaining solvent 
residue, and the low processing temperatures preventing degradation of the polymer during 
processing. The scaffolds often have a closed surface (skin) and mainly non‐percolated pores 
which can be a serious problem as these characteristics limit nutrient transport through the 
scaffold. The porosity of the scaffolds is controlled by combining the method with particulate 
leaching [Ikada et al., 2006]. The mix polymer and porogen are exposed to high pressure until 
they have completed its saturation with carbon dioxide, followed by the removal of porogen by 
foaming process and thereby a highly interconnected pore structure is formed [Huang & 
Mooney, 2005]. 
 
2.2.4. Freeze drying 
Freeze drying technique is used for the fabrication of porous scaffolds [Whang et al., 1995; 
Schoof et al., 2001]. This technique is based upon the principle of sublimation. Polymer is first 
dissolved in a solvent to form a solution of desired concentration. The solution is frozen and 
solvent is removed by lyophilization under high vacuum that fabricate the scaffold with high 
porosity and inter connectivity [Mandal & Kundu, 2009 a, b]. This techniques were applied to a 
number of different polymers including silk proteins [Vepari & Kaplan, 2007, Altman et al., 
2003], PGA, PLLA, PLGA, PLGA/PPF blends. The pore size can be controlled by the freezing 
rate and pH, however a fast freezing rate produces smaller pores. Controlled solidification in a 
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single direction has been used to create a homogenous 3D-pore structure [Schoof et al., 2001]. 
The main advantage of this technique is that, it neither requires high temperature nor separate 
leaching step. The main drawback of this technique is smaller pore size and long processing time 
[Boland et al., 2004].   
In emulsion freeze‐drying, homogenization of a polymer–solvent system and water leads to 
formation of an emulsion [Ho et al., 2004; Whang et al., 1995]. An emulsion exists of two 
phases, a continuous phase and a dispersed phase. The continuous phase consists of the 
polymer‐rich phase, whereas water is the dispersed phase. The emulsion is cooled quickly to 
freeze the solvent and water, resulting in solidification of the polymer directly from the liquid 
state and the creation of a porous polymer structure. Subsequently, the frozen solvent and water 
are removed by freeze‐drying. Emulsion freeze‐drying is attractive for creation of relatively thick 
scaffolds with large pores. Additionally, incorporation of proteins is enabled during the 
fabrication of the scaffold. The obtained morphology is mainly non‐percolated (solid‐wall like 
pores), which is the major drawback of freeze drying as this often limits cell in‐growth and 
nutrient transport through the scaffold. 
 
2.2.5. Phase separation 
Phase separation technique for scaffolds designing requires temperature change that separates the 
polymeric solution in two phases, one having low polymer concentration (polymer lean phase) 
and other having the high polymer concentration (polymer rich phase). Methods often used for 
phase separation are e.g. liquid induced phase separation (LIPS, immersion precipitation) [Kim 
et al., 2004; Liu et al., 2004; Zoppi et al., 1999] and thermally induced phase separation (TIPS) 
[Guan et al., 2005; Hua et al., 2002; Li et al., 2004; Nam et al., 1999]. Polymer is dissolved in 
phenol or naphthalene, followed by dispersion of biologically active molecule in these solutions. 
By lowering the temperature liquid-liquid phase is separated and quenched to form a two phase 
solid and the solvent is removed by extraction, evaporation and sublimation [Mikos et al., 2004] 
to give porous scaffolds with bioactive molecules integrated in to the structure [Sachlos & 
Czernuszka, 2003; Hua et al., 2002]. An appropriate liquid-liquid phase separation is critical for 
the preparation of nanofibers and does not occur in all solvents which involves the selection of 
solvent. Furthermore, the phase separation temperature is crucial for the formation of nanofibers. 
Advantage of the phase separation technique is that, it can easily combine with other fabrication 
technology (Particulate leaching) to design three dimensional structures with controlled pore 
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morphology. It can also be combined with rapid prototyping to create nano fibrous scaffolds for 
tissue engineering applications [Smith et al., 2006]. These methods allow processing of pure 
polymers as well as composites of polymer–(bio) ceramic for application in hard TE [Causa et 
al., 2006]. 
 
2.2.6. Electrospinning 
Electrospinning (ESP) technique for the scaffolds designing is based upon the charging of a 
polymer solution utilizes the electrostatic force and subsequent ejection of polymer solution 
through a capillary tip or needle for the production of polymeric fiber ranging from nanoscale to 
microscale [Bhattarai et al., 2006; Riboldi et al., 2005]. This process is controlled by high 
intensity electric field between two electrodes having electric charges of opposite polarity. To 
obtain continuous fibers, the method requires solutions containing relatively high polymer 
concentrations usually in the range of 10‐15 wt%. Varying the process parameters, e.g. distance 
between needle and collector, strength of the electric field and polymer concentration allows 
tuning of the fiber diameter [Moroni et al., 2006; Boudriot et al., 2006]. More than 200 polymers 
are used for electrospinning like silk fibroin [Zarkoob et al., 2004; Sukigara et al., 2003; Jin et 
al., 2004], collagen [Matthews et al., 2002], chitosan [Ohkawa et al., 2004], gelatin [Ma et al., 
2005] etc. The process is very versatile in terms of use of polymers, non-invasive and does not 
require the use of coagulation chemistry or high temperature for fiber generation. One of the 
main advantages of this technique is the high flexibility and fiber resolution of the obtained 
scaffold suitable for growth of the cell and subsequent tissue organization [Li & Tuan, 2009; 
Liang et al., 2007; Leong et al., 2008]. Additionally, alignment of the electrospun fibers is 
enabled to induce cell and tissue alignment [Buttafoco et al., 2006] favorable for better cellular 
growth for in vitro and invivo. A drawback of electrospinning is the risk of breaking fibers 
during fabrication, which might lead to inferior quality of the scaffold.  
 
2.2.7. Fiber mesh 
Fiber mesh technique for scaffold fabrication consists of individual fiber either woven or 
interweave into three dimensional pattern of variable pore size [Martins et al., 2009]. The 
method is developed by Mikos and his coworkers [Mikos et al., 1993a]. PGA is the first 
biocompatible and biodegradable polymer to spun into the fiber and used as a synthetic suture 
thread. It is prepared by the deposition of polymer solution over a nonwoven mesh of another 
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polymer PLLA [Chen et al., 2002] or collagen [Eberli et al., 2009] matrix followed by 
subsequent evaporation [Ikada et al., 2006]. At a temperature above the melting temperature of 
PGA, fiber bonding occurs and subsequently, the PLLA matrix of the composite is removed by 
dissolving in methylene chloride agent [Sachlos and Czernuszka, 2003] utilizing the fact that 
PGA is insoluble in this solvent. This process yields the scaffolds of PGA fiber that is bonded 
together by heat treatment. PGA mesh provides the high porosity and surface area to polymer 
mass ratio [Mooney et al., 1996]. This provides the mechanical stability and allows the tissue 
ingrowths. Main advantage of this technique is to provide the large surface area for cell 
attachment and rapid diffusion of nutrient that is favorable for cell survival and growth [Chen et 
al., 2002].  
 
2.2.8. Self assembly 
Self assembly is the spontaneous organization of the molecule into well defines acheiving an 
ordered structure required for specific function [Zhang et al., 2003]. Self assembly of natural or 
synthetic molecule produced nanoscale fibers known as nanofibers. Amphiphilic peptide 
sequence is a common method for the fabrication of 3D nanofibrous structure for tissue 
engineering. In aqueous solution, the hydrophobic and hydrophilic domains within these peptides 
interact together with the help of weak non covalent bonds [Joshi et al., 2009; Zhang et al., 2006] 
such as hydrogen bond, Van der Waals interactions, ionic bond and hydrophobic interaction. 
This produces distinct fast recovering hydrogel, with the hydrophobic interactions as the 
molecules come together. The di- and tri-block peptide ampholites (PAs) are designed that are 
self-assembled into a rod-like architecture. So a new technique for the self-assembly of PAs into 
nanofibers by controlling pH and by engineering the peptide head group of the PAs is developed 
[Hartgerink et al., 2002]. The fabricated nanofibers have amino acid residues that may be 
chemically modified by the addition of bioactive moieties. Other advantage of this technique is 
to avoid the use of organic solvent and reduce the cytotoxicity because it is carried out in 
aqueous salt solution or physiological media [Ma et al., 2005]. Main disadvantage of this 
technique is its complicated and elaborated process. 
 
2.2.9. Melt molding/ Sintering 
Melt molding generally referred to the processing of polymeric powders at high temperature 
while the term ―sintering‖ is for ceramics, metals, glasses and their composites to make the 
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particles adhere to each other. Melt molding process involves the filling of teflon mould with 
PLGA powder and gelatin microspheres of specific diameter followed by heating the mould 
above the glass transition temperature of PLGA while applying pressure to the mixture 
[Thompson et al., 1995a, 1995b]. This action causes the PLGA particle to attach together. Once 
the mould is removed, gelatin microspheres are dissolved by immersing the mixture into water 
and scaffolds are then dried. Scaffolds produced by this technique assume the shape of the 
mould. Melt molding process can be modified to incorporate short fiber of hydroxyapatite (HA). 
Uniform distribution of HA fiber throughout the PLGA scaffolds could only be achieved by 
using the solvent casting  technique to prepare the composite material of HA fiber, PLGA matrix 
and gelatin or salt porogen, which are used in melt molding process [Hou et al., 2003]. Scaffolds 
fabricated by sintering are mainly for hard TE constructs. The possibility of creating controlled 
and graded porosity is the main advantage of sintering. The major disadvantage is the possible 
risk of low interconnectivity of the pores and the brittleness of the fabricated scaffold in case of 
using certain biomaterials. 
 
 
2.2.10. Rapid prototyping (RP) 
RP is also called as solid free-form technique. This technique is more advanced technique for 
scaffold fabrication It can rapidly produce 3D object by using layer by layer manufacturing 
method. RP technique generally comprises the design of scaffold model by using the computer 
aided design (CAD) software, which is then expressed as a series of cross section [Lin et al., 
2008, Woodfield et al., 2009]. Corresponding to each cross section RP machine lays down a 
layer of material starting from the bottom and moving up a layer at a time to create the scaffolds. 
In typical example, image of bone defect in a patient can be taken and develop 3D CAD model. 
The computer then can reduce the model to slice or layers. The 3D objects are constructed layer 
by layer by using RP techniques such as fused deposition modeling (FDM), selective laser 
sintering (SLS), 3D printing (3D-P) or stereolithography. Now-a-days, RP is an efficient way for 
generating the scaffolds of desired property.Other advantage of this technique is to produce the 
parts with highly reproducible architecture (size, shape, inter connectivity, branching, geometry 
and orientation) and compositional variations yielding biomimetic structure, that varying in 
design and material composition. The method is able to control the mechanical property, 
biological effects and degradation kinetics of scaffolds [Kai et al., 2009; Hutmacher et al., 2000; 
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2001]. One of the main drawbacks of this technique is achieved low resolution by current 
systems and types of polymeric materials that are used for this technique. 
 
2.2.11. Membrane lamination 
Membrane lamination is another SFF-like technique used for constructing three-dimensional 
biodegradable polymeric foam scaffolds with precise anatomical shapes. Membrane lamination 
is prepared by solvent casting and particle leaching and introducing peptide and proteins layer by 
layer during the fabrication process. The membranes with appropriate shape are soaked with 
solvent, and then stacked up in three-dimensional assemblies with continuous pore structure and 
morphology [Maquet & Jerome, 1997]. The bulk properties of the final 3D scaffolds are identical 
to those of the individual membrane. This method generates the porous 3D polymer foams with 
defined anatomical shape, since it is possible to use the computer assisted modeling to design the 
template with desired implant shape. The disadvantage of this technique is that layering of 
porous sheets, result in lesser pore interconnectivity [Hutmacher et al., 2000; 2001] and that it is 
a time consuming process. 
 
2.3. Silk biomaterial as TE matrices 
Silk from B. mori has been utilized as universal biomaterial with a wide range of processability 
and applications as demonstrated through figure 2.1 and table 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Silk for different tissue engineering application [Kasoju and Bora, 2012] 
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Table 2.1: Silk as a biomaterial for TE scaffold development 
B. mori Silk 
Fibroin 
form 
Fabrication method TE application References 
Fibers 
 
 Tendon tissue engineering 
 
Ligament tissue engineering 
Kardestuncer et al., 2006;   
Chen et al., 2003  
Altman et al., 2002; Moreau et 
al., 2005 
Films Casting 
Layer-by-Layer 
Deposition 
Wound dressings 
 
Bone tissue engineering 
 
Hepatic tissue engineering 
 
Anti-thrombogenesis 
Hu et al. , 2006; Sugihara et al., 
2000; Yeo et al.,2000 
Karageorgiou et al., 2004; Sofia 
et al., 2001; Cai et al. , 2002 
Kino et al., 2006  
 
Lee et al., 1998 
Non woven 
Mats 
Electrospinning 
Fiber deposition 
Connective tissue 
 
Endothelial and blood Vessel 
 
Guided bone repair 
 
Wound dressing/skin repair 
Dal et al.,2005 
 
Fuchs et al.,2006; Unger et 
al.,2004 
Kim et al.,2005b 
 
Min et al.,2004a; 2004b 
Hydrogel Sol–gel transition in the 
presence of acid, 
ions, and other 
additives 
Cartilage and  Bone tissue 
engineering 
Aoku et al., 2003; Fini et 
al.2005 
Sponge (3D 
porous 
sponge) 
Salt leaching 
Gas foaming 
Lyophilization 
Wound dressings 
 
Bone tissue engineering 
 
 
Cartilage tissue engineering 
Karageorgiou et al., 2006; 
Sakabe et al., 1989 
Meinel et al.,2004b;2005; 
2006a,2006b; Marolt et al., 
2006 
Wang et al.,  2005; 2006; 
Meinel et al.,2004a; Marolt et 
al., 2006 
 
 
2.4. Surface modification and Composite/blend development  
The brittleness of pure SF scaffold restricts their application and thus their physical properties 
are enhanced by mixing with other synthetic or natural polymers and other biomaterials [Gobin 
et al., 2005; Kweon et al., 2003; Du et al., 2006].  The cross-linking of such blended system may 
results into different degradation under physiological conditions [Ma et al., 2003] in addition to 
improved mechanical strength [Sabato et al., 2001]. The interaction of such composite scaffolds 
towards host cells have not been explored much. The improvement in tissue engineering 
biopolymers can be achieved by utilizing polymers of natural or synthetic origin, separately or in 
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blended form, with grafted or cross-linked networks. Mixing of glycerin (a commonly used 
plasticizer) has been reported to improve the mechanical properties of silk film [Lu et al., 2010] 
and also to reduce phase separation between silk and PVA in the blend [Dai et al., 1999]. After 
mixing with silk, glycerin molecules interact with silk chains via intermolecular hydrogen bond 
formation between -OH groups of glycerin and -NH groups of silk [Dai et al., 1999]. Chen et al. 
successfully fabricated electrospun silk fibroin [SF]/chitosan [CS] composite nanofibers [NFs] 
that could both support the proliferation (SF component) and osteogenic differentiation (CS 
component) of human fetal osteoblastic [hFOB] cells [Chen et al., 2012a]. Silk-CNT composite 
scaffolds developed by Chen et al. showed improved neuron differentiation efficiency from 
hESCs [Chen et al., 2012b]. 
 
      Surface modification via physical adsorption or chemical immobilization of a protein or 
ligand improves biomaterial properties towards cellular behaviour [Jayasinghe et al., 2010; 
Chrzanowski et al., 2012]. Silk surfaces are hydrophobic, and can be functionalized using the 
AA side chain chemistry. The surface of silk fibroin biomaterials is modified using carbodiimide 
chemistry, which uses amine or carboxyl groups on silk. For example, arginine residues of silk 
fibroin were modified by 1,2-cyclohexanedione resulted into improved cell attachment and 
proliferation [Gotoh et al., 1998]. SF surface coupled with poly(ethylene glycol) (PEG) showed 
decreased attachment of fibroblasts [Gotoh et al., 1997] and also showed protein adsorption and 
hMSC attachment related to the amount of PEG on the surface [Vepari et al., 2010].Surface 
properties of SF biomaterials for improved cell adhesion and proliferation can be modulated by 
conjugation with integrin recognition RGD sequence via carbodiimide coupling [Ruoslahti et al., 
1987]. The RGD peptide plays vital role in cellular adhesion by engaging integrins present over 
surface of many cell types [Hersel et al., 2003].  The remarkable improvement in cellular 
attachment and differentiation promotes ligament, [Chenet al., 2003] bone, [Meinel et al., 
2004b] and dental [Petrini et al., 2013; Karageorgiou et al., 2004] tissue engineering [Xu et al., 
2008]. It‘s fascinating to know that some wild type of silkworms like Antheraea pernyi have 
RGD in their silk fibroin sequence [Minouraet al., 1995]. Sofia et al. reported the covalent 
attachment of RGD to silk fibroin films resulting in increased number of mineral modules 
formed by Saos-2 cells in osteogenic media [Sofia et al., 2001]. T.Damrongrungruang fabricated 
RGD-modified electrospun Thai silk fibroin nanofibers to compare adhesion of human fibroblast 
cell line between RGD- and non-RGD modified electrospun nanofibers and observed a 
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significantly higher cell number in RGD modified silk fibre compared to conventional ones 
[Damrongrungruang, 2010].  
 
 Cell differentiation occurs in response of gradients of morphogens during embryogenesis and is 
repeated during adult tissue regeneration [Teixeira and Urist, 1998]. These signaling cues 
required for tissue development would be useful in biomaterial designing. Protein-based growth 
factors covalently attached to SF scaffolds has also been promising to promote cell 
differentiation cultured within scaffolds. One of the most common growth factor for bone tissue 
engineering is bone morphogenic protein (BMP-2) that can be directly immobilized on SF films, 
[Karageorgiou et al., 2004], scaffolds [Karageorgiou et al., 2006; Kirker et al., 2007] and 
electrospun mats [Li et al., 2006] via carbodiimide coupling. Gradients of BMP-2 were 
covalently immobilized and adsorbed over three-dimensional silk fibroin sponges and studied 
with hMSCs results into significantly higher expression of osteogenic markers [Vepari et al., 
2010]. 
 
Several chemical modification methods to improve SF blood compatibility have been reported. 
Many of them have been modeled after the structure of commonly used anticoagulant, heparin 
the highly sulfated polysaccharide. Strategies have been employed to incorporate sulfate groups 
into SF in order to mimic the heparin structure. SF derivatives produced through the reaction 
with chlorosulfonic acid [Tamada et al., 2004] and sulfonated silk blends [Ma et al., 2006] or 
grafting of 2-methacryloyloxyethyl phosphorylcholine (MPC) onto silk fabric [Furuzono et al., 
2000] were shown to be effective approaches in SF modification for applications where these 
materials will be in blood contact. Sulfated SF derivatives have also shown Anti-HIV activity 
[Gotoh et al., 2000]. Similarly, incorporation of phosphorylcholine (PC) into silk reduces 
inflammatory reactions to these materials in vivo by significantly reducing platelet adhesion 
[Furuzono et al., 2000]. Liu et al. reported the improved mechanical properties and lower 
inflammatory response of modified silk fibre with gelatin in place of sericin using NDGA as a 
cross-linking agent for ligament tissue engineering applications [Liu et al., 2007]. 
 
2.5. PVA as traditional biomaterial for SF scaffold development 
PVA, a synthetic polymer has excellent hydrophilicity, biocompatibility, biodegradability and 
processability with ability to form high strength fibres suitable for medical applications [Mansur 
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and Costa, 2008; Mansur et al., 2004]. In addition, the published literature has indicated that no 
significant difference is found in quantitative or qualitative cytotoxicity evaluation of PVA. It is 
also shown that the amount of PVA accumulated in organs is too small to affect the biological fate, 
which suggested that PVA is excreted to the same extent as for example PEG, supporting the 
cytocompatibility of PVA [Yamaoka et al., 1995]. Furthermore, due to its solubility at room (25°C) 
or body temperature (37°C), it doesn‘t easily leach out into water or cell culture medium. A wide 
range of natural/synthetic polymers blended with PVA have been investigated for tissue 
engineering applications [Choi et al., 2013]. Development of scaffolds from PVA and PVA blends 
with other biopolymers, involves the crosslinking of PVA either chemically (with difunctional 
gluteraldehyde in presence of sulfuric acid, acetic acid or methanol) [Dai et al., 1999; Kim et al., 
1993] or physically (with electron beam or gamma irradiation [Mathew et al., 2013; Wang et al., 
1998], heat-treatment). Recently PVA gels have been prepared without crosslinking agents as a cell 
adhesive surface [Gupta et al., 2011]. Furthermore, a number of natural/synthetic polymer blended 
with PVA [Choi et al., 2013] and Poly(vinylidene fluoride) [Dikshit and Nandi, 2001] have been 
investigated for TE applications.Incorporation of PVA solution in chitosan has shown improvement 
in biocompatibility of the blend system [Huang et al., 2005]. Silk fibroin and PVA have been 
separately investigated as materials for tissue engineered constructs [Meinel et al., 2004a; Hofmann 
et al., 2007] and many research groups have studied the preparation method and properties of 
SF/PVA blends for improved stiffness of SF [Li et al., 2002; Dai et al., 2002; Li et al., 2001; 
Tanaka et al., 1998; Tanaka et al., 1997; Tsukada et al., 1994]. However, silk fibroin/PVA scaffolds 
have not yet been explored much for cytocompatibility and potential bone tissue engineering 
application. 
 
2.6. Utility of SF based matrices in Tissue Regeneration 
An ideal scaffold for tissue engineering application must have the property of biocompatibility 
with host tissue, biodegradability and non immunogenic in nature. Therefore much of the 
research is being done on natural polymer which fulfills these criteria. Silk, which is a naturally 
derived polymer, has been in use for medical application such as suture material due to its high 
mechanical and compressive strength. It proves to be an ideal polymer for tissue engineering 
application owning to its better bioactive properties as compared to synthetic polymers which is 
an important prerequisite for a polymer for the development of construct. They can be easily 
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modified in combination with other materials to acheive required mechanical and surface 
properties of scaffold. Therefore silk is considered as a promising biomaterial for tissue 
engineering application. 
 
2.6.1. Skin wound healing 
Research groups [Chiarini et al., 2003; Dal et al., 2003] have reported the in-vitro dermal 
fibroblasts spreading and proliferation on fibroin substrate without secretion of pro-inflammatory 
interleukins accountable for host response against foreign body. In vitro study of oral 
keratinocytes on woven fibroin meshes have shown promising proliferation [Min et al., 2004]. In 
another study, fibroin-alginate sponges [Roh et al., 2006] and fibroin-chitosan blend [Gobin et 
al., 2006] have been found to enhance skin wound healing compared to currently used clinical 
materials. The effects of the transparent fibroin film (silk film) and dressing were compared with 
an objective to regenerate the epidermis and dermis of the wound and reported the superiority of 
silk films with additional advantages of cost effectiveness, ease of availability, sterilizability, and 
easy observation of tissue recovery due to transparent nature [Sugihara et al., 2000]. Naksupan et 
al. studied the healing effect and toxicity of silk fibroin gel in skin wound ofanimal model and 
observed the accelerated epidermal (keratinocytes) cell proliferation, migration to wound and 
remodeling of wound site without any trace of cytotoxicity anatomical change. This study 
indicates the potential use of silk fibroin gel for wound dressing application in clinical trial 
[Naksupan et al., 2012]. 
 
2.6.2. Skeletal tissues  
2.6.2.1. Cartilage 
Major research on the application of silk fibroin based 3D scaffolds for cartilage tissue 
engineering were reported by D. L. Kaplan group, most often fabricated by salt-leaching [Wang 
et al., 2006; Marolt et al., 2006; Meinel et al., 2004a; Hofmann et al., 2007]. In vitro human 
articular chondrocytes [Wang et al., 2006] and mesenchymal stem cells (MSCs) [Marolt et al., 
2006; Meinel et al., 2004a; Hofmann et al., 2006] cultured on these scaffolds have demonstrated 
chondrogenesis as elevated amount of collagen type II and GAG both in static [Meinel et al., 
2004a, 2004c] and dynamic [Marolt et al., 2006] cultures. Hofmann et al. studied the effect of 
serum in culture media in terms of support to chondrogenesis on silk and collagen scaffolds and 
reported that cartilage synthesis on silk scaffolds in serum-free conditions is highly significant. 
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In the absence of serum, the GAG level was significantly higher on the fibroin scaffolds as 
compared to collagen controls but lower in presence of serum, indicating the promotion of 
chondrogenesis due to surface properties of the silk scaffolds and its potential clinical 
applications where the use of serum is avoided [Hofmann et al., 2006]. However, the engineered 
cartilage tissue had inferior mechanical properties to those of native cartilage [Hofmann et al., 
2006; Marolt et al., 2006] and lower GAG content produced by differentiated MSCs than by 
chondrocytes [Marolt et al., 2006], indicating further need to optimize the culture conditions with 
respect to scaffold properties, cell differentiation and mechanical stimulation. Silk fibroin 
sponges developed by thermally induced phase separation (TIPS) method showed support to 
chondrocyte proliferation for up to 28 days [Morita et al., 2002] with inferior mechanical 
properties as of native tissue due to the inferior expression of synthesized extracellular matrix. 
Alteration in cell culture protocol using the same scaffolds resulted in higher expression of type 
II collagen, GAG and extracellular matrix throughout the culture period of 28 days, signifying 
the application in hyaline cartilage tissue engineering [Aoki et al., 2003]. 
 
2.6.2.2. Bone 
Tissue engineering approach for the repair of bones with different morphologies using silk 
fibroin scaffolds in various forms have been reported [Fini et al., 2005; Kim et al., 2005a; 
Kirker-Head et al., 2007; Hofmann et al., 2007;Marolt et al., 2006; Meinel et al., 2004b; Kim et 
al., 2005b; Meinel et al., 2005]. Initial efforts deal with silk fibroin hydrogels [Fini et al., 2005] 
and membranes/nets [Kim et al., 2005b] without pre-seeded cells for guided bone regeneration. 
While in this decade, techniques have been developed to use 3D porous silk fibroin scaffolds 
seeded with MSCs for the repair of bone defects with complex dimension mostly done by D. L. 
Kaplan group [Meinel et al., 2006a; Kim et al., 2005a; Meinel et al., 2005; Kim et al., 2005b]. In 
their study, regenerated silk fibroin solution (RSF) was processed into films [Sofia et al., 2001, 
Wang et al., 2005], electrospun to form scaffolds [Li et al., 2006] or a 3-D porous scaffold by 
salt-leaching [Kirker-Head et al., 2007; Hofmann et al., 2007;Marolt et al., 2006; Meinel et al., 
2006a; Kim et al., 2005c; Meinel et al., 2005]. The addition of RGD functionality [Meinel et al., 
2005; Meinel et al., 2004b] or growth factors [Kirker-Head et al., 2007; Karageorgiou et al., 
2006; Li et al., 2006] was reported to enhance surface properties for cellular activities. Fibroin 
films coupled with RGD peptides incubated with osteoblast-like cells were found to produce 
mineralized matrix [Sofia et al., 2001]. Silk fibroin films and scaffolds immobilized with bone 
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morphogenic protein-2 (BMP-2) have been demonstrated to induce osteogenesis in vitro [Meinel 
et al., 2006b; Karageorgiou et al., 2004] and bone formation when implanted with or without 
seeded pre-differentiated and undifferentiated MSCs in non-load bearing [Karageorgiou et al., 
2006] and load-bearing [Meinel et al., 2006a] bone defect sites in vivo. Bone formation at the site 
of implantation with fibroin scaffolds seeded with undifferentiated cells in vitro induces early 
osteogenesis than scaffolds withoutpreseeded cells. SF scaffolds cultured with cells before 
implantation also has shown better mechanical properties [Meinel et al., 2006a]. SF based 
hyodrogels have been reported to outperform in vivo bone ingrowth than commercially available 
synthetic polymers [Fini et al., 2005]. For the bone regeneration at bone defect site with complex 
dimension meant that several smaller scaffolds have to be stacked together instead of using a 
larger one. Larger scaffolds though can support bone formation with better mechanical properties 
but problem of mass transport limits their use [Meinel et al., 2006b]. Most reports demonstrate 
the culture medium supplementation when BMP-2 is involved; however, Meinel et al. 
successfully differentiated MSCs along osteogenic lineages with BMP-2 applied via viral 
transfection [Meinel et al., 2006b]. Reports demonstrate the successful differentiation of MSCs 
into osteogenic lineages grown over Fibroin–nano-hydroxyapatite composite films [Tanaka et 
al., 2007] and have been observed to promote osteogenesis at both non-load bearing [Kim et al., 
2005b; Meinel et al., 2005] and load-bearing [Meinel et al., 2006a] sites implanted in rodent 
models. 
 
2.6.2.3. Ligament/tendon 
The adaptability of silk biomaterial into controllable physical and mechanical properties makes it 
promising for ligament and tendon tissue engineering. The natural twisted and wire-rope 
geometrical configuration of silk fibers provide better mechanical properties and larger surface 
area for cell attachment and ECM deposition in a pattern similar to collagen fibers present in 
ligaments and tendons. Silk fibroin fibers devoid of sericin, has been investigated for 
proliferation and differentiation of MSCs towards ligament tissue, expression of ligament-
specific markers (collagen type I, collagen type III, tenascine-C) and cellular response for 
mechanical stimulus [Altman et al., 2002]. Gelatin coated fibroin fibers have been demonstrated 
to restore the mechanical properties that are reduced by sericin removal without influencing in 
vitro cytotoxic effects and in vivo inflammatory response for ligament tissue engineering [Liu et 
al., 2007; Takezawa et al., 2007]. RGD coated silk fibroin matrix showed enhanced ECM 
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production by both MSCs and anterior cruciate ligament (ACL) fibroblasts [Chen et al., 2003] 
and increased expression of Collagen type I (the main constituent of ligaments) as compared to 
unmodified silk fibroin controls. Investigations also reported the mechanical stimulation of 
MSCs seeded in RGD-coated matrices. MSCs remained attached and aligned in the direction of 
the stimulus and shown further improvement by addition of growth factors for ligament tissue 
engineering [Moreau et al., 2005]. Ligament tissue engineering has been better supported by silk-
based scaffolds and sponges as demonstrated by better proliferation of ACL fibroblasts seeded 
with MSCs [Liu et al., 2008; Seo et al., 2007]. Research report have demonstrated the maximum 
load of 2337 ± 72 N, an elastic modulus of 354 ± 26 N/mm and a strain at failure of 38.6 ± 2.4% 
the silk fibroin matrices, which are similar to ACL [Laurencin et al., 2005]. In a similar study 
silk fibroin scaffolds showed support for adherence, spreading, proliferation and differentiation 
of adult human MSCs towards ligament neogenesis [Altman et al., 2002]. The mechanical 
strength of scaffold was retained during three weeks of culture with expression of ligament-
related transcripts (tenascin-C, collagen type III (Col-III) and Col-I) from second week. The 
expression of bone or cartilage related transcripts were not significantly affected suggesting the 
silk fibroin scaffolds promoted the ligament-specific hMSCs differentiation [Altman et al., 
2002]. Studies on cabled yarns have shown that they are suitable for load-bearing applications, 
whereas braided and textured yarns were found suitable for non-load-bearing tissues with 
enhanced cell seeding and tissue ingrowth but with limitation of mass transport and mechanical 
fixation observed in vivo [Altman et al., 2002]. The group led by Vunjak-Navakovik designed a 
6-cord silk fiber matrix with decreased scaffold stiffness and more void space (>90%) while 
maintaining the tensile strength which contribute to an enhanced tissue support and infiltration 
for neotissue formation [Vunjak-Novakovic et al., 2004]. Type-I collagen and mRNA levels for 
decorin (the most abundant proteoglycan in tendon tissue) were found to be highest on silk-RGD 
followed by silk films than on the control [Kardestuncer et al., 2006]. 
 
2.6.2.4. Vascular tissues 
Silk fibroin scaffolds are a possible alternative for vascular grafts due to combination of their 
unique mechanical properties to withstand vascular pulsating pressureand biocompatibility 
towards endothelial cells and smooth muscle cells [Zhang et al., 2008; Soffer et al., 2008]. Soffer 
et al. fabricated electrospun nanofibrous tubular structures from silk fibroin with an objective to 
bioengineer small diameter vascular grafts. Human endothelial cells and smooth muscle cells 
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were successfully proliferated on substratum indicating their potential use as scaffolds for 
vascular grafts [Soffer et al., 2008]. Scaffold porosity of 80% and above is reported ideal for 
endothelialization of vascular grafts [Zhou et al., 2009]. Tubular silk scaffolds electrospun out of 
formic acid can resist up to 575 mmHg, which is much higher than physiological pressure of 120 
mmHg [Marelli et al., 2010]. Drawback of using organic solvents, such as formic acid and HFIP, 
is that traced remained after processing may affect cyto-compatibility. Sulphonated and 
heparinized silk fibroin films have shown suitable mechanical properties for use as artificial 
blood vessels in addition to anticoagulant activity and support to endothelial cell culture [Ma et 
al., 2005]. Reports demonstrates that the blood compatibility of silk fibroin is enhanced by the 
grafting of hydrophilic polymers such as 2- methacryloyloxyethyl phosphoryl choline (MPC) 
[Furuzono et al., 2000], or blending with S-carboxymethyl kerateine [Lee et al., 1998], or coating 
with fibronectin or collagen [Unger et al., 2004; Fuchs et al., 2006]. Couet et al. have developed 
collagen-silk filament composites for vascular tissue engineering [Couet et al., 2007]. For the 
successful engineering of bone and other tissues, it is mandatory for silk fibroin to promote 
vascularization process in the regenerating tissue [Mooney and Mikos, 1999]. 
 
2.6.2.5. Other tissues 
Studies have shown that collagen-fibroin blends [Hu et al., 2006; Cirillo et al., 2004] and lactose-
silk fibroin conjugates [Gotoh et al., 2004] support the attachment and proliferation of 
hepatocytes. It is also been reported that cells cultured on SF-containing films are able to 
eliminate ammonia and synthesize urea [Cirillo et al., 2004], suggesting potential applications 
for liver tissue engineering. Silk fibroin has also been demonstrated to support the growth and 
proliferation of rat dorsal root ganglia (DRG) and Schwann cells on the substrate made up of 
purified silk fibroin fibers [Yang et al., 2007] and has, therefore, been proposed as a potential 
candidate for nerve tissue engineering. 
 
2.7. Conclusions 
In recent years, a wide range of biomaterials have been developed and designed by the scientists 
for tissue engineering includes various types of sysnthetic and natural polymers and their 
composites. The main limitation of using synthetic polymers is the risk of implant rejection due 
to lowering of local pH by their degradation byproduct (CO2 gas) and thus lead to cell and tissue 
necrosis. Whereas, the matrices of natural polymers are biodegradable, biologically active and 
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these promote cellular ingrowth for ECM formation. Gelation of naturally derived polymers is 
reported to be less controllable, although the hydrogels formed are more compatible for hosting 
cell and bioactive molecules.The properties of biopolymer can, further, be modified to induce 
differentiation of cells into specific lineages. The improvement in tissue engineering biopolymers 
can be achieved by utilizing polymers of natural or synthetic origin, separately or in blend form, 
and grafted or cross-linked networks. Surface modification via physical adsorption or chemical 
immobilization of a protein or ligand improves the material properties towards cellular behavior. 
The addition of RGD functionality or growth factors is reported to enhance surface properties of 
the scaffold.  
 
   Among the biopolymers, silk fibroin is reported to be the most attractive candidate for 
developing matrices for tissue regeneration and cell based therapy. In vivo and ex 
vivo experiments have demonstrated that silk based biomaterials show a wide range of 
advantages related to physical, chemical, mechanical, thermal and biological properties that help 
in regaining function  at cell-adhesion sites. However, many problems still to be solved to use 
them for actual clinical application. There is a need to study and develop different silk based 
hybrid scaffolds that could efficiently replace the organ structure and function. The detailed 
study of cell attachment, cell infiltration and vascularization can help in efficient integration of 
the implants into the patient's body, avoiding the generation of fibrosis around the implants. 
Moreover, silk fibroin based hybrid scaffolds should be analyzed for their biodegradation 
properties. Finally, before using silk fibroin based tissue engineering products in medicine, the 
biocompatibility and the possible generation of heterologous amyloid must be tested in vivo, with 
the purpose of assuring their biosafety. 
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MATERIALS & METHODS 
3.1. Materials 
Bombyx mori silk cocoons were obtained from silkworms reared in controlled conditions at the mulberry 
farms in Chittoor district, Hyderabad (Andhra Pradesh, India). Analytical grade Na2CO3 (S. D. Fine 
chemicals, India) and LiBr (>99% purity, Sigma Aldrich, Germany) and chemicals for Bradford Assay 
were used as such without further purification. Poly (vinyl alcohol) (Himedia, RM 6170) were used as 
blend polymeric materials for scaffold preparation and NaCl (Himedia, RM 583) as porogen. Freshly 
broken double membrane bound eggshells were collected from the canteen of National Institute of 
Technology, Rourkela, India for the preparation of soluble eggshell membrane protein (SEP). Standard 
stainless steel sieves (Fisher Scientific) (100 µm, 200 µm, 300 µm, 500 µm) were used for sorting NaCl 
particles into various particle size ranges. Clinical grade of laboratory chemicals and Milli-Q water were 
utilized in processing of scaffold fabrication and cell culture studies. 
 
3.2. Preparation and Characterization of Polymer(s) solutions 
3.2.1. Preparation of regenerated silk fibroin aqueous solution 
Dried B. mori silk cocoon shells were cut into small pieces and treated with boiling aqueous solution of 
sodium carbonate of varying concentration for 20 min with stirring. The whole mass was washed with 
Milli-Q water repeatedly to remove the glue-like sericin protein and then dried in hot air oven.  Before 
further use, the silk was dried in vacuum drying oven at 80°C for 6h. The degummed silks were 
completely dissolved in 9.3M LiBr aqueous solution at 70°C for 2½ h with stirring. The fibroin solution 
was dialyzed in a cellulose membrane based dialysis cassette (molecular cutoff 12,400) against 
deionized water for 3 days with changing of water every 6 h in order to remove LiBr. The dialysed 
regenerated silk fibroin (RSF) solution was centrifuged at 5-10˚C and 9000 rpm for 20 min and stored at 
4°C for further study. The concentration of silk fibroin aqueous solution was calculated by measuring 
the volume of solution and weighing the remaining solid after drying. The concentration of SF solution 
was calculated using the formula: 
2
1
12
C
C
VV   
Where, V1 and V2 are the volume of fibroin solution before and after evaporation, C1 is the concentration 
of the fibroin solution before evaporation and C2 is the concentration that is required in the experiment. 
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The concentration of SF solution was measured as 12% (w/v). Finally, the SF solution with 
concentration 4-6% (w/v) was prepared by dilution. The sequential experimental procedure for protein 
extraction from B. mori silk cocoon has been shown in Figure 3.1. 
 
 
Figure 3.1. Schematic diagramme for extraction of fibroin protein from Bombyx mori silk cocoon 
 
3.2.2. Process optimization of SF extraction 
3.2.2.1. Measurement of protein concentration 
The concentration of fibroin protein was measured by the Bradford protein assay method [Bradford, 
1976]. The fibroin solution was added to the Bradford reagent and incubated at 30°C for 5 min.  The 
absorbance of resultant solution was measured at 595nm. The Bradford assay relies on the binding of the 
dye Coomassie Blue G-250 to protein. Thus, the quantity of protein is estimated by determining the 
amount of dye in the blue ionic form, usually achieved by measuring the absorbance of solution at 595 
nm. Bovine serum albumin was used as a standard protein. 
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3.2.2.2. Degumming loss 
Degumming loss, a quantitative evaluation of the degumming efficiency, is represented by the weight 
loss of the fabric (expressed as a percentage of the initial weight) after degumming. Before the 
measurement of weight loss, the samples were kept at 37°C in hot air oven for 24 h. The degumming 
loss was calculated as, 
100)((%) X
W
WW
D
i
i 
 
                 Where, D is Degumming loss, Wi is initial wt. of silk cocoon and W is wt. of silk fibroin 
recovered after degumming. 
 
3.2.2.3. Experimental design for response surface methodology 
  Box-Behnken rotatable design (BBRD) for three independent variables each at three 
levels was adopted in this study. A total of 17 experiments were necessary for the estimation of the 
various coefficients of the model. The quadratic response surface model was fitted to the following 
equation [Evans et al., 2003; Guaracho et al., 2009]: 


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 Where, kXXX ,......,.., 21 are the input variables, which influence on the 
responseY ; ),....,2,1( kii  , ),.......,2,1;,....,2,1( kjkiij   the unknown parameters and  is a random 
error [Guvenc et al., 2007]. Actual values of independent variables in Box-Behnken design for the 
protein extraction using silk cocoon is shown in Table 3.1. 
 
Table 3.1: Experimental range and levels of independent variables for extraction 
iX  Range and  levels 
 -1 0 +1 
1X : Na2CO3 concentration (mg/l) 0.01 0.02 0.03 
2X : LiBr concentration (mg/l) 9.10 9.30 9.50 
3X : Temperature  (
o
C) 55 70 85 
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It is important to include the second order model to provide good prediction throughout the region of 
interest. The second order response surface design is rotatable; this means that the variance of the 
predicted response is the same at all points. Rotatability is a reasonable basis for the selection of 
response surface design. Because the purpose of response surface methodology ( RSM ) is optimization 
and as the location of the optimum is unknown prior to running the experiment, it makes sense to use 
design that provides equal precisions of estimation in all directions [Kumar et al., 2008]. For Model 
Fitting and Statistical Analysis, a three-dimensional response surface and contour plots of the 
independent variables and their interactions were generated using the statistical software, Design Expert 
software version 6.0.6 (STAT-EASE Inc., Minneapolis, US). The main aim of the optimization of 
protein extraction process was to establish the maxima levels within the independent variables such as 
32CONa  concentration ( 1X ), LiBr concentration ( 2X ) and temperature ( 3X ).  
 
3.2.3. Characterization of RSF solution 
3.2.3.1. Rheological properties    
The rheological property of the prepared silk fibroin solution was assessed by measuring the viscosity 
by a cone and plate viscometer (BOHLIN VISCO-88, Malvern, U.K.). The cone angle is 5.4
o
 and 
diameter 30mm. A gap of 0.15mm was maintained between the cone and plate for all the 
measurements. The temperature was maintained using an external water circulator as 30°C, 35°C, 40°C, 
45°C, 50°C ±1°C. The experiment was done in triplicate (n=3). 
 
3.2.3.2. Measurement of molecular weight 
The molecular weight of the regenerated silk fibroin was determined by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) according to the method described in published 
literature [Laemmli, 1970]. The running gel was prepared using 12% acrylamide gel and 5% condensing 
gel. The gel was stained with the Easy Stain Commassie Blue Kit (Invitrogen, Carlsbad, CA).  
 
3.2.3.3. Particle size analysis 
The average particle size of the prepared regenerated SF solution was determined by Zetasizer Nano ZS 
(Malvern, U.K) particle analyzer based on laser beam scattering technique. The measurement was done 
at 30°C after discarding the precipitated impurities of the solution centrifuged at 9000 rpm for 10 min at 
10°C. The optic unit contained a 4 mW He–Ne (633 nm) laser. 
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3.2.4. Preparation of Soluble Egg Shell Membrane Protein (SEP) 
Freshly broken double membrane bound eggshells, collected from our institute canteen were 
immediately stored in chilled water. The raw eggshell was washed properly and then peeled off 
manually from the membrane. The sample was kept in aqueous acetic acid (70%) for two days to 
dissolve residual eggshell followed by rinsing with Milli-Q water repeatedly to remove acidity and then 
dried in hot air oven (50ºC) for two days [Tsai et al., 2006]. Finally, the SEP was obtained by reductive 
cleavage of disulfide bonds present in ESM with aqueous 3-mercaptopropionic acid (3-MPA) at 90ºC in 
presence of 10% acetic acid, following the method published earlier [Yi et al, 2003; Yi et al., 2004]. The 
average particle size of the prepared SEP solution was determined by same method as mentioned above 
for the RSF solution. 
 
3.2.5. Preparation of SF/PVA blend solution 
Aqueous PVA solution (10% w/v) was prepared by dissolving PVA powder under continuous magnetic 
stirring at 80°C for 4 h. The hot polymeric solution was cooled to ambient temperature and stored for 
further study. The aqueous SF (12% w/v) and PVA (10% w/v) solutions were blended with varying 
ratios of SF to PVA in the range 75/25 to 25/75, under magnetic stirring at 40°C for 48 h. Glycerin (4% 
(w/v), Himedia, RM 018) was added to the SF/PVA blend solution for minimizing phase difference. 
SF/PVA solution was cooled to room temperature and the pH of the blend was adjusted to 2.00 with 0.1 
N HCl (Merck, India). 
 
3.3. Preparation and Characterization of SF and SF based matrices 
 
3.3.1. Preparation of Silk Fibroin Hydrogels and Sponges 
The prepared regenerated silk fibroin  was kept at 20ºC for 3 days under  humid environment to form 
translucent silk fibroin hydrogels (thermgels).The hydrogels were then kept at -20ºC for 24 h and 
lyophilized for 24 h to prepare fibroin sponges.  
   
3.3.2. Fabrication of silk fibroin porous scaffold  
Porous scaffolds were prepared from silk fibroin solution by salt leaching method using NaCl as 
porogen. The silk fibroin was diluted to 8% (w/v) with Milli-Q water and poured into a circular mould 
(15mm dia.) either before or after NaCl was added as a porogen. Samples were then left covered in the 
mould for 24 h and placed in methanol for 30 min followed by the transfer into deionized water for salt 
leaching for 48 h. The salt leached samples were kept in vacuum dryer for 24 h at 40°C and stored in a 
dessicator [Kim et al., 2005c]. 
Chapter3: Materials & Methods 
   
47 
 
3.3.3. Preparation of SEP-SF Scaffolds  
The SF scaffolds were steam sterilized and dried in ethanol ambiance. The scaffolds were then soaked in 
SEP solution 2% (w/v) and incubated in hot air oven at 37 ºC for 24 h for drying. The dried samples 
were cross-linked by pouring onto it a few drops of 1-ethyl-3-(3-[dimethylamino]propyl) carbodiimide 
(EDC) solution (10 mg/ml) mixed with N-hydroxysuccinimide (NHS) solution (10 mg/ml) (50:50), and 
then incubated at 37ºC for 12 h [Hafemann et al., 2001]. The cross-linked samples were desalted with 
70% ethanol and dehydrated with 99.5% ethanol, before drying under an air stream at 37ºC for 24 h. The 
cross-linked SF-SEP scaffolds were kept in desiccator for further study. 
 
3.3.4. Preparation of SF/PVA Scaffold 
A series of scaffold samples with varying SF/PVA blend ratio were prepared in triplicate using porogen 
of different particle size (100-200, 200-300 and 300-500 µm). 4g of granular NaCl (air-dried) was kept 
in autoclavable teflon moulds and 2ml of different blend solutions were poured into it. Sample container 
was covered and kept at 40-50ºC in hot air oven for 24 h. Few drops of methanol were added into the 
samples and kept for 30min for the conformational transition to occur and then dried in vacuum drying 
oven. The dried samples were kept in deionized water for 48 h for leaching of NaCl from the samples. 
These final product samples are dried in vacuum drying oven for 48 h and stored in desiccator for 
further study. 
 
3.3.5. Preparation of SEP-(SF/PVA) scaffolds 
The prepared SF-PVA scaffold was steam sterilized and dried in ethanol ambiance The scaffolds were 
then soaked in 2% (w/v) SEP solution and dried in hot air oven at 37 ºC for 24 h. The dried scaffolds 
were cross-linked by pouring onto it few drops of 1-ethyl-3-(3-[dimethylamino]propyl) carbodiimide 
(EDC) solution (10 mg/ml) mixed with N-hydroxysuccinimide (NHS) solution (10 mg/ml) (50:50), and 
incubated at 37 ºC for 12 h in 4-morpholinoethanesulfonic acid (MES) reaction buffer [Hafemann et al., 
2001; Hermanson et al., 1996]. The cross-linked sample was desalted (with 70% ethanol) and 
dehydrated (with 99.5% ethanol), before being dried under an air stream at 37 ºC for 24 h. The cross-
linked SEP–(SF/PVA) scaffolds were kept in desiccator for further study.  
 
3.3.6. Physico-chemical and Thermal characterization 
3.3.6.1. Porosity and Pore size distribution 
The porosity of the scaffolds were measured by liquid displacement methodfollowing the procedure 
discussed in published literature [Kim et al., 2005] using hexane as the displacement liquid since it is a 
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nonsolvent for silk and is able to permeate easily through the scaffold without causing swelling or 
shrinkage. In brief, a sample of weight W was immersed in a known volume (V1) of hexane in a 
graduated cylinder. The sample was left covered in hexane for 5 min. During this time, the contents in 
the cylinder underwent an evacuation- repressurization cycle to force the hexane to pass through the 
pores. The total volume of the hexane and the hexane impregnated scaffold was V2. The volume 
difference (V2 - V1) is the volume of the polymer scaffold. The hexane impregnated scaffold is then 
removed from the cylinder and the residual hexane volume is recorded as V3. The quantity (V1 - V3), 
volume of hexane within the scaffold, was determined as the void volume of the scaffold. All 
measurements were carried out in duplicate. 
The total volume (V) of the scaffold was, 
 
 
and the porosity of the scaffold (π) was obtained by, 
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Mercury intrusion porosimetry was used to measure pore size distribution of scaffolds. 
 
3.3.6.2. Phase Contrast and Scanning Electron Microscopy  
The morphology of raw and regenerated samples was observed under phase contrast microscope (Carl 
Zeiss, Axiovert 40 C) equipped with a cannon 3 CCD color video camera. The surface morphology of 
degummed silk fibre, raw ESM,SF scaffolds and SEP conjugated SF scaffolds were examined by SEM 
(JEOL JSM -6480LV SEM) observation at different magnification. Scaffold samples were air-dried 
while ESM was kept in 2.8% gluteraldehyde solution overnight before SEM analysis. The samples were 
affixed via carbon tape to the SEM sample holders and vacuum-coated with a 20-nm layer of platinum. 
SEM was performed at a voltage of 15 kV and room temperature. To measure the aperture of the porous 
structure, the SEM analysis was done using image analysis software (JEOL SMileView) and the average 
pore size was calculated. The elemental composition of soluble egg shell membrane protein was also 
determined by EDX analysis. 
 
3.3.6.3. X-ray diffraction 
The diffraction pattern of samples was recorded by an X-ray diffractometer (Phillips PW-1830) with Ni-
filterd Cu-Kα radiation operating at 35 kV and 30mA. The samples were scanned from 20° (2θ) to 70° 
(2θ) at a scanning rate of 3.0/min. Crystallinity was determined by integration using KaleidaGraph 
(Synergy Software).  
)()( 3112 VVVVV 
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3.3.6.4. Fourier transform infrared (FTIR) spectroscopy  
The FTIR analysis was performed using a FTIR spectrometer (model system IRPrestige-21, Shimadzu) 
interfaced with IR microscope operated in absorbance mode. The spectrum was measured and recorded 
solid samples in KBr pellets in the 500–4000 cm-1 region with a resolution of 4.0 cm-1. The spectra were 
smoothened with constant smooth factor for comparison. 
 
3.3.6.5. Differential scanning calorimetry  
The thermal behavior of scaffolds was determined by differential scanning calorimetry (DSC) (Mettler 
Toledo DSC822e). 10-15 mg of each sample was scanned between the range of 30-300°C at a rate of 
20°C / min under nitrogen atmosphere. 
 
3.3.6.6. Thermal gravimetric Analysis 
The thermal stability of scaffolds samples were investigated by TGA using a DTG-6H (Simadzu). The 
amount of samples for each measurement were about 1 mg, and all the measurements were carried out 
with a heating rate of 10°C min
−1 
in flowing N2 heated up to 500 °C. 
 
3.3.7. Mechanical Property 
Compressive tests were performed to determine compressive modulus of the scaffolds (dry state) by 
using a Universal Testing Machine (H10 KS TINIUS OLSEN) with a 1 kN load cell at room 
temperature. The size of the tested specimens was measured with a micrometer. The lengths and 
diameters of the tested specimens for SF scaffolds were 11.94 ± 0.22 mm and 5.64 ± 0.26 mm, 
respectively. The cross-head speed was set at 2 mm min
−1
 and compressive moduli of scaffolds (n = 4) 
were calculated from the slopes of compressive stress–strain curves.  
 
3.3.8. Swelling assay and Biodegradability 
3.3.8.1. Swelling property of silk hydrogel 
The swelling properties of the hydrogels were studied using conventional gravimetric method [Vazquez 
et al., 1997]. The swelling behavior of dried (60°C for 24 h) and pre-weighed hydrogels (disc-shaped) 
was determined by immersing in double-distilled water at 37°C. Swollen gels were weighed by an 
electronic balance at pre-determined time intervals after wiping excess surface liquid by filter paper 
[Gupta and Shivakumar, 2010]. The swelling index (SI) was calculated from the following equation: 
100

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Where Mt is the mass of the swollen gel at time t, and M0 is the mass of the dry gel at time 0. 
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3.3.8.2. Swelling property and biodegradability of scaffolds 
The preliminary cytocompatibility of the scaffold was investigated using a protein-free acellular 
simulated body fluid medium (SBF or Kokubo solution) of pH 7.40 and ionic composition- Na
+
 142.0, 
K
+
 5.0, Ca
2+
 2.5, Mg
2+
 1.5, Cl
− 
147.8, HCO
3−
 4.2, HPO4 
2−
 1.0, SO4 
2−
 0.5 mM [Kim et al., 1999]. The 
SF based scaffold were cut into 5.0mm×5.0 mm square pieces with initial weight measured as W0 and 
soaked in SBF at 37°C and pH 7.4. The samples were soaked in SBF for different time period (30 min., 
2 h, 4 h, 24 h, 96 h and 192 h). After soaking, the remaining solution were carefully removed from the 
medium, excess water on the surface was removed using lint-free tissue paper and weights (W1) were 
determined. Samples were then dried at 40°C in an oven for 24 h and theweights of dried samples were 
measured as W2.  The initial change in weight refers to fluid-uptake measurements (swelling) while the 
final weight difference after sample drying indicates the biodegradability of samples in SBF.  Each 
experiment was performed in triplicate. Swelling index (S) is calculated as, 
100
0
01 


W
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S  
Whereas the biodegradation (B) in SBF is calculated as,  
100
0
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B  
3.3.9. Contact angle measurement 
The hydrophilicity of developed scaffolds was evaluated in terms of contact angle measurement using a 
sessile drop technique with a Digital Contact Angle Measurement System fitted with a CCD camera 
(KGV-5000) [Kim et al., 2003]. First of all, scaffolds were attached smoothly to the silicon wafer 
surface by gradual evaporation of small water droplets placed along each edge of scaffold (2×2 cm
2
). A 
5 μl droplet of pure water (Milli-Q-water) was pipetted onto the scaffold surface and temporal images 
were automatically taken. Using the computer simulation software, the contact angles were calculated 
from these images. The experiment was performed at 25°C and about 60% humidity. The measured 
contact angle value reflects the hydrophilicity of scaffold with respect to the pure water (Milli-Q-water) 
as lower the contact angle more is the hydrophilicity of scaffold. 
 
3.3.10. In vitro Cell Study 
3.3.10.1. Preparation of matrices for cell study 
The scaffolds were soaked in 10% NH4OH to neutralize any acidity, and rinsed 3 times with sterilized 
distilled water. The samples were then sterilized by exposure to saturated steam and then immersed in 
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70% ethanol for 24 h for sterilization followed by rinsing with sterile PBS 3–4 times. After drying, 
samples were kept in UV radiation for 6 h on each side. Sterilized samples were then soaked in PBS 
overnight on a shaker (25 rpm) and immersed in the culture medium for 4–10 h to result in a more 
hydrophilic surface for optimal cell adhesion. 
 
3.3.10.2. Isolation and culture of hMNCs on silk hydrogels 
Mononuclear cells (MNCs) were isolated from fresh peripheral blood of healthy, middle aged human 
using Ficoll-paque separation technique as described previously [Neagu et al., 2005]. The work was 
approved by Institutional Ethical Committee. The hMNCs culture was expanded in growth media 
containing 90% DMEM-F12, 10% foetal bovine serum (FBS), 100 U/mL penicillin, 1000 U/mL 
streptomycin and 0.2% fungizone antimycotic. After passaging of culture 3 times, the cells were 
cultured to obtain a cell density of 3x10
7
 cells/ml. Autoclaved 15 ml of sterilized SF solution (12% w/v) 
were supplemented with powder DMEM-F12 and NaHCO3. For the induction of gelation, solutions 
were sonicated for 20 min in a laminar hood. After sonication, solution was cooled to room temperature. 
A volume of 50 µL cell suspension was added and well mixed with SF solution to make the final 
concentration of 1X10
5
 cells/ml. The solution was put into 5 culture petridishes (Tarson, 32 mm) and 
incubated at 37°C and 5% CO2. At the end of day 3 & 7, small plugs were punched out of the gels, 
washed 2-3 times with PBS, cut into two halves and incubated in Trypan blue for 15 min at 37°C.  
 
3.3.10.3. Isolation and culture of  hMSCs 
Human umbilical cord blood (UCB) was collected from nearby Ispat General Hospital, Rourkela, India 
from 37year old delivery patient with informed consent and due approval from the Institutional Ethics 
Committee. Mononuclear cells (MNCs) were isolated from UCB by Ficoll gradient centrifugation 
technique and cultured in Dulbecco‘s modified Eagle‘s medium (DMEM), supplemented with 10% fetal 
calf serum (FCS), 1% non essential amino acids, L-ascorbic acid (0.150 g/l), 1% of 200 mM L-
glutamine, 2% of 1 M HEPES, penicillin (100 U/ml) and streptomycin (0.1 mg/ml) at 37°C, under 5% 
CO2 and 80% RH environment with the medium being replaced every 2–3 days. hMSCs were selected 
due to their property of short-term adherence to tissue culture flasks when incubated under standard 
conditions (37 °C, 5% CO2 and 80% RH). After 24 h, non-adherent cells were discarded and adherent 
cells were further cultured, with the medium being replaced every 2–3 days.When culture flasks became 
semiconfluent after about 7 days, the cells were detached and serially subcultured [Kamihira et al., 
2007]. hMSCs harvested at third to four cycles of passaging at viable cells/ml were used for seeding into 
scaffolds. 
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3.3.10.4. Phenotypic characterization of hMSCs by Flowcytometry 
Phenotypic analysis of cultured hMSCs was performed by flow cytometry study. The fourth passage of 
cultured hMSCs were detached and properly washed with PBS followed by incubation for 20 min in 5% 
FBS (Foetal bovine serum) in PBS. The cells (1×10
5
 cells per antibody) were resuspended in 100 μl PBS 
after washing with PBS. 1 μl of phycoerythrin (PE) or ﬂuorescein isothiocyanate (FITC) conjugated 
mouse monoclonal antibodies against human CD34, CD45, CD90 (BD Biosciences, San Jose, CA) and 
CD105 (Invitrogen, Carlsbad, CA, USA) were added and incubated for 60 min in the dark at 4°C. After 
thorough washing cells three times with PBS, cells were resuspended in 400 μl PBS and analysed by 
BD LSR Fortessa and FACS Diva software (Becton Dickinson, San Jose, USA).  
 
3.3.10.5. Cell seeding and culture 
The sterilized scaffolds were placed in a 6 well plate. MSCs were seeded with 1x10
5
 cells/ml into the 
scaffoldby static methodand cultured in CO2 incubator at 37°C, 5% CO2 and 80% RH.  The cultural 
medium was replaced every 2-3 days. The MSCs-seeded scaffolds were grown in vitro. MSCs seeded-
scaffold was then assessed for cell attachment, proliferation and viability at various time points over the 
14 days period of culture. 
 
3.3.10.6. Cell Morphology 
The photomicrographs of cells were observed under phase contrast microscope (Carl Zeiss, Axiovert 40 
C) equipped with CCD camera. The surface morphology of MSCs on the scaffolds was examined by 
SEM (JEOL JSM -6480LV SEM) observation at different magnification. Adhered hMSCs in culture 
plate and cell seeded scaffolds were kept in 2.8% gluteraldehyde solution overnight before SEM 
analysis. The samples were affixed via carbon tape to the SEM sample holders and vacuum-coated with 
a 20-nm layer of platinum. SEM was performed at a voltage of 15 kV and room temperature. 
 
3.3.10.7. Cell seeding efficiency and cell proliferation assay 
For the study of cytocompatibility of salt leached SF scaffolds, (3-[4,5-dimethyltriazol-2-y1]-2,5-
diphenyl tretrazolium) (Sigma, St Louis, MO, USA) assay was performend as reported in the published 
literature [Cory et al., 1991; Wilson et al., 2000]. This colorimetric assay is based on the ability of live 
cells to reduce yellow MTT reagent to a purple formazan product [Mosmann ey al., 1983]. In brief, 
5×10
4
 cells were seeded on scaffolds in a 96-well plate. The cells were incubated at 37°C in humidified 
atmosphere containing 5% CO2. After 24 h incubation, supernatant of each well was replaced with MTT 
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diluted in serum free medium and the plates incubated at 37°C for 4 h. After that, 10%SDS/ 0.04 N HCl 
solution was added to supernatant and plates were re-incubated for 24 h, 200μl was transferred to a clean 
96-well plate and absorbance was measured at 595 nm using ASYS EXPERT PLUS spectrometric 
microplate reader. For analysis, all data were expressed as average ± standard deviation for number of 3 
replicates (n=3).  
 
Figure 3.2: Stepwise representation of cell based bone regeneration. MSCs isolated and characterized from 
adult tissues, incorporated into scaffold, cultured, proliferated and differentiated, finally implanted 
into defective site. 
 
3.3.10.8. Alkaline phosphatase (ALP) Assay 
ALP assay is based on measuring the change in colorimetric absorbance of colourless para-nitrophenol 
phosphate (pNPP) cleaved to yellowish (paranitrophenol + phosphate) by membrane bound alkaline 
phosphatise enzyme. The alkaline phosphatase (ALP) activity of hMSCs grown on the scaffold was 
estimated to investigate the osteogenic differentiation following the method described in literarture 
[Mauney et al., 2005]. In brief, the hMSCs seeded scaffolds were cultured in osteogenic differentiation 
medium for 1, 7 and 14 days.At each time interval, the scaffold were thoroughly washed with PBS to 
remove the residual serum and then 1 ml of 0.02% Triton® X-100 was added to dissolve the cells. The 
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solutions were centrifuged at 14,000 rpm at 4°C for 15 min. 100 μl 1 mol/l Tris-HCl, 20 μl 5 mmol/l 
MgCl2 and 20 μl 5 mmol/l p-nitrophenylphosphate were added to the supernatant and incubated for 30 
min at 37°C. The reaction was stopped with 50 μl of 1N NaOH and the absorbance was measured at 410 
nm using a UV-VIS spectrophotometer (Systronis-117). The standard curve was prepared using p-
Nitrophenol of known concentrations [Sun et al., 2008]. All solutions were components of the Alkaline 
Phosphatase Assay Kit (Abcam, Cambridge, MA, ab83369-500). 
 
3.3.10.9. Histology 
Samples were fixed in 10% neutral buffered formalin (4% formaldehyde in phosphate buffered saline), 
embedded in paraffin, sectioned (5 µm thick) and observed histologically by hematoxylin and eosin 
(H&E). The cross-sections of the grafts were analyzed after 3, 7 and 14 days of in vitro culture. A 
general assessment of histology was performed using light microscopy. 
 
3.3.11. In vivo biocompatibility test in animal model 
The developed scaffolds were transplanted under the skin of 4- to 6-week-old ICR recipient mice as per 
procedure described previously [Jung et al., 2008] with a slight modification. In brief, Intra-peritoneal 
injection of avertin (Tri-bromoethanol, 0.25 mg/g of body weight; 2-methyl-2-butanol, 0.16 ml/g) was 
performed to anesthetize the mice and the skin was sterilized with 70% (v/v) ethanol. Approximately ~1 
cm linear incision was made on the dorsolateral side of the skin and a small pouch was created in the 
subcutaneous layer. Scaffolds of dimension 5 x 5mm
2
 were transplanted into the surgically-created 
subcutaneous pouch and the incision was closed using nylon suture. The mice were monitored routinely 
for the skin and systemic diseases, if any. After one month, they were sacrificed by cervical dislocation 
and the scaffolds were explanted. Histological analysis was done with the skin around the site of 
transplantation. The skin samples were fixed in 10% (v/v) neutral buffered formalin and dehydrated in 
ascending grades of 40%, 60%, 80%, 95% and 100% ethanol and embedded in the paraffin wax. 5µm 
thick slices of specimens were made by microtome sectioning and were examined histologically after 
hematoxylin and eosin staining. All testing were performed under the aseptic conditions in compliance 
with the Guide for the Care and Use of Animals in Research and Teaching, published by the Federation 
of Animal Science Societies (3rd Edition, 2000) in Bio-Organ Research Centre, Konkun University, 
South Korea, and were approved by the Institutional Biosafety and Ethical Committee. Efforts have 
been given to ameliorate the suffering of animals. 
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3.3.12. Statistical analysis 
Statistical significance was determined for all groups of scaffold samples for a number of 3 replicates 
and P values were generated by ANOVA using the Dunnett Test for multiple comparisons to one control 
(p 0.05, n≥3 assays). This method relies on assumptions of normality and homogeneity of the variances 
of the distributions.  
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Extraction ofsilk fibroin protein extraction from B. mori silk cocoon 
and its characterization 
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Silk fibroin (SF), a natural macromolecule derived from domestic silkworm (Bombyx mori), has 
attracted the interest of scientists of various disciplines for a long time.  It has a long history of use 
in medicine, for example, as sutures and artificial ligaments. Recently it has been considered asa 
promising biomaterial that offers a wide range of biomedical applications because of its excellent 
mechanical properties, environmental stability, biocompatibility and biodegradability [Ning et al. 
1999; Altman et al., 2003]. These properties make SF as most attractive and promising biomaterial 
for bone, cartilage and ligament tissue engineering [Altman et al., 2003]. Silk consists of two 
different proteins: sericin and fibroin [Perez-Rigueiro et al., 1998]. Silk must be regenerated into a 
desirable form to meet a specific biomedical application. Removal of sericin from silk fibre 
traditionally known as degumming requires a thermo-chemical treatment [Perez-Rigueiro et al., 
2002]. The detail procedure and reason for degumming of the silk has been reported earlier [Kadhar 
et al., 2008]. The weakening of non-covalent bonds with fibroin and involvement of hydrophilic 
bond with ionic solution leads to removal of sericine. The fibroin has highly oriented crystalline 
domain and it is insoluble. The fibroin content of naturally spun silk fibers can be separated from 
sericin in vitro[Rui et al., 1998]. Degummed silk fibers is soluble in certain high ionic-strength 
aqueous solutions of chaotropic salts namely CaCl2, LiBr and so on, which destabilize proteins in 
solution and increase their solubility [Kweon et al., 2001a], leading to a transparent solution [Ayub 
et al., 1993; Sashina et al., 2006]. To date many researchers have attempted to find suitable solvents 
for preparing SF solutions, which may be subsequently spun into fibers. However, very few 
published reports are available that can provide complete processing of silk, optimization of process 
conditions and the characterization of silk solution. In this chapter, effort has been given to study 
the effect of various key process parameters to maximize the yield of SF from silkworm 
cocoon.The study uses Box–Behnken design for the optimization purpose using RSM to understand 
the effect of important process variables and their interactions on SF extraction process.  
 
4.1.1. Degumming of B. mori silk cocoon 
Degumming is a method of removing sericine from silk cocoon. The mechanism of sericin removal 
in chemical degumming is a combination of various effects such as: dispersion/solubilization and 
hydrolysis of different sericin polypeptides [Freddi et al., 1996]. Hydrolysis prevails when strong 
alkaline compounds are added to the degumming bath. Therefore, it was investigated the effects of 
key process parameters, such as temperature, time, and salt concentration on sericin removal 
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without triggering the hydrolytic degradation of fibres, that is easily induced by the presence of 
harsh chemicals in the treatment bath.  
 
4.1.1.1. Effect of Na2CO3 salt concentration 
To study the effect of salt concentration on the extent of sericin removal, the chopped silk cocoons 
were treated with varying concentration of aq. Na2CO3 in the range 0.01 to 0.04M. The degumming 
temperature and treatment time were kept constant at 70°C and 60 min. The effect of salt 
concentration on the formation of degummed silk fibers is shown in Figure 4.1.1. It is observed that 
the amount of silk fiber sharply decreased with increase in salt concentration from 0.01M to 0.02M 
which may be due to the loss of most of sericine from the silk fibre into the solution. The 
degumming loss was found to be increased from 19.9 % to 24.4 % with increase in concentration 
from 0.01 to 0.02M Na2CO3 solution and no significant increase in degumming loss with further 
increase in concentration of Na2CO3 is observed. However, the maximum degumming loss of 25.4 
% was achieved at the concentration of 0.04M (Fig. 4.1.1). Therefore 0.02M Na2CO3 has been 
established as the most favourable salt concentration for degumming achieving maximum sericine 
removal. The minimum salt concentration also offers the silk fibre to be intact as high concentration 
of harse chemical may cause hydrolytic degradation of silk fibroin. Furthermore, at 0.02M, the silk 
surface was found smoother as compared to higher concentration as revealed by SEM (Fig. 4.1.4). 
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Figure 4.1.1: Effect of aq. Na2CO3 concentration on degumming of silk at 70°C and 60 min, The 
degumming loss is increasing with increase in Na2CO3 concentration. However most of the 
degumming loss representing maximum sericine removal is acheived with 0.02M Na2CO3 .   
 
4.1.1.2. Effect of degumming time 
The treatment time has a significant influence on the degumming of silk [Kadhar et al., 2008]. To 
study the effect of the treatment time on the extent of sericin removal, the silk cocoon were treated 
with 0.02M aq. NaCO3 solution at 70°C at a varying time period in the range 20-80 min. At 20 
min., degumming loss was calculated as only 11% recovery of 8.9 g of silk fibre as shown in Fig. 
4.1.2. At 40 min the loss increases to 18.8 % and the amount of silk recovered was 8.12 g. A loss of 
degumming 25.1 % was achieved after 60 min. Though a slightly increase in degumming loss (25.6 
%) was observed with 80 min treatment time, the recovery of silk fibroin was found to be less (Fig. 
4.1.2). This reduction in recovery of silk fibre with longer treatment time may be due to increased 
hydrolysis of interlinking bond between sericine and fibroin and more solubility of sericin into the 
solution. Moreover, the increase in treatment time probably exposes sericin to the action of 
hydrolysis by salt. Therefore, it has been established that 60 min is the most favourable degumming 
time. 
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Figure 4.1.2: Effect of treatment time on degumming process performed at 0.02M NaCO3 and 70°C. 
Degumming loss is increased steadily with increase in treatment time and reached maximum at 60 
min. 
 
4.1.1.3. Effect of degumming temperature 
It is evident that sericincan be removed using water alone, but high temperature is required to attain 
complete degumming (110–120ºC, under pressure) [Freddi et al., 1996]. The effect of degumming 
temperature on the sericin removal was studied by conducting degumming experiment at varying 
temperature range 60-90ºC. Below 60ºC no significant degumming is achieved as reported earlier 
[Sukigara et al., 2003]. The concentration of Na2CO3 and treatment time were kept constant at 
0.02M and 60 min respectively. The degumming temperature of 60ºC probably contributed to 
enhance the solubility of partially hydrolyzed sericin fractions adhering to the fibrous core of the 
silk as depicted in Fig. 4.1.3. The rise in temperature from 60 to 70ºC resulted in the loss of most of 
the sericin acheiving 24.4% degumming loss. A slight increase in degumming loss was observed at 
80ºC and 90ºC. The corresponding degumming loss is 25.1% and 25.5% (Fig. 4.1.3). Thus, 
degumming temperature of 70ºC is established as optimum temperature. The rise in temperature not 
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only provides the activation energy for the breakdown of interlinking bonds but also increases the 
solubility of sericin into solution [Kadhar et al., 2008]. 
 
 Figure 4.1.3: Effect of temperature on degumming process. The graph showing an increase in 
degumming loss with temperature and most of the degumming is achieved between 60-70ºC.  
 
4.1.1.4. SEM study with degummed silk fiber  
The SEM observation of silk fibers obtained by the treatment with different concentration of 
Na2CO3 salt is shown in Fig.4.1.4. It is observed that the removal of sericin resulted in the 
separation of the individual silk filaments, which were glued together by sericin and sizing agents in 
the raw silk. This conferred on the fabric the denser texture and rough surface typical of light 
weight silk fibres. The dull appearance and stiff handle of the raw silk fibre disappeared, and the 
degummed silk became shiny, soft, and scroopy. Fig. 4.1.4(a) clearly confirms the presence of 
sericin stick as white spots to the surface of silk fiber. The presence of sericin in silk fiber is more 
when treated with 0.01M salt concentration showing non-uniform removal of gum from interlacing 
regions of fibers compared to the use of 0.03M salt concentration. So it is concluded that increase in 
concentration of Na2CO3 decreases the sericin content of silk fiber. The closer observation of SEM 
images of the silk fibroin fibre showed that the individual silk filaments split off and their surface 
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was clean and free of sericin. On the other hand, the presence of sercicin on the fibre was observed 
when silk degummed with lower salt concentration. Furthermore, it is interesting to note that the 
deposits were mainly located at the cross over points between silk fibers making it stick together. 
The diameter of silk fibre was analysed and measured as 10-12 µm using SEM JEOL software. 
 
4.1.2. Preparation of regenerated aqueous SF solution 
The solubility of silk fibroin in ionic liquids depends on the identity of both the cation and anion, 
with the anion having a much larger effect. It is reported that more the cation and anion are able to 
participate in hydrogen bonding, the greater the solubility of the silk fibroin [Phillips et al., 1989]. 
Presumably, the ionic liquid disrupts hydrogen bonding present in the β-sheets. The solubility 
depends on various factors like temperature, salt concentration and exposure time. Therefore, the 
effect of these parameters on solubilisation of degummed silk fibre was investigated in this study. 
 
4.1.2.1. Effect of temperature on solubilization 
The effect of temperature on solubility of protein is shown in figure 4.1.5. It is observed that the 
solubility is steadily increased with increases in temperature from 50 to 70C and then becomes 
almost constant with further increase in temperature. However, the complete dissolution of silk 
fibre occurs at 70C and higher temperature. Furthermore, though a reasonable solubilisation was 
obtained at 60C, it was very difficult to separate SF solution. Thus, it is established that 70C is the 
optimal temperature for dissolving degummed silk fibre. 
 
 
 
  
Chapter 4: Result & Discussion 
   
64 
 
 
 
 
 
Figure 4.1.4: SEM micrographs illustrating morphology of degummed silk fibre with (a) 0.01M 
Na2CO3, shows comparatively incomplete removal of sericin. (b) 0.02M Na2CO3, shows 
relatively smooth and individual longitudinal strands and (c) 0.03M Na2CO3, shows individual 
longitudinal strands.  
a 
b 
c 
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Figure 4.1.5: Effect of temperature on solubility of SF protein. A steady increase in solubility of silk 
fibroin is observed with temperature upto 70 C 
 
4.1.2.2. Effect of LiBr concentration on solubilization 
The effect of LiBr concentration on solubility of protein is shown in Fig.4.1.6. LiBr is selected 
among other chaotropic reagents viz. CaCl2 and NaSCN due to its higher dissolving ability as 
reported earlier [Addis and Raina, 2013]. The amount of protein present is more at 9.3M than 
obtained with other salt concentrations. So as the concentration of LiBr increases, the solubility of 
protein also increases. At concentration of 9.1M, protein concentration is 1.4 mg/ml that increases to 
1.7 mg/ml at 9.3M concentration. There is no further increase in protein concentration beyond 9.3M. 
An increase in solubility is obserbed upto 9.3M that may be due to enhanced breaking of disulfide 
bonds between the heavy and light chains of silk fibroin [Kweon et al., 2001]. A comparable protein 
concentration is also obtained with LiBr concentration of 9.4M and 9.5M. However, the maximum 
protein concentration is obtained with 9.3M LiBr concentration. The slight decrease in protein 
concentration may be due to increased partial molar concentarion of salt in solution. 
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Figure 4.1.6: Effect of LiBr concentration on the solubility of protein. Protein concentration increases 
with increase in concentration of LiBr upto 9.3M and then a decline in trend is observed. 
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Figure 4.1.7: Effect of exposure time on dissolution of silk fibroin. Figure shows a steady increase in 
dissolution of SF with treatment time 1-3 h achieving maximum dissolution and no signicant 
change is observed beyond 3h. 
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4.1.2.3. Effect of exposure time on solubilization 
The exposure time facilitates the solute with thermal energy to break bonds that binds molecules 
together. More is the exposure time, more of the heat energy accumulates to break inter and intra-
chain covalent bonds in silk fibroin. Therefore, the effect of exposure time on solubilization of 
degummed silk fiber was studied with 9.3M LiBr solution at 70 °C. As it is indicated in Fig. 4.1.7, 
the SF concentration found to increase with increase in exposure time from 1-3 h. There is no 
further increase in SF concentration observed beyond 3 h of exposure. 
 
4.1.3. Characterization of regenerated aqueous SF solution 
During dissolution of degummed silk fiber in LiBr, the amide bonds of fibroin molecular chain is 
reported to cleave to a different extent resulting in easy solubilization in water. This regenerated 
silk fibroin is easily denatured and gelled by various factors [Zhang et al., 2005]. Besides 
temperature and pH, the stability of silk fibroin solution largely depends on its molecular weight 
[Zhang et al., 2005]. The particle size measurement of polymeric materials confirms the structural 
stability in solution and provides a high degree of control over processed material performance 
[Horiba Scientific Inc., 2012]. The prepared SF aqueous solutions were kept at 4°C and 
characterized by SDS-PAGE and particle size analysis within a month. Fig. 4.1.8a (SDS-PAGE) 
shows a smear band of silk fibroin corresponding to molecular marker ranging between 200 kDa to 
30 kDa. As the result indicates that the regenerated protein solution are composed of a mixture of 
polypeptides with different molecular weights. A broad dull band at 200 to 35 kDa and dense band 
at 25 kDa are observed in Fig. 4.1.8a. The former band may be attributed to the  degradation 
products of heavy chain (350 kDa) formed by the cleavage of amide bonds of raw silk protein, 
while the band at 25 kDa corresponds to light chain of raw silk protein. The result is further 
confirmed by particle size analysis of silk fibroin solution as shown in Fig. 4.1.8b. The particle size 
distribution profile is observed to be binodal, with peaks at around 100nm and 5µm. Since particle 
size of the starting SF solution is disintegrated due to extraction process with salts, the result shows 
the presence of light chain (25 kDa) with disintegrated heavy chain(350 kDa) [Horan et al., 2005]. 
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Figure 4.1.8: (a) SDS-PAGE (12% gel) of silk fibroin protein. Marker and fibroin lanes mean the 
standard protein ladder from 10 to 200 kDa (Gibco Co., USA) and molecular mass range of 
silk fibroin, respectively and (b) Particle size distribution of silk fibroin. 
 
4.1.4. Optimization of SF extraction by RSM 
The optimization of any process using response surface methodology (RSM) is more advantageous 
than the traditional single parameter optimization in terms of saving time, working space and raw 
material. Therefore, an attempt has been made in the present study to establish the optimum 
conditions of key variables for maximum SF protein extraction. The process variables used are the 
Na2CO3 concentration (X1), LiBr concentration (X2) and temperature for dissolution (X3). All the 
experiments were conducted for optimizing the three individual parameters using Box–Behnken 
design (Table 4.1.1). The results were analyzed by multiple regression analysis. Table 4.1.2 shows 
the experimental conditions and results of extracted SF yield based on the factorial design. 
Maximum yield of protein (2.10 mg/ml) was recorded under the experimental conditions of Na2CO3 
concentration 0.01 M, LiBr concentration 9.10 M, and temperature 70 Co . 
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Table 4.1.1: Selection of a satisfactory model for protein extraction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To decide about the adequacy of the model for SF yield, three different tests such as Sequential 
Model Sum of Squares, Lack of Fit Tests and Model Summary Statistics were carried out and p 
values for all the regressions were  found to be lower than 0.01 (see Tab. 4.1.2). This means that at 
least one of the terms in the regression equation had a significant correlation with the response 
variable. The model summary statistic showed the highest regression coefficient as R
2
 = 0.9761 for 
the quadratic model with minimum standard deviation of 0.041. ANOVA analysis confirmed that 
Sequential Model Sum of Squares 
Source Sum of Squares df Mean Square F p Remark 
Mean 49.20 1 49.20 - - - 
Linear 0.36 3 0.12 11.56 0.0006 - 
2FI 0.019 3 6.217E-003 0.53 0.6735 - 
Quadratic 0. 11 3 0.035 20.60 0.0008 suggested 
Cubic 3.875E-003 3 1.292E-003 0.64 0.6299 Aliased 
Residual 8.120E-003 4 2.030E-003 - - - 
Total 49.70 17 2.92 - - - 
Lack of Fit Tests 
Source Sum of Squares df Mean Square F p Remark 
Linear 0.13 9 0.014 7.03 0.0380 - 
2FI 0.11 6 0.018 9.01 0.0259 - 
Quadratic 3.875E-003 3 1.292E-003 0.64 0.6299 suggested 
Cubic 0.000 0 - - - Aliased 
Pure error 8.120E-003 4 2.030E-003 - - - 
Model Summary Statistics 
Source Std. Dev. R
2
 Adj. R
2
 Pre. R
2
 PRESS Remark 
Linear 0.10 0.7274 0.6645 0.4501 0.28 - 
2FI 0.11 0.7647 0.6235 -0.1233 0.56 - 
Quadratic 0.041 0.9761 0.9453 0.8509 0.075 suggested 
Cubic 0.045 0.9838 0.9352 - - Aliased 
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the form of the model chosen to explain the relationship between the factors and response is 
validated [Tarangini et al., 2009]. 
 
Table 4.1.2:.Box–Behnken design matrix of the three variables in coded units along with the 
experimental and predicted values of protein yield 
 
Trial no 
1X  2X  3X  Protein yield (mg/ml) 
    Experimental Predicted 
1 0.01 9.10 70 1.89 1.92 
2 0.01 9.50 70 1.84 1.85 
3 0.03 9.10 70 1.71 1.70 
4 0.03 9.50 70 1.65 1.62 
5 0.02 9.10 55 1.45 1.45 
6 0.02 9.50 55 1.30 1.32 
7 0.02 9.10 85 1.76 1.74 
8 0.02 9.50 85 1.74 1.74 
9 0.01 9.30 55 1.64 1.61 
10 0.03 9.30 55 1.50 1.51 
11 0.01 9.30 85 2.1 2.09 
12 0.03 9.30 85 1.72 1.75 
13 0.02 9.30 70 1.70 1.72 
14 0.02 9.30 70 1.69 1.72 
15 0.02 9.30 70 1.73 1.72 
16 0.02 9.30 70 1.80 1.72 
17 0.02 9.30 70 1.70 1.72 
 
 In order to determine the significance of quadratic model, ANOVA analysis was done. The p-
values were used as a tool to verify the significance of each coefficient, which also indicates the 
interaction strength of each parameter. The smaller the p-values are, the bigger is the significance of 
the corresponding coefficient [Zhao et al., 2009]. Here, the p-value of the model is found to be 
smaller than 0.0001, which indicates that the model is suitable for use in this experiment. The P -
value of ‗‗lack of fit‖ is 0.64 (p> 0.01), which indicates that ‗‗lack of fit‖ is not significant relative 
to the pure error. The coefficient of determination ( 2R ) and adjust coefficient of determination 
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( 2.RAdj ) are shown in Table 4.1.3. The values indicate that the accuracy and general availability of 
the polynomial model are adequate [Tarangini et al., 2009]. The regression coefficients and the 
corresponding p-values are presented in Table 4.1.4. From the p-values of each model term, it is 
concluded that three linear coefficients ),,,( 321 XXX three quadratic coefficients ),,,(
2
3
2
2
2
1 XXX and 
three cross-product coefficients )( 31XX are significant. Using the designed experimental data 
(Table 4.1.1), the polynomial model for the protein extraction was regressed as follows (in terms of 
actual factors): 
 
31
2
3
2
2
2
1321 01.000432.462.1113002.008.2970.1613.132 XXXEXXXXXY       (3) 
Table 4.1.3: Analysis of variance for the fitted quadratic polynomial model for protein yield 
R
2
=0.9761; Adj R
2
=0.9453 
 
Table 4.1.4:  Regression coefficients and their significance of the quadratic model for protein yield 
 
Model term Coefficient 
estimate 
Df Standard error Probability (p)>F 
Intercept 1.72 1 0.019 - 
1X  -0.11 1 0.015 0.0001 
2X  -0.35 1 0.015 0.0481 
3X  0.18 1 0.015 <0.0001 
2
1X  
0.11 1 0.020 0.0008 
2
2X  
-0.065 1 0.020 0.0151 
2
3X  
-0.097 1 0.020 0.0019 
31XX  -0.060 1 0.021 0.0230 
 
Source Sum of 
squares 
df Mean square F-value Probability 
(p)>F 
Model 0.49 9 0.054 31.71 <0.0001 
Lack of fit 0.0039 3 0.0013 0.64 0.6299 
Pure error 0.0082 4 0.002   
Correlation 
total 
0.50 16 - - - 
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A normal probability and a dot plot of residuals are shown in Fig. 4.1.9. The data points on this plot 
lie reasonably close to a straight line, indicating that X1, X2, X3, ,,,
2
3
2
2
2
1 XXX and 31XX  are the only 
significant effects and that the underlying assumptions of the analysis are satisfied. Fig. 4.1.10 
shows the relationship between the actual and predicted values of Y for protein extraction from 
Bombyx mori silk cocoon. It is observed from Fig. 4.1.9 that the developed models are adequate as 
indicated by the residuals for the prediction of each response are minimum. 
 
 
Figure 4.1.9: Normal % probability versus residual error 
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Figure 4.1.10: Scatter diagram of predicted versus actual response for silk fibroin extraction 
 
Many parameters can influence the extraxtion of protein. Eq. (3) shows that the yield of SF protein 
has a complex relationship with independent variables that encompass both first and second-order 
polynomials and may have more than one maximum point. Fig. 4.1.11 represents the effects of 
32CONa  concentration, temperature and their reciprocal interactions on protein yield. The 
degumming SF yield is shown to increase with increase in temperature at constant 32CONa  
concentration. However, the maximal SF protein yield is obtained at of 85 Co . Fig. 4.1.12 shows the 
effects of LiBr  concentration, temperature and their reciprocal interactions on protein yield. At a 
high temperature, the SF yield is increased with increase in temperature.  
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Figure 4.1.11: Response surface plots representing the effect of Na2CO3 concentration and 
temperature and their reciprocal interaction on SF yield 
 
Figure 4.1.12: Response surface plots representing the effect of LiBr concentration, temperature and 
their reciprocal interaction on SF yield 
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4.1.5. Validation of the model 
The optimal values of the selected variables were dtermined by solving the regression equation (Eq. 
3) using Design-Expert 6 software. The optimal conditions for SF protein yield estimated by the 
model equation are as follows: Na2CO3 concentration, X1= 0.01 M, LiBr concentration, X2= 9.23 M 
and temperature, X3= 85ºC. The theoretical protein yield (Y) predicted under the above conditions is 
2.09 mg/ml. In order to verify the prediction of the model, the optimal reaction conditions were 
applied to three independent replicates for protein yield. The average protein yield is measured as 
2.1±0.01 mg/ml which is quite matching with the estimated value using model equation. This 
demonstrated the validation of RSM  model. The good correlation between these results confirmed 
that the response model is adequate for reflecting the expected optimization. The results also 
suggest that the models of Eq. (3) are satisfactory and accurate. 
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PART II 
Preparation, characterization and in vitro biocompatibility study of 
silk fibroin hydrogel 
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Hydrogels are three-dimensional polymeric networks that are prepared by physical or chemical 
crosslinking and resist swelling in aqueous solution without dissolving in it [Vepari et al., 2007; 
Lee et al., 2001]. Since hydrogels are highly hydrated hydrophilic polymer networks that contain 
pores and void spaces between the polymer chains, it can be implanted for tissue restoration or local 
release of therapeutic factors. Such hydrogels are biocompatible and provide many advantages over 
the conventional solid scaffold materials, including an enhanced supply of nutrients and oxygen for 
the cells and space to cells for proliferation and expansion. Due to their high water content, 
hydrogels have similarities to some tissues and extracellular matrices (ECM) [Park et al., 1992]. 
Because of this property, hydrogel has been considered as an attractive biomaterial and widespread 
research is under way on using hydrogels as scaffold materials for possible application in tissue 
engineering. Hydrogels prepared from a variety of polymers such as alginates, chitosan, and 
collagen have been studied for use as scaffold material [Lee et al., 2001; Drury et al., 2003]. 
Hydrogels made from synthetic polymers offer the benefit of gelation and gel properties that are 
controllable and reproducible through the use of specific molecular weights, block structures, and 
modes of crosslinking. However, the less biocompatibility and use of toxic reagents for their 
preparation limit their applications. Generally, gelation of naturally derived polymers is reported to 
be less controllable, although their hydrogel forms are reported to be more compatible for hosting 
cell and bioactive molecules [Lee et al., 2001; Smidsrod et al., 1990]. Injectable biomaterials for 
tissue engineering are defined as cell seeded engineered scaffolds that directly injected at the site of 
defect. Such fluidly material takes the complex shape of site, fixes it and exchanged with body fluid 
while the seeded cells proliferate and differentiate to form tissues. Such approach in tissue 
engineering has been reported to reduce surgical operations [Balakrishnanet al., 2005; Kretlow et 
al., 2007]. Therefore, in this part of thesis work, efforts have been given to examine the 
processability of concentrated aqueous silk fibroin solutions into highly porous gel sponges and 
study their properties for possible tissue engineering applications. 
 
4.2.1. Morphological Study   
Morphologically, the hydrogels shows a sponge-like cross-linked structure formed by physical 
entanglement as well as chemical hydrogen and covalent bindings. Water-stable hydrogels were 
formed from SF aqueous solutions after 24 h of incubation that leads to the formation of porous 
matrices. The formation of porous matrices is due to the induction of a sol-gel transition in 
concentrated solution sample [Garg et al., 2012]. 
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Figure 4.2.1: (a) Simple vertical view and (b,c,d) microscopic images of SF hydrogel obtained from 
12% (w/v) aq. SF solution, when kept at 20°C for 3 days observed at magnification (b) 5X, (c) 
10X and (d) 20X  
 
 
Figure 4.2.2: SEM images of (a) porous lyophilized hydrogel with leaf-like structure prepared from 4 
wt % SF and (b) hydrogel sponge prepared from >12 wt % SF solutions. 
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   Regenerated silk fibroin solution when kept at 20ºC in humid environment for more than 72 h, the 
solution was converted into gel and ultimately hydrogel (thermgel) formed. The process was 
induced by adding a few drops of methanol as crystallinity inducing solvent. The silk hydrogel 
intact in shape is formed and stabilized due to inter-networking. The gel doesn‘t lose its integrity 
when kept vertically as shown in Fig. 4.2.1(a).Fig. 4.2.1(b, c, d) is a representative optical 
micrograph of prepared silk fibroin hydrogel sample. Morphological study of silk fibroin  porous 
matrices are observed by SEM (Fig. 4.2.2(a, b)) after lyophilizing the hydrogel samples at −80° C. 
Lyophilized hydrogels prepared from silk fibroin solutions of 4-12 wt% concentration showed leaf-
like morphologies while sponge-like structures were observed with concentration more than 12 
wt%. This is in good agreement with the observation reported earlier [Kim et al., 2004]. The 
sponge-like structure is more liable to be applicable for tissue regeneration as it provides better 
niche and channel for cellular activities. 
 
4.2.2. Swelling Property  
 
The swelling state of the polymer is reported to be important for its bioadhesive property [Smart et 
al., 1984; Smart et al., 2005]. It is also reported that the molecular structure of fibroin doesn‘t 
change by change in water content of the gel, while the physical properties of the gel changes 
significantly [Ayub et al., 1993]. Therefore, the swelling behavior of the prepared hydrogel was 
studied and the experimental data is tabulated in Table 4.2.1. It is observed that water uptake by 
hydrogels increased with time until equilibrium is reached at 24 h. The swelling was found to occur 
uniformly in all direction with increase in volume and change in physical appearance from 
translucent to opaque and semi-fluid was observed (Fig. 4.2.3). 
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Figure 4.2.3: Pictorial view of (a) dehydrated and (b) swollen SF hydrogel  
  
The dehydrated gel is found to be non-brittle representing the presence of water molecule to 
maintain equilibrium with respect to physical properties of the gel. The gel became brittle when it 
was dehydrated in oven. The higher swelling rate at the initial stage indicates the sucking of water 
molecules into the collapsed gel and adsorption of water over the dried surface of gel. Though the 
swelling ratio increased with increase in time of soaking, a decline in rate is observed beyond 16 h 
and the rate becomes constant with further increase in time. Therefore, the maximum swelling 
index of 286.7 is obtained at 16 h (Table 4.2.1). No further change was observed beyond 24 h of 
soaking which may be due to the entry of water molecule at a slower rate to the collapsed gel 
network. 
 
Table 4.2.1: Swelling behaviour of dehydrated SF hydrogel in water at different time period 
 
 
 
 
 
 
 
 
 
Time (h) Weight of gel (mg) Swelling Index (%) 
0 77.19 0  
2 135.12 75.05 
4 244.14 216.28 
16 298.54 286.76  
24 301.12 290.1  
28 301.15 290.14  
32 301.155 290.15  
36 301.155 290.15  
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4.2.3. Thermo-rheological Behavior 
The thermorheological behavior of prepared SF hydrogel was examined by measuring shear stress 
and viscosity at 5 degrees interval. Fig.4.2.4 shows the changes in viscosity with temperature. 
Thermal behavior of SF samples recently studied through differential scanning calorimetry (DSC) 
depicts a broad endotherm with a peak near 45°C indicating gradual structural change with increase 
in temperature and a new structure is formed above 45°C. This thermal behavior shows consistency 
with the viscoelastic behaviour of SF hydrogel. Preliminary ATR FT-IR studies have indicated that 
the fraction of antiparallel β -sheet conformation appreciably increased at 45°C [Ochi et al., 2002]. 
Irreversible structural change could be considered as a reason to the observed thermoreheological 
behavior.  
 
Figure 4.2.4: Thermo-rheological behavior of SF hydrogel 
 
Fig. 4.2.4 shows the linear proportionality between viscosity and temperature at the low shear rate 
region less than 100 s
-1
. It has been reported that the rheopectic fluids increase their viscosity over 
time with application of shear forces, while thixotropic fluids have a reversible time-dependent loss 
of viscosity accompanying the application of shear force [Miller et al., 1960]. If the time-dependent 
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loss of viscosity is nonreversible, the fluid is considered to have rheodestructive properties. The 
present study shows that the prepared gel exhibits rheopectic and either thixotropic or 
rheodestructive properties. Furthermore, repeated observation reveals that continuous swirling of 
the mixture leads to an irreversible decrease in the viscosity. Therefore, the time-dependent 
reduction in viscosity of gel is rheodestructive rather than thixotropic. 
 
4.2.4. Structural Analysis 
Structural characterization of silk fibroin fibre and lyophilized hydrogels were performed by X-ray 
diffraction and FTIR analysis. The XRD patterns and FTIR peaks of degummed silk fiber and 
lyophilized RSF hydrogel are shown in Fig. 4.2.5 & 4.2.7 respectively. 
 
4.2.4.1. XRD Analysis 
X-ray profiles of lyophilized hydrogels prepared from aquous SF solutions are shown in Fig. 4.2.5. 
It has been reported that when silk fibroin solutions freeze, below the glass transition temperature 
between −34°C & -20°C, the protein structure doesn‘t change significantly [Li et al., 2001]. The 
amorphous structure of lyophilized SF hydrogel samples are indicated by the exhibition of a broad 
peak at around 20° [Magoshi et al., 1996]. Silk fibroin hydrogels showed a distinct peak at 20.6° 
and two minor peaks at around 9° and 24°, that is very similar to β-sheet crystalline SF structure 
(Silk I) [Ayubet al., 1993; Asakuraet al., 1985]. X-ray diffraction result shows that the gelation of 
silk fibroin solutions induced a transition from random coil to β-sheet conformation (Fig. 4.2.6) 
which is also reported in published literature [Hanawa et al., 1995; Ayub et al., 1993; Kang et al., 
2000]. 
 
Furthermore, the regenerated silk fibroin (RSF) hydrogel (line b in Fig. 4.2.5) shows more 
amorphous state, while the degummed silk fiber (line a in Fig. 4.2.5) shows a typical X-ray 
diffractogram of β -sheet crystalline structure, depicting four diffraction peaks at 18.9°, 20.6°, 24.3° 
and 28.1°, corresponding to β-sheet crystalline spacing of 4.69°, 4.31°, 3.66° and 3.17 A°, 
respectively [Ayub et al., 1993; Asakura et al., 1985]. While the lyophilized fibroin hydrogel shows 
the characteristic peak at 20.6°. Other peaks corresponding to degummed silk fibre is not visible 
indicating the more α-helical secondary structure. In conclusion, the processing of silk fibroin 
results in a loss of β -sheet structure thus making it more biodegradable and lower mechanical 
strength.  
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Figure 4.2.5: X-ray diffraction of (a) degummed silk fiber and (b) lyophilized SF hydrogel. RSF 
hydrogel (line b; 18.9°, 20.6°, 24.3° and 28.1°) shows more amorphous state, while degummed 
silk fiber (line a; 4.69°, 4.31°, 3.66° and 3.17 A°) shows a typical X-ray diffractogram of β -
sheet crystalline structure. 
  
 
Figure 4.2.6: Sol-gel transition of silk fibroin. Figure depicts the formation of silk fibroin hydrogel 
with a stable and irreversible intermolecular β-sheet structure. 
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4.2.4.2. FTIR study 
IR spectrum represents typical absorption bands sensitive to the molecular conformation of SF. 
Therefore, in order to confirm the conformational changes of SF, FTIR spectroscopy of degummed 
silk fibroin and lyophilized silk fibroin hydrogel was performed and the results are shown in Fig. 
4.2.8. Silk protein exists in three conformations, namely, random coil, silk I (R form), and silk II (β-
sheet) [Um et al., 2001].The absorption bands at 1657, 1525, 1245 and 651 cm
-1
 which correspond 
to amide I, amide II, amide III & amide V bands, respectively, confirm that the degummed silk 
fiber is mainly in β-sheet conformation similar to the native silk fibre [Mandal et al., 2008a; Mandal 
et al., 2008b]. The corresponding peaks of silk fibroin lyophilized hydrogel are observed at 1625, 
1509, 1245, 667 cm
-1
 respectively indicating the β-sheet conformation at the end of processing 
through regeneration, gelation and lyophilization. Besides, few more peaks were found in 
lyophilized fibroin powder at frequencies corresponding to 1327-1393 cm
-1
 indicating stretched C-
O bonding and thus relatively unstable state. All the peaks observed in three amide band regions 
varied in their width and intensities. 
0 500 1000 1500 2000 2500 3000 3500 4000 4500
10
20
30
40
50
60
70
80
90
100
110
b
Lyophilized Silk Fibroin Hydrogel
Degummed Silk Fiber
IR
 t
ra
n
s
m
it
ta
n
c
e
 (
  
  
  
  
  
 )
Wavenumbers (cm 
-1
)
a
 
Figure 4.2.7: FT-IR spectra of (a) degummed silk fibers and (b) lyophilized SF hydrogel 
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4.2.5. Thermal Analysis 
The thermal behavior of degummed silk fibre and fibroin hydrogel were assessed by TGA and 
DSC. Degummed B. mori silk fibre and lyophilized fibroin hydrogel showed different 
thermogravimetric curves. As indicated in Fig. 4.2.8, the initial weight loss below 100 ºC may be 
due to the water evaporation [Um et al., 2001]. At temperature above 200ºC, the weight loss is 
observed to occur again. However, silk fiber did not completely decompose even at 700ºC. It is 
evident from result that silk fibre underwent at least three thermal decomposition stages in the 
temperature range 200-300ºC, 300-350ºC and 350-400ºC. A similar decomposition pattern is also 
observed with lyophilized hydrogel. However, the rate of degradation is comparatively faster in 
case of SF hydrogel. 
 
Figure 4.2.8: TGA curves of (a) degummed silk fibers and (b) lyophilized SF hydrogel 
  
The decomposition at approximately  300ºC may be attributed to a disintegration of the 
intermolecular side chains during the crystalline melting process, while that at around 400 ºC due to 
a main chain disintegration, coupled with simultaneous carbon atom rearrangements [Hirabayashi et 
al., 1974]. It has been reported that the decomposition at 300ºC indicates the low crystallinity of the 
unoriented β-type configuration and, thus it can be concluded that there is less possibility of 
obtaining a crystalline β-structure, which occurs in the temperature range 325-330 ºC. Furthermore, 
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the low weight loss at 400ºC observed with gels may be due to its low water content. This suggests 
that the fibroin molecules come to close contact with each other during lyophilization process and 
form a dense aggregate which could mechanically resist the carbon atom rearrangements, thus 
resulting in low weight losses. This phenomenon of the fibroin molecules could be a possible 
reason for the lyophilized fibroin gel.  
 
 
Figure 4.2.9: DSC curves of (a) degummed silk fiber and (b) lyophilized SF hydrogel 
  
            Thermal analysis of degummed silk fibroin and lyophilized fibroin hydrogel has shown 
different thermal calorimetric curves (Fig. 4.2.9). In the DSC curve of degummed silk fiber, an 
endothermic peak is observed to start at 56.8 ºC and reached maximum at 76.3 ºC without any trace 
of exothermic transition which may be due to β-sheet structure of the sample. Whereas the DSC 
curve for lyophilized fibroin hydrogel starts at 35.4 ºC and reached maximum at 67.7 ºC. This 
difference in results may be attributed to the change in β-sheet conformation. A conformational 
change through the crystallization of SF from random coil to β-sheet causes an exotherm curve to 
exist [Chen et al., 2012]. As indicated from DSC curves, two exothermic peaks are observed at 
around 166 ºC and 255 ºC which can be attributed to the conformational change to β-form, while 
two endothermic peaks observed around 220 ºC and 286 ºC may be because of the conformational 
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change of β-form into random coils. The exotherm at 220°C indicates the crystallization of the 
fibroin random coils to α-form of crystals. The decomposition peaks of all the regenerated fibroins 
(endotherms around 290 °C) are lower in comparison to the original silk fiber [Warwicker et al., 
1954], indicating the lower thermal stability of regenerated samples. The low thermal stability may 
be due to lower crystallinity as well as decrease in molecular weight during the degumming process 
of the regenerated SF. 
 
4.2.6. In vitro Biocompatibility Study 
Human mononuclear cells (hMNCs) have been successfully encapsulated in various hydrogel 
systems due to the potential regeneration of damaged tissue and prololonged drug release [Liang et 
al., 2011]. In this work hMNCs were isolated for the study of cytocompatibility of SF hydogels. 
Due to physical limitation of silk hydrogel prepared from SF with low concentration (< 4% (w/v)), 
the hMNCs were encapsulated in hydrogel system with higher concentration (prepared from SF aq. 
solution of concentration >4 % (w/v). 
 
        The success of tissue engineering biomaterials not only relies on the non-toxic supportive 
structure for cell adhesion but also on facilitating cell proliferation. The microscopic images (Fig. 
4.2.10) of cells proliferated on hydrogel were taken on consecutive days. Cell size and number were 
observed to increase with culture period while maintaining the round shape. Fig. 4.2.11 shows the 
uniform adherence and spreading of mononuclear cells over fibroin hydrogel. The cells are found to 
be embedded in SF gel matrix. Detachment of cells from the substratum is observed to be minimal 
after 2 days in vitro cultivation. The morphology of monocytes during in vitro cultivation was 
observed by phase-contrast microscopy. The cells are found to retain round shape and homogenous 
distribution at day 1 (Fig. 4.2.10a &4.2.10b) and the cells retained their original round shape (Fig. 
4.2.10c) at day 3. Initially, the monocytes were found to be small (7-9 pm) [Birmingham et al., 
1980] and rounded with cytoplasmic spreading. 
 
A progressive enlargement of monocytes occurs in culture with increasing granulation and 
vascularization of the cytoplasm. After 1 week of cultivation, the monocytes are observed 
approximately twice the size of freshly isolated monocytes (Fig. 4.2.10d). With 4% gel, cell 
numbers are observed to be stopped increasing after 7 days which may be due to limiting spatial 
and nutrition, indicating that maximal level of cell proliferation is reached (Fig. 4.2.11). The SEM 
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of hMNCs laden SF hydrogel is depicted in Fig. 4.2.12. Similar observations are found with 
hydrogel systems such as alginate and PEGas reported earlier [Ramdi et al., 1993; Nuttelman et al., 
2006]. However, the morphology of hMNCs encapsulated in > 4% gel is found to change 
drastically leading to cell death, aggregated and/or dissolved, as evident from the empty cavities in 
histological images (Fig. 4.2.13). The loss of cellular activity with higher gel concentration is most 
likely due to mechanical restrictions and mass transport limitations.  
 
 
 
Figure 4.2.10:Microscopic images of hMNCs encapsulated and cultured in SF hydrogels prepared 
from aquous SF solution  at concentration 4%(w/v) after day 1 (a,b),  3 (c), and 7 (d).  hMNCs 
retained round shape morphology and nonaggregated in the gel as compared to floating cell 
clusters in day 1 (Fig. a). Bar = 100 μm in all images. The viable cells can be seen as bubbles 
rounded with trypan stain indicated by arrows. 
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Figure 4.2.11: Micrographs of hMNCs adhered on the hydrogel surface observed by phase contrast 
microscope at different magnification (5X, 10X, 20X) 
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Figure 4.2.12: SEM Morphology of cell encapsulated in SF hydrogel 
 
 
Figure 4.2.13: Micrograph of hMNCs seeded fibroin hydrogel (prepared from >4% (w/v) SF solution) 
cultured over 2 weeks. Empty cavities are clearly visible indicating non-supportive behavior 
towards cell proliferation. 
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PART III 
Development of porous SF scaffolds with and without SEP 
conjugation 
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A number of surface modification methods that involve the use of radiation [Mathew et al.; 2013] 
or a variety of bioactive molecules [Son et al., 2008; Mann et al., 2002; Yang et al., 2001; Lee et al., 
2000] have been the choice of many researchers to improve scaffold material characteristics. 
Different biolactive molecules (RGDs and other short repetitive peptide chains) have been 
immobilized physically or chemically on polymeric scaffolds [Mann et al., 2002; Yang et al., 
2001], and amphiphilic block polymers as additives [Lee et al., 2000]. In this study, we used 
soluble form of egg shell membrane protein (SEP) for surface modification of the developed SF 
scaffold. To the best of our knowledge, this is the first report of modifying the surface of porous SF 
scaffold with SEP. The reason behind the selection of eggshell membrane (ESM) biopolymer is the 
long history of SEP used in Chinese medicine prescribed as, Bencao Gangmu for injuries. Eggshell 
membrane (ESM) is a double layered insoluble and semipermeable sheet located between the 
eggshell and egg white [Carrino et al., 1996], and is functionally behave as scaffold for 
biomineralization to develop egg shell and chick embyo [Nakano et al., 2003; Tsai et al., 2006; 
Rose and Hincke 2009]. ESM consists of 70% organic, 10% inorganic and 20% water.The major 
organic components includes insoluble proteins, such as collagens (type I, V, and X), osteopontin, 
and sialoprotein [Nys et al., 2001], alongwith a small amount of carbohydrates and lipids [Suyama 
et al., 1977; Baker et al., 1962]. Previous studies have developed SF scaffolds with defined small 
pore sizes with limited inter connections [Nazarov et al., 2004], or large (>500μm) with well 
connected pores [Kim et al., 2005c]. Attempt has been made in the present study to fabricate 3-D 
SF scaffolds with improved surface characteristics using SEP as bioactive molecule. The SEP 
conjugated SF scaffolds were further evaluated to assess the improvement in their physico-chemical 
and biochemical characteristics in terms of biodegradability, thermal stability, compressive 
strength, cell adhesion and proliferation property. Thus it is expected to obtain a novel scaffold with 
improved bioactivity for its potential use in tissue engineering.  
 
4.3.1. Morphological Study 
The light milky white colored fibroin solution (12%w/v), observed under phase contrast microscope 
shows a porous wet matrix and that of ESM membrane as a bed of granular particles as shown in 
Fig. 4.3.1a and 4.3.1b. The SEM images of degummed silk fibroin (Fig. 4.3.1c) reveal the fibrous 
nature of starting material, while ESM (Fig. 4.3.1d) structure as membrane fiber embedded in white 
collagen-like matrix. ESM fibers come out from the tubular gland cells present in oviduct and wrap 
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the surface of rotating egg white protein followed by the deposition of mineralized shell as reported 
earlier [Burley et al. 1989; Kodali et al., 2011]. Thus after peeling off the eggshell from the 
membrane, it doesn‘t contain any CaCO3 as observed in Fig. 4.3.1d. This is further confirmed by 
elemental (Table 4.3.1) and XRD (Fig. 4.3.5) analysis. 
 
 
Figure 4.3.1: Microscope images of (a, b) SF hydrogel and (c,d) ESM by (a,c) phase contrast 
microscope and (b,d) SEM 
 
4.3.2. Pore size and Porosity 
SF scaffolds with varying pore size and porosity were prepared using NaCl as porogen from 4-6% 
SF solution by salt leaching method following the procedure published earlier [Lee et al., 2000]. 
Table 1 show the pore size and porosity of the scaffolds prepared under study. The pore size was 
measured from SEM images as shown in Fig. 4.3.2.  The particle size of porogen is shown to have a 
great influence on the pore size and porosity of scaffolds. Scaffolds with pore size in the range of 
30 to 350 µm were obtained using porogen of size < 100 µm (Fig. 4.3.2a), 100-200 µm (Fig. 
4.3.2b), 200-300 µm (Fig. 4.3.2c) and 300-500 µm (Fig. 4.3.2d). The porosity and pore size of 
scaffolds were obtained in the range of 81-93% and 30-350 µm respectively using porogen of the 
size range 100-500 µm. Particle size below 100µm and above 500µm (data not shown) is not found 
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to be favorable for scaffold due to the limitation in pore interconnectivity [Hulbert et al., 1970]. The 
pore size of the scaffolds is 10–20% smaller than the particle size of NaCl used which may be due 
to the partial dissolution of the crystal surface. The recommended pore size for a scaffold system 
based on cell size and migration is minimum 100 μm as reported earlier [Hulbert et al., 1970]. 
However, subsequent studies have shown better vascularization and cell migration in implants with 
pore size >300 μm [Karageorgiou et al., 2005; Murphy et al., 2010; deGrootet al., 1996]. In 
previous studies, aqueous-derived SF scaffolds prepared with different particle size range of NaCl 
resulted in similar trend in pore size and supported cell migration and enhanced vascularization 
during tissue regeneration [Zhau et al., 2009; Kim et al., 2005; Altman et al., 2003]. 
 
 
Figure 4.3.2: SEM of SF scaffold prepared by salt leaching method using NaCl as porogen of different 
particle size range: (a) < 100 µm (b) 100-200 µm (c) 200-300 µm (d) 300-500 µm 
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Table 4.3.1: Pore size and porosity of SF and SEP-SF scaffolds prepared with RSF 4-6% (w/v) using 
NaCl as porogen (n=3)  
 
Sample NaCl particle size Pore Size Porosity  Remarks 
SF <100 µm  30-70 µm  85-88 %  Not interconnected 
SF 100-200 µm  90-150 µm  81-86 %  Interconnected and suitable for skin 
TE [Yang et al., 2002] 
SF 200-300 µm  140-230µm  87-89%  Interconnected but moderate  
applicable for osteogenesis [Murphy et 
al., 2010] 
SF 300-500 µm  225-350µm  90-93%  Interconnected and more applicable for 
osteogenesis and chondrogenesis 
[Murphy et al., 2010; deGrootet al., 
1996] 
SEP-SF 300-500 µm 200-300µm 85-90% Interconnected and more applicable for 
osteogenesis and chondrogenesis 
[Murphy et al., 2010; deGroot et al., 
1996] 
 
4.3.3. SEP conjugated SF scaffold 
The SF scaffold with pore size 225-350 μm were further modified with SEP as bioactive material. 
As a chemical crosslinker, EDC reacts with the carboxylic acid groups of peptide chain which can 
then bind to the amino group in the reaction mixture of SEP, loaded in SF scaffold. The detailed 
mechanism of EDC/NHS crosslinking (Fig. 4.3.3) is reported in the published literature [Burdick et 
al., 2011]. The SEM image (Fig. 4.3.4) shows the porous structure of SEP-SF scaffold. It is 
observed that the pore size and porosity of the scaffold are not much affected by the conjugation 
with 2% (w/v) SEP. The pore size of the modified scaffold was obtained in the range 200-300 µm 
with porosity approximately 85-90%. The slight reduction in porosity and pore size may be due to 
blockage of pores after SEP conjugation. However, the scaffold has desired pore size and porosity 
to be used for tissue engineering applications. 
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Figure 4.3.3: Mechanism of SEP conjugated with SF scaffold 
 
Figure 4.3.4: SEM of SEP conjugated SF scaffold 
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4.3.4. Elemental Analysis 
The elemental analysis was done to measure the elements of SF, SEP and SEP-SF scaffolds. Each 
analysis was performed in triplicate and average value is shown in Table 2. The elemental 
composition of SF and SEP are very close to the experimental data published by wang et al. [Wang 
et al., 2011] and Yi et al. [Yi F. et al., 2004]. The elemental composition of SEP-SF which lies in 
between SF and SEP indicates the immobilization of soluble eggshell protein throughout the SF 
scaffold. 
Table 4.3.2: Elemental composition of SEP, SF and SEP-SF scaffolds 
Sample wt.(mg.) C (wt. %) H (wt. %) N (wt. %) O (wt. %) S (wt. %) 
SF 2.001 43.30 6.04 14.78 27.9 0.35 
SEP 1.989 46.53 6.7 15.93 11.76 2.89 
SEP-SF 2.015 45.33 6.51 15.11 22.7 0.93 
 
4.3.5. Structural Analysis  
4.3.5.1. XRD Analysis 
The conformational changes during the processing for scaffold fabrication were conﬁrmed by 
analysing X-ray diffraction patterns of SEP and SF scaffolds as shown in Fig. 4.3.5. According to 
the research on the molecular conformation of silk fibroin protein [Tao et al., 2007], the XRD 
patterns (Fig. 4.3.5a) is determined as 12.5° (2θ) for α-helix (Silk I) and 20.4° (2θ) for β-sheet 
structure (Silk II). The XRD curve of the conjugated SF scaffold (Fig. 4.3.5b) shows two peaks 
around 12.6° (2θ) and 20.5° (2θ) indicating the co-existence of α-helix and β-sheet with partially 
induction of α-helix to β-sheet due to SEP conjugation.The XRD pattern of SEP (Fig. 4.3.5c) holds 
a broad peak at 20.2° (2θ) indicating the amorphous nature of material and the absence of 
crystalline material (eg. CaCO3).  
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Figure 4.3.5: XRD pattern of (a) SF scaffold; (b) SEP-SF scaffold and (c) SEP 
 
4.3.5.2. FTIR Study 
The chemical characteristics of functional groups exposed to the extracellular matrix (ECM) and 
cells were studied by FTIR spectra. As shown in Fig. 4.3.6, the amide I band (1600-1700 cm
-1
) is 
associated with the stretching vibrations of carbonyl groups (C=O bond) along the polypeptide 
backbone [Payne and Veis, 1988] and has been found most important for infrared spectroscopic 
analysis of the proteins secondary structure [Surewicz and Mantsch, 1988]. The FTIR spectrum of 
SF scaffold shows strong absorption bands at amide I (1654 cm
−1
), amide II (1519 cm
−1
), amide III 
(1220 cm
−1
) and amide V (555 cm
−1
) which can be attributed to mainly random coil conformation 
and the helix. It is indicated that the formation of SF scaffolds from regenerated SF solutions 
induced a conformational transition from random coil to β-sheet.  The FTIR spectrum of SEP shows 
the main absorption bands of amide A (3215 cm
-1
), amide B (2126 cm
-1
), amide I (1654 cm
-1
), 
amide II (1545 cm
-1
) and amide III (1253 cm
-1
). Amide A and amide B bands are related to NH 
stretching coupled with hydrogen bond and CH2 asymmetrical stretch respectively. Amide II is 
associated with NH bending and CN stretching. These results are very close to FTIR analysis curve 
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of collagen from yellow fin tuna dorsal skin as reported earlier [Wang et al., 2008]. The specific 
absorption peaks of SF scaffold and SEP are evident in the spectrum of SEP-SF scaffold, indicating 
conjugation. The amide B group (2126) of SEP is also found to be present in the conjugated silk 
fibroin. The characteristic amide groups of silk fibroin (amide I, 1654cm
−1
 and amide II, 1519 
cm
−1
) [Gil et al., 2007] are also detected in the SEP-SF scaffold. These results confirm the proper 
conjugation of SEP to SF by covalent immobilization method. EDC/NHS as a zero-length 
crosslinking agent is used to link carboxyl groups of SEP and primary amines of SF. The results 
suggest that the SEP conjugated silk fibroin scaffold contains bioactive functional groups at the 
interface of surface and ECM/Cells. 
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Figure 4.3.6: FT-IR spectra of (a) SF scaffold, (b) SEP-SF scaffold and (c) SEP 
 
4.3.6. Thermal properties 
The thermal properties of SEP, SF and SEP conjugated SF scaffolds were investigated by standard 
DSC and TGA (Figs. 4.3.7-8) methods. The results indicate that the weight loss of SEP (Fig. 
4.3.7a) starts at about 180°C whereas the weight loss is observed with SF scaffold at 200°C (Fig. 
4.3.7a). A slight weight loss as observed below 100°C may be due to the evaporation of a small 
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quantity of water which is also reported by Kweon et al. [Kweon et al.,2001b]. The major weight 
loss with SEP is observed to occur in the temperature range of 230–400°C. However, a sharp and 
rapid weight loss is observed with SF scaffold at 330°C which may be due to the thermal 
degradation of SF protein. Thus the result indicates the high crystallinity and molecular 
configuration of SF proteins which is also supported by the result of structural analysis. The 
residues of both SEP and SF samples at 500°C is about 25%. Thus SEP is found to be thermally 
stable. 
 
Figure 4.3.7: TGA curves (a) SF scaffold (b) SEP-SF scaffold and (c) SEP 
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Figure 4.3.8: DSC curves (a) SF scaffold (b) SEP-SF scaffold and (c) SEP 
 
From DSC curve (Fig. 4.3.8), it is indicated that, the denaturation of SEP onset at 46.10°C and 
reaches maximum at 65.03°C. The thermal stability of ESM is associated with the temperature 
inside and outside of the body and directly linked with amino acids (proline and hydroxyproline) 
content [Wong et al., 1989]. The thermal analysis of SF scaffold showed a different thermal 
calorimetric curve as compared to SEP-SF scaffold. SF scaffold exhibited a weak endothermic peak 
around 100°C which is also indicated in the corresponding TGA curve. This phenomena may be 
due to the evaporation of low water content of SF scaffold [Kweon et al., 2001b]. The exothermic 
peaks at 220°C, attributes to the crystallization of thermally induced SF protein and due to β-sheet 
structure of samples [Chapter 4, Part III; Kweon et al.,2001b]. A slight upward shift of the 
decomposition peak for SEP conjugated SF sample (endotherms around 260°C) as compared to the 
SF sample indicate a little higher thermal stability of the conjugated samples. This higher thermal 
stability of conjugated scaffold may be due to higher crystallinity and higher molecular weight 
(because of the presence of stabilizing amino acids eg. proline and hydroxyproline) compared to SF 
scaffold. No denaturation of SF and SF-SEP scaffolds was observed in the temperature range of 30-
40°C. Thus it has been demonstrated that the scaffolds are thermally stable at both room and body 
temperature. 
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4.3.7. Compressive Strength  
Scaffold material must have required mechanical strength to withstand the cellular in situ growth 
and tissue organization. The mechanical strength was determined from stress–strain graphs of the 
prepared scaffolds as shown in (Fig. 4.3.9a and4.3.9b). SF and SEP-SF scaffolds are shown to have 
different line patterns which are the typical characteristics of the elastic/plastic material. For both 
scaffolds investigated, the steepest portion of the stress-strain curve is occurred in the range of 0-
2% strain. The uncoated fibroin scaffold breaks between 200 and 300 KPa with a strain of 1.8 to 
2.2%. The mechanical resistance was increased after SEP coating, supporting breaking forces 
higher than 3 N and strain over 2.8%. However, the average compressive strength was found to be 
279.8 ± 36.2 KPa for SF and 321.5 ± 42.2 KPa for SEP-SF scaffolds. 
 
 
Figure 4.3.9: Stress-Strain Curve of (a) SF and (b) SEP-SF scaffolds 
 
4.3.8. Swelling Behavior  
Water molecules, the component of coordination bond act as swelling agent, are undoubtedly 
needed for the dissolution of silk fibroin. Fig. 4.3.10 shows the swelling behavior of scaffolds. As it 
is indicated from graph, swelling index of 60.3% is achieved after 30min of soaking and that has 
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been increased to 133.36% after 48 h. The similar trend was observed with SF scaffold modified 
with SEP as well with a slight increase in swelling index during the period of study. The increase in 
swelling index may be due to the enhanced hydrophilicity of scaffold surface after SEP 
conjugation. 
 
Figure 4.3.10: Swelling behavior of SF & SEP-SF scaffolds 
 
4.3.9. Biodegradability 
From Fig. 4.3.11, the initial weight loss of 0.08% and 0.04% were observed with SF and SEP-SF 
scaffolds respectively. However, the maximum weight loss achieved is 1.89% and 2.38% for SF 
and SF-SEP respectively after 192 hrs. The increase in biodegradation in conjugated scaffold as 
compared to control may be due to enhanced hydrophilicity and partial surface erosion from 
scaffolds in PBS [Jia et al., 2008]. 
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Figure 4.3.11: Biodegradability of SF & SEP-SF scaffolds 
 
4.3.10. Hydrophilicity 
The hydrophilicity of the scaffolds was evaluated by contact angle measurement between the 
scaffold and pure water droplet. It is observed that the initial contact angle of the SF scaffold was 
62.4±1.5°, indicating the higher wettability of SF scaffold surface. The contact angle decreases after 
SEP conjugation to 52.7±1.0° may be due to enhanced hydrophilicity of SEP material. It is evident 
that conjugation of SEP makes SF scaffold more hydrophilic suitable for cellular reponse in 
aqueous medium. 
 
4.3.11. Characterization of MSCs 
The morphology of UCB derived hMSCs passaged upto 4
th
 cycle is depicted in Fig. 4.3.12. The 
fibroblast-like cells with protrusions as obtained were further characterized by FACS analysis. The 
immunophenotypic profiling of cell surface markers CD34, CD45, CD90 and CD105 on isolated 
hMSCs was done using flowcytometry analysis. Fig. 4.3.13 shows that the isolated and cultured 
cells from fourth passage were positive for CD90 and CD105 and the expression level were 98.3% 
and 98.7% respectively but negative expression for CD34 (1.39%) and CD45 (1.30%) confirming 
the characteristics of mesenchymal stem cells. The cultured MSCs were further used for in vitro 
cytocompatibility evaluation.  
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Figure 4.3.12: Morphology of cultured UCB derived hMSCs after passage 1(a, 200X; b, 400X), 
passage 2 (c, 400X; d, 400X), passage 3 (e, 200X; f, 400X) and passage 4 (g, 200X; h, 400X) 
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Figure 4.3.13: Surface marker expression of CD34, CD45, CD90 and CD105 for cultured hMSCs 
analysed via FACS (fluorescence-activated cell sorting) incubated with relevant cell surface 
antibody. 
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4.3.12. Cell Morphology in Scaffolds 
The SEM images of cell-scaffold constructs are shown in Fig. 4.3.14. After one day of cell seeding, 
cells were started to adhere and aggregate in the pores of both SF and SEP-SF scaffolds. Though 
initially cell adherence followed the similar trend for both the scaffolds, however cell adherence and 
spreading were found to be spread uniformly throughout the SEP-SF scaffolds during 7 to 14 days 
culture than that in the case of SF scaffold.   
                                
 
Figure 4.3.14: SEM of cell-scaffold construct on day 3(a, b), 7(c, d) and 14(e, f) days of culture. Figure 
shows the progressive adherence of MSCs in SEP conjugated scaffolds (b, d, e) and control (a, 
c). SEP conjugated scaffolds shows early adherence and morphological changes in cell shape 
than control. After 14 day of MSCs culture in modified scaffold (f1, f2, f3) was compared with 
SF scaffold (e1, e2, e3). The cells areere found to spread all over the scaffold as depicted from 
the SEM images.  Scale bar= 10 µm (a, b, d, e3, f3); 50µm (c, e1, e2, f1, f2) 
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4.3.13. Cell Adhesion and Proliferation  
Attachment and the proliferation of cells on a given substrate are fundamentals for a functional 
tissue engineering scaffold. The viability of cells cultured on the scaffold was determined based on 
the linear correlation between cell count and OD570 value of MTT formazan [Zund et al., 1999]. 
The number of cells were observed to be increased with increase in culture period as observed with 
both SF and SEP-SF scaffolds though at varying proliferation rate as shown in Fig. 4.3.15.  The 
viability of the proliferated cells on the SF scaffolds was found to gradually increase from 
0.191±0.018 to 0.493±0.015 during 14days culture (Fig. 4.3.15). The proliferation rate was 
observed to be higher with SF-SEP scaffold achieving 0.675±0.031 OD on day 14 compared to the 
proliferation rate achieved with SF scaffold used as control. Cells entrapped inside the scaffold 
without adherence didn‘t show much spreading and proliferation at all. The cells did not survive 
during further cell culture as indicated by MTT assay done on 3rd day. Cells adhered over the 
surface and inside the scaffold were found to be grown, proliferate and differentiate. However, 
confluence of large number of cells was observed on 7th day of culture covering entirely the 
conjugated scaffold as compared to the SF scaffold. After 14 days of culture, cells were more 
prominently and uniformly spread on the pore surface with flat morphology (Fig.4.3.14f). Thus it is 
demonstrated in this study that the modified SF scaffold is more effective than SF scaffold which is 
evident from an improved cell proliferation and cell viability observed during cell culture. This 
enhanced expansion of cell culture could be attributed mainly to the SEP mediated improved 
surface hydrophilicityrather than the scaffold morphological change, as there is no significant 
morphological changewas observed using 2% SEP solution for surface modification. 
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Figure 4.3.15: Comparison of optical density of MTT formazan on SF and SEP-SF Scaffolds during culture 
period (p<0.05, n=3) 
 
4.3.14. ALP Activity Assay 
 
The osteogenic differentiation of hMSCs on the SF and SEP conjugated SF scaffolds was 
determined by endogenous alkaline phosphatase (ALP) activity measured on days 1, 7 and 14 of 
cell culture. Increased ALP production was observed with culture time. However, SEP conjugated 
SF scaffold showed significantly higher activity than the ALP production achieved with SF scaffold 
(p < 0.01) as indicated in Fig.4.3.16. This implies that the conjugated scaffolds prepared from SF 
conjugated with SEP are more favorable for cell differentiation. 
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Figure 4.3.16: ALP activity of hMSCs grown on SF and SEP-SF scaffolds for 1, 7 and 14 days. Each 
value represents the mean value ± SD (p<0.05, n=3) 
 
 
4.3.15. In vivo Biocompatibility Study 
Transplantation of SEP-SF scaffolds was performed under surgically-created subcutaneous pouch 
in apparently healthy mice (Fig. 4.3.17a, both male & female for gender effect, if any). During the 
period of experiment, all mice remained in healthy condition and did not show any wound 
complications and no inflammatory and/or adverse tissue reactions were observed. Thus, 
transplanted scaffolds did not have any adverse effect on the physiology of animals (Fig. 4.3.17b). 
After one and four weeks of transplantation, mice were sacrificed and the host tissue reaction was 
analyzed by H&E staining. Macroscopically, all the scaffolds were encapsulated in thin 
fibrovascular tissues of recipient. After implanted for 7 days, more ﬁbroblasts were grown into the 
scaffold and the inﬂammatory cells were in existence (Fig. 4.3.18a). However, when the test had 
processed for 4 weeks, a large number of ﬁbroblasts were inﬁltrated into the scaffold and the 
morphology of scaffold was close to the surrounding dermal tissue (Fig. 4.3.18b). Thus, conclusion 
can be made as SEP-SF scaffold support the attachment, proliferation in vivo condition without 
causing infection, inflammation and/or tissue cell death. 
Chapter 4: Result & Discussion 
   
111 
 
 
 
Figure 4.3.17: In vivo biocompatibility study of SEP-SF scaffolds using ICR mice strain (a) Implantation of 
scaffold in male (b) Surgical recovery after one month in female 
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Figure 4.3.18: Histological section of subcutaneous skin at the site of implanted SEP-SF scaffolds in 
ICR mice model after (a) 7 days and (b) 4 weeks. Bar indicates 200µm. M: the implanted 
scaffold site. T: the subcutaneous connective tissue. M-T: the meso-dermal site as the interface 
of scaffold-tissue. 
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PART IV 
Development of porous SF/PVA scaffolds with and without SEP 
conjugation 
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It is evident from published literature taht the brittleness of pure SF scaffold limits their application 
in tissue engineering. The physical properties of SF scaffold can be enhanced by mixing it with 
other synthetic or natural polymers, such as poly-(vinyl alcohol) (PVA), collagen and chitosane 
[Gobin et al., 2005; Kweon et al., 2003; Du et al., 2006].  The cytocompatibility behaviour of such 
polymeric blend scaffolds has not been explored much. It has also been reported that polymer 
blended crosslinked system may show differential degradation behavior under physiological 
conditions [Ma et al., 2003]. In addition, a crosslinking process improves permeability and 
mechanical strength of polymers [Sabato et al., 2001].   Furthermore, the addition of glycerin (a 
commonly used plasticizer) improves silk film properties [Kawahara et al., 2006] and helps to 
reduce phase separation between silk and PVA in the blend [Dai et al., 1999]. Glycerin content in 
blend films is important for the control of silk secondary structural transitions and influencing the 
mechanical properties of the films [Lu et al., 2010]. PVA, a synthetic polymer has excellent 
hydrophilicity, biocompatibility, biodegradability and processability with ability to form high 
strength fibres suitable for medical applications [Mnasur et al., 2008; Mnasur et al., 2004]. In 
addition, the published literature has indicated that the amount of PVA accumulated in organs is too 
small to affect the biological fate, which suggested that PVA is excreted to the same extent 
supporting the cyto-compatibility of PVA [Yamaoka et al., 1995]. Incorporation of PVA solution in 
chitosan has shown improvement in biocompatibility of the blend system [Huang et al., 2005].Silk 
fibroin and PVA have been separately investigated as candidate materials for tissue engineered 
constructs [Meinel et al., 2004a; Hofmann et al., 2007]. Though many research groups have studied 
the preparation method and properties of SF/PVA blends for improved stiffness of SF [Li et al., 
2002; Dai et al., 2002; Li et al., 2001; Tanaka et al., 1998; Tanaka et al., 1997; Tsukada et al., 
1994], it has not yet been explored much for its cytocompatibility and potential tissue engineering 
application. So efforts has been given in this phase of research work to prepare SF/PVA scaffold 
and its further improvement in surface properties by conjugation with SEP which has been found to 
enhance cell adhesion and proliferation property of SF scaffold in our previous research work 
[Chapter 4, Part III].  In the present study, green process has been employed for the fabrication of 
SF/PVA scaffolds of various pore sizes, modification with SEP and study of their biorelevant 
properties such as morphology, structure, mechanical properties, in vitro cell culture and in vivo 
biocompatibility. 
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4.4.1. Miscibility of SF/PVA Blend 
Due to a noteworthy influence of the miscibility of polymer blend on their properties, the study of 
phase behavior during blending of polymers has been an important research area [Vucovic et al., 
1999]. The effect of glycerin and ultra-sonication on the phase behavior and miscibility of SF and 
PVA were investigated by SEM. A series of SEM micrographs of SF/PVA (50:50) with different 
combination of blended system (with and without glycerine) and processing method (with and 
without ultrasonication) were studied, vizually (-Glycerine/-Ultrasonication), (-
Glycerin/+Ultrasonication), (+Glycerine/-Ultrasonication) and (+Glycerine/+Ultrasonication) as 
shown in Fig. 4.4.1. As reported earlier, SF molecules are unstable and exist as colloidal state in 
aqueous system due to hydrophobic amino acids of SF and result in to molecular aggregation and 
gelation [Um et al., 2001]. On the other hand, PVA molecules are readily dissolved in water and 
are found as stable solution state in aqueous system. Due to the different solution stability in 
aqueous system between these two components, SF molecules tend to aggregate and form a 
separated domain in PVA matrix [Wang et al., 2010]. Ultrasonication induces the intra - and 
interchain crosslinking without any chemical additives [Jakobs, 2013]. In the present study, during 
sonication some of the silk fibroin chains in the SF/PVA blend were observed to form physical 
cross-links via β-sheet crystal networks rapidly by absorbing energy from the ultrasound process. 
The method is controllable and based on the energy input from ultrasonication to the system 
without involving any additional chemical processes. However, blending under ultrasonication 
without glycerine couldn‘t set homogeneity and still the distinct patches of SF and PVA exist (Fig. 
4.4.1b). 
 
The SF/PVA blend mixed under magnetic stirring using glycerine as plasticizer shows homogenous 
phase. SEM reveals patches of SF molecules at many places as shown in Fig. 4.4.1c. The silk 
fibroin film prepared by adding glycerin to SF solution is highly flexible as reported by Curvelo et 
al. [Curvelo et al., 2001]. The similar effect may act to reduce the heterogeneity between 
hydrophobic SF and hydrophilic PVA. The blend film of SF/PVA treated with glycerin, had shown 
the indistinct homogenous phenomenon, and presumably due to the glycerin induced 
intermolecular interactions between the polymers, such as hydrogen bonding of -OH groups of 
PVA, -OH groups of glycerin and -NH groups of SF [Dai et al., 2002]. In glycerin system, since SF 
molecules exist as a stable form, the possibility of heterogeneity due to solution instability may be 
excluded. SF molecules have polar groups including CO and NH. Therefore, there is some 
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possibility of molecular interaction between polar groups of SF and side groups of a second 
polymer. In addition, as mentioned above, OH group in PVA molecule is partially changed to ester 
group when PVA interacts with glycerin. It is well known that the miscibility of polymer blend is 
strongly connected to amorphous phase. Therefore, the increase in amorphous phase of PVA in 
SF/PVA blend system might enhance the miscibility with SF. Glycerol esterifies with SF and PVA 
greatly modify the compatibility and processing ability of SF/PVA blends as reported earlier [Dai 
et al., 2002]. A combination of ultrasonication and glycerine as plasticizer found to make a 
homogenous phase of SF/PVA blend as shown in Fig. 4.4.1d. This observation can be explained by 
two separate effects of ultrasonication and glycerine as mentioned above. The uniform blending of 
SF/PVA polymers influences the physical properties [Vucovic et al., 1999] of processed 
biomaterials.  
 
 
Figure 4.4.1: SEM images of SF/PVA in aq. solution processed (a) without glycerine with magnetic 
stirring (b) without glycerine under ultrasonication (c) with glycerine with magnetic stirring 
(d) with glycerine under ultrasonication 
Chapter 4: Result & Discussion 
   
117 
 
4.4.2. Morphological Study 
SEM images of salt leached porous SF/PVA (100:0) and SF/PVA (0:100) scaffolds are shown in 
Fig. 4.3.2 of (Chapter 4, Part III) and Fig. 4.4.2 respectively. Fig. 4.4.3 shows the scaffolds 
prepared from SF/PVA (75:25; 50:50; 25:75) by salt leaching using NaCl of various particles size 
as porogen. The pore size and porosity of the scaffolds corresponding to different particle size are 
presented in Table 4.4.1. The size of porogen is shown to have great influence on the pore size of 
the scaffold, while the polymer to porogen ratio is directly correlated to the amount of porosity of 
the final structure. From the SEM morphological study, it is revealed that the pore size is 
approximately 80% of particle size of NaCl particle. Methanol treatment during the processing for 
scaffold development is shown to enhance the crystallinity of the scaffold and results into water 
insoluble PVA component of scaffold.  The scaffolds showed rough surface on the pores that are 
highly interconnected by a number of smaller pores (Fig. 4.4.3). The highly porous scaffolds with 
91-94% porosity were developed from SF/PVA (50:50; 25:75) with pore size being in range of 
230-360 μm (Table 4.4.1). The SF/PVA scaffolds with pore size range of 225-350 μm as 
recommended for cell based therapy [Karageorgiou et al., 2005; Murphy et al., 2010] were used 
for further modification with 2% SEP. The porosity of these modified SEP-(SF/PVA) scaffolds 
was measured around 84% with pore size range of 200-300 μm. The crystellites of SEP is found 
embedded with scaffold surface affecting the pore size of scaffold to some extent (Fig. 4.4.4). 
 
Table 4.4.1: Pore size and porosity of SF/PVA scaffolds prepared from different blend ratio of SF (8 
wt%) and PVA (10 wt%).*(n=3) 
 
SF/PVA Ratio NaCl particle size Pore Size Porosity* 
 
75:25 
100-200 µm 90-150 µm 80 % 
200-300 µm 140-230 µm 85 % 
300-500 µm 225-350 µm 75 % 
 
50:50 
100-200 µm   80-150 µm 85 % 
200-300 µm 150-250 µm 87 % 
300-500 µm 230-360 µm 91 % 
 
25:75 
 
100-200 µm   80-140 µm 81 % 
200-300 µm 150-260 µm 89 % 
300-500 µm 250-360 µm 94 % 
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Figure 4.4.2: SEM images of porous SF/PVA (0:100) scaffold prepared using NaCl particle size of range 
300-500 μm 
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Figure 4.4.3: SEM images of SF/PVA scaffolds with blend ratio: 25/75 (a,d, g), 50/50 (b, e, h), 75/25 (c, f, 
i) prepared from 10 wt% PVA and 8 wt% SF aqueous solutions with NaCl particle size range of 
100-200 (a, b, c), 200-300 (d, e, f) and 300-500 (g, h, i) μm. 
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Figure 4.4.4: SEM images of SEP-(SF/PVA) scaffold prepared from SF/PVA (75:25, 50:50 and 25:75, 
300-500 μm) scaffolds conjugated with 2 wt% SEP solution. (a) The conjugated SEP 
macromolecule shows crystalline structure.  Porous morphology of SEP-(SF/PVA) scaffolds with 
SF/PVA blend ratio of 75:25 (b), 50:50 (c) and 25:75 (d) are also accessible. 
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4.4.3. Structural Characterization 
 
4.4.3.1. X-Ray Diffraction 
 
X-ray diffraction curves of SF, PVA, and SF/PVA scaffolds with and without SEP conjugation are 
shown in Fig. 4.4.5. Pure SF scaffold showed characteristic major peak at 2θ=19.7° (d=3.5 Å) and 
minor peaks at 2θ=8.8° (d=8.1 Å) and 2θ=23.2° (d=4.8 Å) which are attributed to the silk II β-sheet 
crystalline structure [Um et al., 2001, Min et al., 2004]. PVA scaffold (Fig. 4.4.5f) cast from water 
as solvent is characterized by the presence of a minor broad peak at 2θ=11.9° (d=9.7 Å), in addition 
to a major broad diffraction peak at 2θ=19° (d=4.4 Å) [Nakane et al., 1999]. It is observed with 
SF/PVA scaffold that 2θ = 19.7◦ peak broadens and 2θ = 8.8◦ peak disappears with increase in PVA 
content indicating the increase in total crystallinity. In addition, a new peak not corresponding to SF 
or PVA lattice spacing appeared at around 2θ=7.4°, which may be originated from crystalline 
fibroin–PVA complex. The β-sheet crystalline structure of SF in the polymer blend scaffold is 
partly induced by the addition of glycerine [Dia et al., 2002]. In SEP-(SF/PVA) scaffold, a new 
characteristic peak for SEP at 2θ=22.6 indicate the conjugation with SF/PVA scaffold [Guo et al., 
2011]. 
 
4.4.3.2. FT-IR Spectroscopy 
 
FTIR spectroscopy in transmittance mode was used to characterize the presence of specific 
chemical groups in SF, PVA, SF/PVA and SEP-(SF/PVA) scaffolds (Fig. 4.4.6). To minimize 
redundancy, the FTIR spectra were normalized and major vibration bands were analyzed for 
correlation with chemical groups.  The FTIR spectrum of SF scaffold as illustrated in Fig. 4.4.6a 
shows strong absorption bands at amide I (1654 cm
−1
), amide II (1519 cm
−1
), amide III (1220 cm
−1
) 
and  amide V (555 cm
−1) which can be attributed to mainly random coil conformation and the α 
helix [Um et al., 2001]. The FTIR analyses indicatea conformational change from random coil to β-
sheetwith the formation of SF scaffolds from SF solutions. The PVA scaffold (Fig. 4.4.6f) shows 
absorption bands at 3425 (OH stretching), 2923 (CH stretching), 2850 (CH stretching), 1735 (C=O 
stretching), 1429 (CH2 bending), 1250 (C-O stretching of acetate group) and 1091 (OH bending) 
cm
-1
 resonance which is in good agreement with the published literature [Finch et al., 1973; Finch 
et al., 1992]. The spectra for PVA also show a peak at 3398 cm
–1
 that indicates the presence of OH 
and N-H groups with polymeric association. Crystalline fraction of the polymeric chains affects the 
intensity of this peak for different SF/PVA blend ratio.  
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Figure 4.4.5: XRD pattern of SF/PVA scaffolds with different blend ratios (100:0, a; 75:25, b; 
50:50, c; 25:75; e 0:100, f) and SEP-(SF/PVA) (50:50, d) scaffolds 
 
 
Figure 4.4.6: FTIR spectra of SF/PVA scaffoldS with different blend ratios (100:0, a; 75:25, b; 
50:50, c; 25:75; e 0:100, f) and SEP-(SF/PVA) (50:50, d) scaffolds 
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The FTIR spectra of SF/PVA scaffold (Fig.4.4.6b-e) is characterized by the presence of typical 
absorption bands of SF and PVA scaffold whose intensity lies in between that of SF and PVA. 
However, the addition of glycerin causes the stretching of OH group in absorption band (3500-3200 
cm
-1
) [Speakman et al., 1975]. Such alteration in frequencies indicates the induction of 
intermolecular hydrogen bonding between two polymers namely SF and PVA. The polar OH group 
of glycerin plays vital role in strengthening OH group of PVA and NH group of SF [Lu et al., 1996]. 
The shifting of 1735 cm
-1
 of PVA to 1715 cm
-1
 in SF/PVA blend system is attributed to carbonyl 
groups which may be formed due to the esterification reaction of PVA and glycerol. The 
conjugation of SEP with SF/PVA (50:50) blend scaffold was confirmed by the presence of 
characteristics absorption peak of SEP at 2126 cm
-1
 (amide B group) (Fig.4.4.6d) as per reported 
literature [Wang et al., 2008].  
 
4.4.4. Thermal Analysis 
Even though microscopic observations depict no phase separation between SF and PVA, thermal 
analysis was carried out to make clear the interaction between SF and PVA during scaffold 
development and the effect of SEP conjugation on their thermal properties. Fig. 4.4.7 shows the 
DSC thermograms of various scaffolds prepared under study. The DSC curves of SF scaffold 
showed a weak endothermic peak around 100°C that is attributed to the evaporation of water content 
[Kweon et al., 2001b]. The typical endothermic peak near 240°C is due to the crystallization of 
thermally induced SF protein and β-sheet structure of samples while an endothermic peak at 283°C 
is attributed to thermal decomposition of scaffolds [Chapter 4, Part II; Kweon et al., 2001b]. The 
main endothermic peak for SF/PVA scaffolds at around 292°C is contributed by the thermal 
decomposition of both polymers. As the PVA content of SF/PVA scaffold increased, the thermal 
decomposition temperature increased which is depicted by the shifting of peaks to a higher 
temperature. The broad endothermic peak of PVA scaffold became sharper in SF/PVA scaffolds and 
shifted to a lower temperature indicating possible interactions between SF and PVA. 
The glycerin content of hybrid scaffolds has been reported to shift melting peak towards the low 
temperature [Dai et al., 2002]. A weak but somewhat different endothermic peak for SF/PVA 
(50:50) scaffold is observed with SEP-(SF/PVA) scaffold at around 45°C indicating SEP 
conjugation. Both group of scaffolds, SF/PVA and SEP-(SF/PVA) scaffolds exhibit similar 
endothermic peaks at 292°C, that is probably assigned to the breakdown of peptide bonds within 
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chain and side chain groups of SF and SEP proteins.A slight upward shift in the decomposition peak 
for SEP conjugated SF/PVA scaffold as compared to SF/PVA (50:50) scaffold indicate higher 
thermal stability of conjugated samples. This behavior may be due to increasedcrystallinity and 
molecular weight particularly promoted by the presence of stabilizing amino acids eg. proline and 
hydroxyproline in SEP. 
 
Figure 4.4.7: DSC thermograms of SF/PVA scaffold with different blend ratios (PVA:SF; 100:0, a; 
75:25, b; 50:50, c; 25:75, e; 0:100, f) and SEP-(SF/PVA) (50:50, d) scaffolds 
 
4.4.5. Mechanical Property 
 
The optimal mechanical properties of scaffold to withstand the movement of surrounding tissues are 
required for tissue engineering applications. The mechanical properties of SF, SF/PVA, SEP-
(SF/PVA) and PVA scaffolds were assessed based on stress–strain graphs (Fig. 4.4.8). The initial 
compressive modulus was measured as the maximum slope of the stress-strain curve over a 1.6% 
strain. It is observed that all scaffolds have the same line shapes which are the typical pattern of the 
plastic material demonstrating spongy behavior of scaffold materials with different stiffness. The 
addition of PVA to SF has shown to have a significant change in the mechanical properties. The 
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compressive strength of SF scaffolds (300 KPa) decreased when it wasblended with PVA (235 ± 67.1 
KPa) which maybe due to the closer packing of PVA polymer chains with SF.For most of the 
scaffolds investigated in this study, the steepest portion of the stress-strain curve is shown to  
 
Figure 4.4.8: Stress–strain graph of SF/PVA scaffolds with different blend ratios (100:0, a; 75:25, b; 
50:50, c; 25:75, e; 0:100, f) and SEP-(SF/PVA) (50:50, d) scaffolds measured at constant 
compression rate of 2 mm/min 
 
occur in the range of 0-4% strain. The uncoated SF/PVA scaffolds break by external forces in 
between 200 and 300 KPa with 1.8 to 2.8% strain. The mechanical resistance is found to be 
increased with SEP modified scaffold as depicted from Fig. 4.4.8, supporting the breaking forces 
higher than 2.5 N and strain over 4%. The corresponding average compressive modulus is measures 
as 235 ± 67.1 KPa for the uncoated scaffolds and 247.5 ± 23.7 KPa for SEP coated scaffolds. The 
increase in amorphous PVA content has been reported to reduce the crystallinity of SF/PVA blend 
and act as lubricant for extensibility and flexibility [Lee et al., 2007] resulted into decrease in 
compressive strength of SF/PVA scaffold in comparison to SF scaffold. Overall, the scaffold 
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compressive modulus decreased with increased PVA reinforcement with same porosity. The 
research reports show that the increase in PVA content upto 50% decreases the tenacity while 
increases the elongation at break [Lee et al., 2007]. Hence, the SF/PVA blend with 40–50% PVA 
has a optimal mechanical properties (compressive strength and elongation at break) than filaments 
with lower/higher PVA [Lee et al., 2007]. According to Dai et al., although strength and elongation 
of the blend films are above that of the pure silk film, the value is relatively low as compare to the 
blends with the addition of glycerin [Dai et al., 2002]. Therefore SF, SF/PVA (50:50), SEP-
(SF/PVA) scaffolds with pore size range of 230-360 μm were used for further study. 
 
4.4.6. Swelling Behavior  
From the experimental result shown in Fig. 4.4.9, the swelling pattern indicated an initial rapid 
water uptake at about 30 min, followed by mass stabilization over a period of 48hrs. Visual 
examination also showed appreciable increase in volume of the samples. Within a period of 30 min, 
SF scaffolds showed swelling of 60.3% and about 133.36% up to a period of 48 h. In comparison, 
the PVA scaffold showed much higher swelling index of 80.94%. As reported earlier, PVA scaffold 
without physical (cryogelation) or chemical (GA, 5%) crosslinking, doesn‘t withstand the water 
penetration and dissolves within a period of 48 hrs. [Dai et al., 2002], however, in our study the 
chemically crosslinked PVA, showed the swelling of 200% over a period of 48 hrs. Furthermore, 
SF/PVA (50:50) scaffold showed rapid swelling in comparison to SF scaffold with 227.06% 
swelling achieved at 48 hrs. The swelling behavior is markedly inﬂuenced by the presence of PVA 
in the blend, crosslinked by ultrasonication and glycerine. The observed swelling pattern is probably 
related to the crosslinking between –NH group of SF chains and -OH group of PVA chains by 
ultrasonication and glycerine, causing the formation of a rigid structure amongst the SF/PVA chains 
and reducing their solution uptake. SEP-(SF/PVA) scaffold shows higher rate of swelling which 
may be due to the presence of hydrophilic SEP and maximum swelling of 254.9% was observed at 
48 h. The initial swelling behavior of SEP-(SF/PVA) scaffold is attributed to the combined effect of 
a more rigid net-work formed by the inter – intra polymer chain reactions as well incorporation of 
covalent bonds on scaffold surface, thus reducing the ﬂexibility and number of hydrophilic groups 
of scaffold surface which is unfavorable to the swelling property. Similar trends in swelling 
behavior of PVA and SF supported these ﬁndings, where PVA has a swelling degree above 300% 
and SF of about 200%, depending on course of the solution conditions [Wang et al., 2004a; Wang et 
al., 2004b; Lin et al., 2008; Zhang et al., 2012]. 
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Figure 4.4.9: Swelling Index of SF, PVA, SF/PVA (50:50) and SEP-(SF/PVA) scaffolds in SBF for 
different time period 
 
4.4.7. In vitro Biodegradation 
The degradation profile of scaffolds is shown in Fig. 4.4.10. it is observed that the rate of 
degradation of SF/PVA scaffold is more than SF scaffold. The faster degradation may be due to 
more hydrophilic PVA that shows strong intra and interchain H-bonding with polar solvent. The rate 
of degradation is further increased with SEP conjugation which may be due to the surface erosion 
caused by SEP conjugation. PVA scaffold (without physical or chemical crosslinking) showed low 
degradation initially and the rate bacame faster after 4 h and complete degradation achieved within 
48 h. Polymer solubility in aqueous solution is reported to be controlled by intra and inter-molecular 
hydrogen bonding in which polymer–polymer hydrogen bonds are replaced by polymer–water 
hydrogenbonds [Tao et al., 2007]. At the end of 192 h, SF/PVA (50:50) scaffold is shown to have 
more degradation than SF scaffold which may be attributed to the presence of PVA (-OH group) but 
was found intact in SBF due to water resistance and penetration into the blend system. The presence 
of glycerine as plasticizer of thermoplastic blends, influences the degradation behavior of scaffold.  
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Figure 4.4.10: Weight loss of SF, SF/PVA (50:50) and SEP-(SF/PVA) scaffolds in SBF for different 
time period. The % weight loss of PVA scaffold (uncrosslinked) is not shown due to rapid 
dissolution in PBS within a period of 48 h. 
 
4.4.8. Hydrophilicity 
The wettability of the developed scaffolds was evaluated by contact angle measurement using sessile 
drop technique. The results for different scaffolds (SF, SF/PVA (50:50) and SEP-(SF/PVA)) are 
shown in Table 4.4.2. Results show that scaffold surface of each type is completely wettable. 
However, considerable decrease in water contact angles from 62.4±1.5° to 41.0±1.3° is observed due 
to much hydrophilicity of PVA that further decreases to 39.2±1.1° because of  the conjugation of 
SEP over the scaffold surface. It is evident that conjugation of SEP as hydrophilic components make 
the surface of SF based scaffold more hydrophilic that is suitable for cellular reponse in aqueous 
medium. 
Table 4.4.2: Water contact angles measured on various SF scaffolds 
   
 
 
 
*testing at three different sites for each scaffold 
Exp # Sample  Water contact  
angle (X
o
)* 
1. SF 62.4±1.5 
2. SEP-SF     52.7±1.0 
3. SF/PVA (50:50) 41.0±1.3 
4. SEP-(SF/PVA) 39.2±1.1 
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4.4.9. In vitro CellCulture Study 
 
4.4.9.1. Cell morphology in seeded scaffolds 
Human mesenchymal stem cells (hMSCs) isolated from umbilical cord blood by differential density 
gradient centrifugation and plastic adherence technique are proliferated to achieve required viable 
cell density. The morphology of hMSCs in different culture time (Fig. 4.3.12), was observed and the 
cell culture upto 4th passage were seeded into scaffolds by static method for in vitro culture study. 
The morphology of cell-seeded scaffold (construct) as shown in Fig. 4.4.11, depicts the uniform 
distribution of cells on the scaffolds. hMSCs are observed to be attached and grown well on the 
SF/PVA and SE-(SF/PVA) scaffolds, as evident from SEM images (Fig. 4.4.11). On day 3, hMSCs 
are shown to be attached on the scaffold and formed small cell aggregates, which increased in size 
on day 7.  
 
4.4.9.2. Cell adhesion and proliferation 
The hMSCs proliferation on SF, PVA, SF/PVA and SEP-(SF/PVA) scaffolds was evaluated on day 
1, 3, 7 and 14 using MTT assay. The results of MTT assay are presented in Fig. 4.4.12. As it is 
indicated in figure, SF, PVA, SF/PVA and SEP-(SF/PVA) scaffolds show supported cell viability 
and proliferation. After day 1, the cell count on scaffolds was higher in PVA as compared to SF 
scaffold. SF/PVA scaffold shows intermediate cell count between SF and PVA scaffold. This may 
be due to lowering in hydrophilicity and amorphous component of SF. SEP-(SF/PVA) scaffold has 
lowest value of cell count, may be because of coated SEP over scaffold restricting the cellular 
movement into the pores. On day 3, cell count is decreased due to washing out of non-adhered cells 
from the scaffold. While there is no significant difference in cell proliferation observed with PVA 
and SF/PVA scaffolds, however, the cell viability was found more for SEP-(SF/PVA) scaffold. This 
indicated the improved surface of composite scaffold due to introduction of SEP and proliferation of 
viable cells, capable of moving inside and adhered over scaffold. The SEM images (Fig. 4.4.11) 
show the cell spreading over the SF/PVA and SEP-(SF/PVA) scaffold. hMSCs are observed to be 
well acclimatized with the blended and conjugated scaffold and showed an increase in cell count 
with time. On day 7, while the cell count for SF/PVA were found a little more than SF scaffold, the 
SEP-(SF/PVA) scaffold has shown exponential increase in cell count. The hydrophilicity of PVA 
sample support the cell adherence but with progress in culture, the viability of cells is not supported 
much. Introduction of PVA in SF forming SF/PVA scaffold greatly enhances the cell viability and 
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proliferation. However, SF/PVA scaffold modified with SEP shows the highest cell proliferation, 
representing biocompatibility and surface property enhancement of SEP. The absorbance value 
being much higher in hybrid scaffolds as compared to that of control, confirms that hybrid scaffolds 
(SF/PVA and SEP-(SF/PVA) are having enough pores and desired pore size allowed hMSCs to 
acclimatize and proliferate inside the scaffolds. 
 
 
 
Figure 4.4.11: MTT Assay of hMSCs in SF (control), PVA, SF/PVA (50:50) and SEP-(SF/PVA)  
                         scaffolds for different culture period (1, 3, 7 and 14 days) 
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Figure 4.4.12: SEM of cell-scaffold constructs developed from SF/PVA (a, c, e, g) and SEP-(SF/PVA) 
(b, d, f, h) scaffolds for day 1 (a, b), day 3 (c,d), day 7(e, f) and day 14 (g, h) with umbilical cord 
blood derived hMSCs 
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Figure 4.4.13: H&E stained cross-section of the constructs developed from SF/PVA (a&b) and SEP-
(SF/PVA) (c&d) cultured for 7(a, c) and 14 (b, d) days (Scale Bar: 500µm) 
 
Thus, UCB derived hMSCs on blended scaffolds showed relatively better cell viability and 
proliferation compared to the control. The histology of cell seeded scaffolds was examined after 7 
and 14 days with H&E staining (Fig. 4.4.13). Stained sections of scaffolds were observed using an 
inverted light microscope. Both SF/PVA and SEP-(SF/PVA) scaffolds have shown good 
proliferation of MSCs. These cell viability results based on in vitro MTT assay and H&E staining 
have offer further investigation on scaffold for in vivo testing in biomimic environment involving 
scaffolds direct contact with cells leading to human tissue regeneration.  
 
4.4.10. ALP Activity of Scaffolds 
 
To determine the early osteogenic differentiation of hMSCs on the scaffolds, the alkaline 
phosphatase (ALP) activity of the prepared scaffolds was measured. SF, PVA, SF/PVA (50:50) and 
SEP-(SF/PVA) scaffolds showed an enhanced ALP activity over the culture period of 14 days (Fig. 
4.4.14). In comparison, PVA scaffolds showed slightly lower activity than SF and SF/PVA scaffold 
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(p < 0.01). SF and SF/PVA scaffolds has shown very close ALP activity (p < 0.01), while SEP 
conjugated SF/PVA scaffolds has the highest level of activity (p < 0.05). Elevated level of ALP, a 
marker for osteoblastic phenotype thus confirm enhanced differentiation of hMSCs on SEP 
conjugated scaffolds compared to the SF scaffold [Park et al., 2010]. 
 
 
 
Figure 4.4.14: ALP activity of hMSCs grown on developed scaffolds for 1, 7 and 14 days. Each value 
represents the mean value ± SD (P<0.05, n=3) 
 
 
4.4.11. In vivo Evaluation of Scaffolds 
 
In vivo biocompatibility evaluation of SF/PVA (50:50) and SEP conjugated SF/PVA scaffolds were 
performed using ICR mice model (Fig. 4.4.15). Test animals for both groups of scaffolds were 
recovered after 1 month and showed no inflammatory reactions to host tissue as depicted by H&E 
stained micrographs (Figs. 4.4.16 & 17).  The scaffolds were completely degraded without causing 
any necrosis. All mice were remained healthy and the scaffolds were found encapsulated in thin 
fibrovascular tissues of recipient. Observation made after 7 days showed ﬁbroblasts grown into the 
scaffold with minor inﬂammation around implantation site (4.4.16a &17a). However, after 4 weeks, 
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a large number of ﬁbroblasts were inﬁltrated into the scaffold and the morphology of scaffold was 
similar to the adjacent dermal tissues (Fig. 4.4.16b &17b). Thus the scaffolds are shown to be 
134iocompatible with recipient tissue. 
 
 
 
Figure 4.4.15: Implantation of (a) SF/PVA (50:50) and (b) SEP-SF/PVA scaffold into ICR mice strain 
for in vivo biocompatibility study 
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Figure 4.4.16: Histological section of subcutaneous skin of ICR mice at the site of implanted SF/PVA (50:50) 
scaffolds after (a) 7 days & (b) 4 weeks. Bar indicates 200µm. M: the implanted scaffold site. T: 
the subcutaneous connective tissue. M-T: the meso-dermal site as the interface of scaffold and 
tissue 
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Figure 4.4.17: Histological section of subcutaneous skin of ICR mice at the site of implanted SF/PVA (50:50) 
scaffolds after (a) 7 days & (b) 4 weeks. Bar indicates 200µm. M: the implanted scaffold site. T: 
the subcutaneous connective tissue. M-T: the meso-dermal site as the interface of scaffold and 
tissue 
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Comparison of the results 
A comparison in terms of physico-chemical, thermal and biological properties of the various 
scaffolds developed under study were made as given in Table 4.4.3. It is observed that all the 
prepared scaffolds are shown to have integrated structure with interconnected pore network with a 
slight variation in porosity.  The compressive strength of SF scaffold (279.8 ±36.2 KPa) is increased 
with conjugation with SEP (321.5 ±42.2 KPa), while a decrease in compression strength is observed 
with SF-PVA blend (235 ± 67.1 KPa). A further increase in compressive strength of SF/PVA 
(247.5± 23.7 KPa) is achieved with SEP conjugation which is, however, less than SEP-SF scaffold. 
The wettability of SF scaffolds (62.4±1.5°) are found to be increased with SEP conjugation (SEP-
SF;52.7±1.0°) and blending with PVA polymer (SF/PVA;41.0±1.3°). However, the highest wettable 
surface is obtained with SEP-(SF/PVA) scaffolds (39.2±1.1°) representing better cell support. In 
vitro and in vivo study of all matrices showed cell-supportive behaviour with a varying degree. The 
improved cell adhesion and proliferation were achieved with SF and SF/PVA scaffolds conjugated 
with SEP. However, SEP-SF/PVA scaffold has shown the superior cell adhesion and proliferation 
with hMSCs culture. Comparable cell viability is also achieved with SF-SEP scaffold. Though 
comparatively low compressive stress is shown by SEP-SF/PVA scaffolds, comparing all the 
properties as shown in table and the added advantage ofovercoming the problem of brittleness of SF 
scaffold using PVA, it is established that SEP-SF/PVA is the best scaffold among all the prepared 
SF scaffolds. 
 
Table 4.4.3: Comparison of different SF based matrices based on some of the key properties 
*Swelling (%) after 48 hrs., **Wt. loss (%) after 192 hrs., 
±
Contact angle,
 ±±
OD of MTT on 14
th
 days of culture 
Sl.  
No. 
Porous  
Matrices 
Compressive 
Strength   
Swelling 
Index (%)* 
Wt. Loss 
(%)** 
Wettability 
(Degree)
±
 
Cell Count 
(OD)
±±
 
Porosity 
(%) 
Morphology 
1.. SF Scaffold 279.8 ±36.2 KPa 133.36 % 1.89% 62.4±1.5 0.49 90-93% Porous & 
interconnected  
2.. SF-SEP  321.5 ±42.2 KPa 138.42% 2.38% 52.7±1.0 0.67 85-90% Less porous & 
interconnected 
than SF 
3. SF/PVA (50:50)  235 ± 67.1 KPa 227.06% 3.07% 41.0±1.3 0.517 90-92% Porous and 
interconnected 
4.. (SF/PVA)-SEP  247.5± 23.7 KPa 254.9% 4.66% 39.2±1.1 0.693 83-87% Less porous & 
interconnected 
than SF/PVA 
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             SUMMARY & CONCLUSION 
 
In recent years tissue engineering has been considered as a promising alternative to the conventional 
clinical method for the treatment of patients suffering from tissue related diseases. The development 
of tissue engineered scaffold from a variety of biopolymers with a set of desired properties that can 
mimic the extracellular matrix is the key aspect of this new technique. In this context, silk fibroin is 
considered as a promising biopolymer to use as a scaffold material.  Keeping this in view, the 
present work has been undertaken to develop silk fibroin (SF) based scaffolds with improved 
surface, mechanical and biological properties by blending with other polymers and modified with 
additive as surface enhancer. The outcome achieved through this research work is summarized as 
follows: 
 
Part I: In the first phase of the dissertation work, silk fibroin solution was prepared from B. mori 
silk cocoon. Silk fibroin was extracted from raw silk cocoon by degumming method. The effect of 
key parameters on the extraction process was investigated to find the most favorable degumming 
condition. The optimum condition thus established as 0.02 M aq.Na2CO3, 70°C and 60 min 
degumming time achieving maximum amount of SF with maximum removal of sericin.  
 
SF solution was prepared by the dissolution of SF in LiBr solution. The maximum solubility of silk 
fibroin was achieved at 9.3M LiBr concentration, 70°C and 3 hrs of treatment time. The SF solution 
was characterized by SDS-PAGE and particle size analysis. The extraction process was further 
optimized by Response Surface Methodology using Box-Behnken Design. The solution thus 
prepared was used as biopolymer for the development of scaffolds.  
 
Part II:  In this phase of study, an effort has been given for the preparation, characterization and in 
vitro biocompatibility study of silk fibroin hydrogel for its possible use in tissue engineering. A 
structurally and thermally stable fibroin hydrogel with well interconnected and open pores was 
prepared with β-oriented close network of fibroin molecules. Morphologically, the hydrogels show 
a sponge-like cross-linked structure formed by physical entanglement as well as chemical bonding 
envolving hydrogen and covalent bonds. The rheological and swelling behaviors of fibroin hydrogel 
were appreciable at 37ºC representing to mimic the body tissue. Thermal analysis supported the 
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prepared hydrogel as biomaterial with degradation characteristics suitable for human in vivo 
application. The cytocompatibility study by hMNCs culture has shown that the three-dimensional 
network of SF hydrogel facilitated cell adherence, cell proliferstion and distribution throughout the 
scaffold. Thus it is concluded that the SF hydrogel is suitable as injectable biomaterial for soft 
tissue engineering.  
 
Part III: In this part of the thesis work, an attempt has been made for the improvement of the 
surface properties of the SF scaffold. SF scaffolds were fabricated by salt leaching technique using 
NaCl as porogen. The effect of particle size of porogen was investigated and found to have a great 
influence on the pore size and porosity of the prepared scaffolds. The pore size and porosity of SF 
scaffold were measured as 70-350 µm and 85-93%.  SF scaffolds were further modified with 
soluble egg cell protein (SEP) with the intention to improve its surface properties for better cell 
attachment and proliferation. The elemental analysis, XRD, FTIR, DSC and TGA study confirm 
successful conjugation of SEP over SF scaffold and structural and thermal stability of the modified 
scaffold. The pore size of the modified scaffold (SEP/SF) is found to be in the range 200-300 µm 
with porosity 85-90%. An increased compressive strength of SEP/SF scaffold is achieved (321.5 
±42.2 KPa) in comparison to SF scaffolds (279.8 ±36.2 KPa).  The modified scaffold has further 
shown to have enhanced hydrophilicity (52.7±1.0 contact angle with water droplet) representing 
more favorable to in vivo application as compared to SF scaffold as control.  
 
The in vitro cell culture study has shown a significantly higher cell adhesion and proliferation on 
the conjugated scaffold in comparison to SF scaffold.  The in vivo animal model evaluation depicted 
the biocompatibility of SEP-SF scaffolds. Therefore, this study has demonstrated that the porous SF 
scaffolds modified with SEP offers enhanced cell adhesion and proliferation and hence improved 
biocompatibility to facilitate its application in practical tissue engineering. Furthermore, the non-
inflammatory response towards host ICR mice model indicated in vivo biocompatibility of the 
scaffold. 
 
Part IV: It is evident from literature that the brittleness of SF scaffolds limits their use in tissue 
engineering. Poly vinyl alcohol (PVA), a synthetic polymer has excellent hydrophilicity, 
biocompatibility and biodegradability property. It is reported that the blending of SF with PVA can 
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reduce the crystallinity and improves the surface property as well. Therefore, in this phase of 
dissertation work, efforts have been given to develop SF/PVA scaffold by blending these two 
polymers followed by salt leaching. The SF/PVA blend was also modified with SEP to investigate 
its effect on the further improvement of the properties of SF/PVA scaffold. As in part III, three 
dimensional porous SF/PVA and SEP modified SF/PVA (SEP-SF/PVA) scaffolds were prepared by 
salt leaching method using NaCl as porogen. These scaffolds exhibited a hierarchical structure with 
interconnected macropores of different pore size range depending on particle size of porogen. The 
results have shown that the proportion of PVA to SF has a great impact in controlling porosity and 
interconnectivity of scaffold. FTIR spectroscopy associated with XRD has proven to very powerful 
tools for investigating the formation of conjugated and unconjugated SF/PVA blend scaffolds. 
Among the various SF/PVA scaffolds prepared with different blend ratio, SF/PVA (50:50; 230-360 
µm) and SF/PVA (75:25; 250-360 µm)have shown most favorable pore size range, but since the later 
has more fragile nature causing mechanical stiffness, SF/PVA (50:50; 230-360 µm) is most 
preferred for tissue engineering application. The SF/PVA and SEP-SF/PVA have the desired 
compressive strength though the compressive strength is lower than that of SEP/SF scaffold. The 
corresponding compressive strength of SF/PVA and SEP-SF/PVA are 235 ± 67.1 KPa and 247.5± 
23.7 KPa respectively. Further, the swelling and degradation of SEP-SF/PVA scaffolds were higher 
due to enhanced hydrophilicity (39.2±1.1 contact angle) compared to SF/PVA (50:50) scaffolds 
(41.0±1.3) and other SF scaffolds developed in this study. 
 
The cytocompatibility of the scaffolds were confirmed by cell viability (MTT) assays. The SF/PVA 
scaffold was observed to support cell attachment and proliferation during culture of hMSCs in 
SF/PVA scaffolds. The cell proliferation result was similar to the result observed with SF scaffolds.  
 
However, significantly increase in cell proliferation and cell spreading were observed with SF/PVA 
scaffold conjugated with SEP. Furthermore, the in vivo biocompatibility of the scaffolds was 
confirmed by animal testing using ICR mice model. 
 
Furthermore, though comparatively low compressive stress is shown by SEP-SF/PVA scaffolds, 
comparing all the other properties and the added advantage of overcoming the problem of 
brittleness of SF scaffold using PVA, it is established that SEP-SF/PVA is the best scaffold among 
all the developed SF scaffolds under study. 
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Overall, the research provides a potential SEP conjugated SF/PVA scaffold (SEP-SF/PVA that has 
the superior surface property (hydrophilicity), biological property (cell adhesion and proliferation) 
and compressive strength desired for its use in tissue engineering. It has been further demonstrated 
that SEP is an excellent additive that can be used as surface modifier for the scaffold biomaterials.  
Thus it is concluded that the SEP-SF/PVA can be a potential artificial extra cellular matrix 
particularly for soft and other non-load bearing tissue engineering applications. SEP conjugated 
SF/PVA scaffolds could be further designed utilizing more advanced fabrication technology 
according to patient prerequisite. Furthermore, developed scaffold material may be mechanically 
improved to make it suitable for hard tissue engineering.   
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